The Effect of CLN3 Disease on Organellar Characteristics by Coode, Emily
Open Research Online
The Open University’s repository of research publications
and other research outputs




Coode, Emily (2021). The Effect of CLN3 Disease on Organellar Characteristics. PhD thesis The Open University.
For guidance on citations see FAQs.
c© 2021 Emily Coode
https://creativecommons.org/licenses/by-nc-nd/4.0/
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.21954/ou.ro.0001368c
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright











Emily Coode, BSc, MSc 
 
A Thesis submission to The Open University 
for the degree of Doctor of Philosophy 
 
Faculty of Science, Technology, Engineering 
and Mathematics 
 










I declare that the work presented in this thesis is my own original work and does not contain any 
material submitted for any other qualification at the Open University, or any other University. 










CLN3 disease, or juvenile dementia, is a lysosomal storage disorder with largely neurological 
symptoms. Towards the end of their lives, individuals with CLN3 disease develop a cardiac 
phenotype, which has not yet been systematically studied. On a cellular level, mutations in CLN3 
have been shown to disrupt the endo-lysosomal system. However, the function of the CLN3 protein, 
which is localised on the lysosomal membrane, is still unknown. 
Positioning of lysosomes is affected by the physiological state of a cell and can be changed in 
diseases. This study developed a powerful assay for the automated analysis of lysosomal movement 
and positioning. This assay was then applied to study different cell lines with mutations in their 
CLN3 gene, specifically a CLN3 knockout HeLa cell line and patient-derived fibroblasts with two 
different CLN3 mutations. Lysosomal movement was found to be reduced in CLN3 patient 
fibroblasts. Additionally, the calcium signalling, mitochondrial membrane potential and responses 
to oxidative stress were characterised in the cells. These were found to be not affected by the 
mutations in CLN3.  
Another part of this study aimed to characterise changes in the structure and function of cardiac 
myocytes in CLN3 disease. This was approached in two ways: Firstly, changes in the structure of 
ventricular cardiac myocytes were investigated in hearts from mice with a common mutation 
causing CLN3 disease. Hearts from animals of three different ages were analysed, and changes in 
the mitochondria were found. Surprisingly, only little of the storage material, characteristic for 
lysosomal storage disorders, was found. Secondly, iPSC-derived cardiac myocytes were to be used 
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1.1 The Neuronal Ceroid Lipofuscinoses 
The Neuronal Ceroid Lipofuscinoses (NCLs) are hereditary lysosomal storage diseases, 
characterised by an accumulation of fluorescent proteins in cells (Palmer et al., 2013). The NCLs 
broadly share clinical symptoms of a progressive dementia, although specific symptoms, onset and 
prognosis depend on the subtype. NCL diseases are classified by gene, although the age at which 
the first symptoms emerge is still taken into consideration. In some NCLs such as CLN1, age of onset 
may vary from infantile to adult (Schulz and Kohlschutter, 2013). 
1.2 Juvenile NCL: CLN3 disease 
The most common NCL is CLN3 disease, which has a typical age of onset between 4 and 8 years old 
(Schulz et al., 2013). CLN3 disease is also referred to as Juvenile NCL (JNCL) and in this subtype, age 
of onset is consistently in juvenile years (Schulz and Kohlschutter, 2013). In some cases, CLN3 
disease may be referred to as Batten disease, a name which is also used for other NCLs. Throughout 
this report, the juvenile NCL will be referred to as CLN3. 
1.3 Clinical progression and prognosis 
One of the earliest indicators of CLN3 disease is eyesight deterioration, which is often the trigger 
for referral and eventual diagnosis of CLN3 in a patient (Ouseph et al., 2016). Previously, eyesight 
deterioration has been discussed in context as a precursor to the onset of other CLN3 symptoms 
(Schulz et al., 2013). However, a recent clinical study has indicated that cognitive decline is already 
present at age of diagnosis and this may therefore be present alongside eyesight deterioration 
(Kuper et al., 2018). Another early symptom is a behaviour and mood change, followed by the start 
of progressively worsening seizures. The final dementia like symptoms include a decline in motor 
function and speech. Finally, cardiac symptoms emerge, typically in the second decade, towards 
the end of life (Schulz et al., 2013). 
While the majority of CLN3 patients will deteriorate at a similar pace and the onset of symptoms 
follows an expected pattern, there are cases of protracted CLN3, where age of onset is later, 
progression is slower and death is later (Sarpong et al., 2009). Statistical analysis of data from 
around 60 CLN3 patients found that gender differences and the disease emerged on average 1 year 
later in females, but in the 226 recorded patient deaths, the average was 1 year earlier in females 
(Cialone et al., 2012). The same study also found that female patients were reported to have a more 
rapid deterioration in quality of life due to CLN3 symptoms (Cialone et al., 2012). The genetic 
variation in CLN3 disease is also linked to the disease progression, with less common mutations 
being responsible for protracted or delayed CLN3 cases (Sarpong et al., 2009, Licchetta et al., 2015, 
Cortese et al., 2014). 
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1.4 The CLN3 gene and CLN3 protein 
The CLN3 gene is located on chromosome 16 (16p2.1.) (Mole, 2017). There are a number of 
mutations responsible for CLN3 disease, however the most common is a 1.02kb deletion of exons 
7 and 8 is responsible for ~74% homozygous cases and ~22% heterozygous cases paired with a rarer 
mutation. The remaining ~4% have a combination of rare mutations (Cotman and Staropoli, 2012). 
The progression of CLN3 may depend on the mutation responsible and patients with the rarer 
mutations may follow a protracted course when compared to the 1.02kb deletion (Sarpong et al., 
2009, Licchetta et al., 2015, Cortese et al., 2014). CLN3 disease is an autosomal recessive genetic 
disorder, which means that both inherited genes are mutated, and the presence of a normal gene 
renders the individual a carrier, with no CLN3 phenotype.  
It has been proposed that some CLN3 protein function remains in CLN3 patients with the 1.02kb 
deletion (Kitzmuller et al., 2008). However, this has been directly refuted by a further study which 
claims that the results are an artefact of inadequate methods (Chan et al., 2008). Without deviating 
too far into a discussion of genetics, there is clearly some debate over the mouse models and the 
methods used to investigate them. More recently, the significance of genetic background in CLN3 
mouse models has been investigated to compare the neurological phenotype closest to CLN3 
(Kovacs and Pearce, 2015). 
The CLN3 gene encodes the CLN3 protein, also known as battenin, which is primarily found located 
on the lysosomes, but has also been identified in Golgi, mitochondria, lipid rafts and in neurons, 
also in the synapse (Kyttala et al., 2006). Lysosomes are intracellular organelles known primarily for 
their role in engulfing, digesting and clearing waste material from the cell, as part of the processes 
of endocytosis and autophagic flux (Ballabio, 2016, Walkley, 2009). Interestingly, CLN3 protein 
expression may not be static; a study in baby hamster kidney cells found that lysosomal location 
was altered by osmotic stress. An increase in osmotic stress increased CLN3 protein expression in 
lysosomes, particularly around the nucleus (Getty et al., 2013). 
The CLN3 protein has been hypothesised to have 6 transmembrane domains and may function as 
a transporter, due to the similarities between the SLC29 family of transporters and several of the 
major facilitator superfamily (Cotman and Staropoli, 2012). The SLC29 family of proteins transport 
nucleosides and nucleobases and are found in a range of cell types, with two being characterised 
on plasma membranes and perinuclear membranes (Baldwin et al., 2004). The MFS proteins are a 
large family of transporters which carry a range of materials including sugars, amino acids, inorganic 
anions and cations and more (Cotman and Staropoli, 2012). A direct link has been established 
between MFS proteins and the NCLs, as mutations encoding the lysosomal transporter MFSD8 is 
responsible for the late-infantile NCL, CLN7 (Kousi et al., 2009).  
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1.5 The cellular effects of CLN3 disease 
The key cellular pathology of CLN3 disease is the abnormal accumulation of lipofuscin, which gives 
its name to the NCLs. In addition to the accumulation in NCL, lipofuscin is described as a normal 
product of cellular senescence and accumulation is expected with age in healthy cells (Katz and 
Robison, 2002). There is currently no consensus on the exact origin of lipofuscin, even in healthy 
cells, but the most accepted theory is a failure in degradation of mitochondria via the autolysosomal 
pathway (Marani et al., 2009). Lipofuscin is not identical in composition in all cells, depending on 
type, animal and origin, for example the ageing process of senescence, or a disease such as the 
NCLs (Katz and Robison, 2002, Marani et al., 2009). Other cellular effects include a disruption in 
Ca2+ handling and upregulation of autophagy (Chandrachud et al., 2015). 
1.6 Models of CLN3 disease 
There are many CLN3 models available from patient derived or CRISPR-engineered stem cells, to 
simple model organisms such as zebrafish, yeast and Drosophila for genetic analysis, as well as more 
complex animal models such as mouse and pig.  
In addition to the wide range of cells and animals available, there are multiple CLN3 mutations. Due 
to the prevalence of the 1.02kb deletion in CLN3 patients, this mutation is desirable for studying in 
a model of CLN3 as it captures the disease as it is expressed in the majority of cases and therefore 
holds the greatest impact. Nonetheless, the rarer mutations are important, especially as the disease 
course is known to be altered, which could improve understanding of CLN3 as a whole, including 
the function of the gene/ protein. Furthermore, as a rare disease which is still anecdotally difficult 
to obtain a diagnosis for, the rarer mutations may be more common in populations that currently 
have poor awareness and diagnosis of CLN3. Regardless, when considering an area of CLN3 which 
is poorly researched such as the heart, the starting point will be the common 1.02kb deletion in 
order to contribute the greatest value and achieve comparison to the studies in other cell types.  
The use of patient cells in CLN3 research enables a range of assays requiring only cell culture for 
cultivation. Patient cells have a significant advantage over animal models, as they represent the 
human disease without the complication of variation between species. Patient derived cells do not 
require interference to knock-in the mutation as the genotype is already present and identical to 
the patient. Additionally, iPSC technology allows the possibility of access to a wide range of cell 
types from a living patient without invasive biopsy. On the other hand, a limitation of patient cells 
is the difficulty of acquiring a control cell line from and age- and gender-matched healthy donor. 
The relatively new gene editing technology CRISPR Cas9 does provide the possibility of obtaining 
an isogenic control for the CLN3 cells by repairing the mutation. The creation of CLN3 cells from a 
healthy donor, ideally a healthy sibling of the patient, or rescue of patient cells could in either case 
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would generate a good control, removing concerns over variation between cell lines and genetic 
background. 
For all cell culture models of disease there are two major flaws; the lack of longitudinal changes 
related to the development of CLN3 in a living being, and the full complexity of an organ, including 
multiple cell types. For example, the heart would be comprised of cardiac myocytes, as well as 
fibroblasts. Animal models address both the lack of longitudinal changes and provide whole organs 
to study. This is especially relevant for the heart, as an animal model will include the full conduction 
system. Therefore, a mouse model captures not only the cellular pathology in the cardiac myocytes, 
but provides an option to measure the system as a whole, which could be relevant in CLN3 patients 
as the symptoms can include arrhythmias and could be a result of aberrant pacing through the sinus 
and atrioventricular nodes (Reske-Nielsen E, 1981, Ostergaard JR, 2011). Animal models are 
therefore a valuable tool for research; but for research purposes they may be best used alongside 
human cells in order to make full use of the advantages of both models and to address their 
weaknesses. 
1.7 Induced pluripotent stem cells (iPSCs) 
First successfully published in 2006, the ability to differentiate human fibroblasts into a different 
cell type by inducing pluripotency is a powerful research tool (Takahashi and Yamanaka, 2006). 
iPSCs allow researchers to culture human patient cells carrying the desired mutations, which can 
then be differentiated to the cell types found within an organ of interest, such as the heart.  
iPSC derived cardiac myocytes (iPSC-CMs) were studied and had action potential and ion channel 
characteristics comparable to adult cardiac myocytes; but a greater number of action potentials, 
spontaneous beating and other subtle differences in electrophysiological properties (Ma et al., 
2011). A similar study confirmed that although successfully able to observe disease phenotypes in 
the iPSC-CMs, once again spontaneous beating and alterations to electrophysiological properties 
indicated immaturity (Hoekstra et al., 2012). Arrangement of t-tubules is important in ventricular 
myocytes and is important for the global Ca2+ transient (Bootman et al., 2011) although these are a 
key feature which are under-developed in iPSC-CMs (Cadet and Kamp, 2017). A review of iPSC 
derived cardiac myocytes in research, although acknowledging the immaturity of the iPSC-CMs, 
summarises and describes the successful analysis of several congenital diseases including 
dysfunctions of ion channel intracellular communication and intrinsic cardiomyocyte dysfunction 
such as Cardiomyopathy (Yang et al., 2015). However, a study of ageing iPSC-CMs was able to 
identify markers such as lipofuscin from day 18 in culture, more pronounced at day 24, suggesting 
a window in which iPSC-CMs are able to mature to a certain extent in culture (Kim et al., 2013). 
Based on literature, iPSCs cannot be expected to behave exactly as adult cardiac myocytes, but for 
the vast majority of diseases are a suitable model to capture changes alongside an appropriate 
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model (Ma et al., 2011, Hoekstra et al., 2012, Yang et al., 2015). The challenge will be identifying 
the CLN3 markers in iPSC-CMs. iPSC technology has been used in the generation of cell types for 
several lysosomal storage disorders. While the strengths of iPSC derived cells are acknowledged, 
concerns are raised such as the possible influence of disease metabolism on the differentiation 
process, the lack of matching control and the possible limitations arising from the relative 
immaturity of the cells (Borger et al., 2017). For CLN3, an iPSC-derived neuronal cell line containing 
homozygous 1.02kb deletion has been established and presents the expected CLN3 cellular 
pathology (Lojewski et al., 2014). 
1.8 Mouse models 
There are two primary models of the common 1.02kb deletion in mice, a knock-out and knock-in. 
The global knock-out mouse was generated by partial deletion of exon 1 and complete deletion of 
exons 2-6, denoted as Cln3-/- and the resulting mouse has a CLN3 phenotype (Mitchison et al., 1999). 
The global knock-in mouse model inserts a ~1kb deletion at exons 7-8 in order to mimic the deletion 
in the human disease, denoted Cln3Δex7/8 and again the CLN3 phenotype was observed in the mice 
(Cotman et al., 2002). At present, both models are generally accepted, however the knock-in 
Cln3Δex7/8 mouse model is considered to be the closest genetically (Staropoli et al., 2012). 
Subsequent publications have reiterated the CLN3 phenotype such as vision loss and markers 
including vacuolated peripheral blood lymphocytes in blood identifiable in this mouse model, which 
has been inbred and provides a good match to human patients (Staropoli et al., 2012, Brenneman 
et al., 2017). 
Contrary to expectation, behavioural analysis of male and female mice of multiple genetic 
backgrounds, from models Cln3Δex7/8 and Cln3-/-, found that Cln3-/- was most suitable in capturing 
the CLN3 cognitive phenotype, specifying the male and genetic background 129S6/SvEv (Kovacs 
and Pearce, 2015). However, it is important to consider that this study was exclusively based on 
behavioural analysis which is severely limiting in relevance to research into the functional effect on 
organs and subtle cellular changes which may not express as a behavioural phenotype. 
Furthermore, the recommendation to use the male mouse based on earlier onset of symptoms may 
not be taking into consideration the known differences between male and female mice, which is 
reflected in the human course of CLN3 disease (Staropoli et al., 2012, Cialone et al., 2012). Taking 
this into consideration, it would seem inappropriate to dismiss the female mouse model. Moreover, 
it is widely discussed and acknowledged in the research community that heart dysfunction outside 
of CLN3 disease is affected by sex, for example physiological differences between the sexes cause 
twice as many incidences of heart failure with preserved ejection fraction in women compared to 
men (Eisenberg et al., 2018). Considering that sex is implicated in the progression of CLN3 disease, 
and that decline in heart function in non-CLN3 patients is linked to sex, studies of the heart in CLN3 
should not be exclusively limited to a single sex. 
Page 6 of 264 
 
1.9 The heart in CLN3 disease  
Cardiac symptoms of CLN3 have been described in clinical research multiple times in studies of 
individuals or groups of patients (Reske-Nielsen E, 1981, Michielsen et al., 1984, Tomiyasu et al., 
2000, Ostergaard JR, 2011, Dilaveris P, 2014). Figure 1 and Figure 2 illustrate the range of cardiac 
abnormalities which are identified in the studies discussed below. 
 
Figure 1. The mammalian heart and changes in CLN3. (a) Simple illustration of the heart and its 
chambers. Action potentials originate from the sinoatrial node (SA), pass through the 
atrioventricular node (AV) and then travel through the heart as illustrated by the blue arrows. CLN3 
can cause; (b) cardiac hypertrophy, an enlarged heart, and (c) left ventricular hypertrophy, an 
increase in mass on the left ventricle. 
One of the earliest papers (referring to CLN3 as ‘Juvenile Amaurotic Idiocy’) examined a 
combination of ECG history where available and post-mortem results on 13 CLN3 patients and 
describes a range of cardiac disorders. These included; cardiac enlargement, abnormal p-waves, 
increased atrial and diastolic pressure, bradycardia and a right bundle branch block Figure 1 (Reske-
Nielsen E, 1981). This paper was published in 1981, based on the 13 patients who died over 7 years. 
The authors state that death is typically around age 20, although current papers suggest that CLN3 
patients can live for a decade beyond this, which may reflect the more advanced knowledge and 
healthcare available to CLN3 patients (Schulz et al., 2013). Therefore, as patients live longer after 
the onset of cardiac symptoms, it is of greater importance that these symptoms are addressed and 
quality of life can be improved. 
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Figure 2. Electrocardiograms illustrating changes in CLN3. (a) A normal electrocardiogram showing 
the P wave as atrial contraction (systole), QRS wave as ventricular contraction (systole) and T wave 
as relaxation (diastole). An illustration of some changes in CLN3; (b) bradycardia, (c) atrial flutter, 
(d) inverted T wave and (e) right bundle branch block. 
A study of 29 CLN3 patients found cardiac abnormalities from age 14, increasing with age. For 
example, an inverted T wave was identified in no patients aged <14 years, 15% patients aged 14-19 
and 86% aged >19 years (Ostergaard JR, 2011). Other findings included hypertrophy of the left 
ventricle, bradycardia, atrioventricular block, atrial flutter and sinus arrest. During the study, the 
cause of death in 2 of 10 patients was heart failure at the age of 26-27 and the authors recommend 
monitoring CLN3 patients, with increased regularity from the age of 18 (Ostergaard JR, 2011). 
A nationwide study of people aged between 14 and 35 years, provides some insight into cardiac 
abnormalities within the normal population (Chandra et al., 2014). This study found inverted T 
waves in only 2.8% of their non-athlete group, far lower than the incidences described in CLN3 
patients. Interestingly, the study did show that some abnormalities were not uncommon, such as 
sinus bradycardia in 26.1% and isolated left ventricular hypertrophy in 24.7% of the young non-
athlete participants (Chandra et al., 2014). 
A case study describes a hemodynamically unstable 32 year old CLN3 patient, with a low blood 
pressure and heart rate of only 36 beats per minute. An echocardiogram showed severe 
abnormalities, in addition to hypertrophy of the left ventricle. The authors report that a pacemaker 
not only improved alertness, but also improved dysphagia, a difficulty in swallowing (Dilaveris P, 
2014). While this is only one patient, there is a strong indication that treatment of underlying 
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cardiac abnormalities can improve quality of life and have an impact beyond the direct cardiac 
symptoms.  
In addition to the clinical reports, cardiac abnormalities are described in animal models. For 
example, an enlarged heart and abnormal shape in comparison to the control was also observed in 
the zebrafish model of CLN3, although functional effects were not further investigated by the 
authors (Wager et al., 2016). In the CLN3Δex7/8 mouse model, the average weight of the heart was 
found to be greater than the control at 20 weeks, however there was no significant effect on heart 
function (Staropoli et al., 2012). While there was no obvious phenotype in the mouse model, the 
lipopigment accumulation observed in the mouse cardiac cells is comparable to the accumulation 
observed in human disease (Reske-Nielsen E, 1981, Staropoli et al., 2012). 
Although cardiac dysfunction is not at the forefront of CLN3 research and even the symptoms are 
not widely reported, there is plenty of evidence showing that CLN3 affects the heart, which may be 
of greater significance as patients live longer with improved care and the possible therapeutic 
intervention. Therefore, research must consider the effect of CLN3 on the heart to improve quality 
of life and reduce the risk of death from heart failure. 
1.10 CLN3 research in the cell 
In the single cell, Ca2+ interacts with a variety of proteins to inhibit or initiate a range of events 
(Bootman, 2012). These can include differentiation, transcription of genes and in muscle cells, 
contraction (Bootman, 2012). Cardiac myocytes are the muscle cells responsible for the contraction 
of the heart. Contraction of the heart pumps blood through the chambers and into the body and 
lungs. To be effective, timing has to be strictly paced by an electrical impulse originating from the 
sinoatrial node. Excitation-contraction coupling is the process through which the electrical impulse 
triggers the contraction; mediated by Ca2+ release (Bers, 2008). The arrival of the action potential 
causes depolarisation of the cardiac myocytes, an opening of the L-type voltage-gated Ca2+ channels 
and subsequent release of Ca2+, which in turn activates the ryanodine receptors and causes a larger 
Ca2+ release from the sarcoplasmic reticulum (Fearnley et al., 2011). The contraction itself is a result 
of Ca2+ binding to troponin, shortening the muscle fibres in order to cause a contraction of the 
entire chamber when all cardiac myocytes in a chamber contract simultaneously (Eisner et al., 
2017). 
If excitation-contraction coupling is altered, the resulting cardiac changes can be responsible for a 
range of cardiac diseases (Bootman, 2012). Consequently, Ca2+ has a significant role in the heart. 
To summarise; during systole, the heart contracts and the cytosolic Ca2+ concentration is increased. 
During diastole, the drop in the cytosolic Ca2+ concentration causes troponin to release from the 
myofilaments and the heart muscle relaxes (Eisner et al., 2017).  
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Fluorescent indicators can be used to measure Ca2+ in living cells, enabling characterisation of Ca2+ 
signalling such as Ca2+ release during an action potential or spontaneous activity observed in 
excitable cells like cardiac myocytes (Bootman et al., 2013). 
Changes in the calcium signalling have been described for several diseases. These can, for example 
be changes in the ER Ca2+ content and ER Ca2+ release characteristics, as commonly found in heart 
dysfunctions (Roderick et al., 2007), changes in the Ca2+ entry following the emptying of the 
endoplasmic reticulum (ER) in cellular immune functions (Shaw and Feske, 2012) and persistent 
increase in the cytosolic Ca2+ concentration found in Alzheimer’s disease and affecting the memory 
formation (Berridge, 2014).. These alterations to calcium signalling, alongside changes in the 
lysosomal Ca2+ concentration, have been described for several neurodegenerative disorders. For 
example, patient cells from the lysosomal storage disorder Niemann-Pick disease type C (Feng and 
Yang, 2016, Lloyd-Evans, 2016). While cells from patients with mucolipoidosis IV, based on a 
mutation in the TRP-ML1 channel, showed an increased lysosomal Ca2+ concentration (Ruas et al., 
2010). Cerebellar cells from the Cln3Δex7/8 mouse model showed an elevated lysosomal Ca2+ 
concentration and an increased Ca2+ leak from cells (Chandrachud et al., 2015). 
CLN3 is classed as a lysosomal storage disorder, which is a group of diseases in which lysosomes are 
unable to process waste material normally, resulting in an accumulation of lysosomes containing 
only partially digested waste products. 
Lysosomes are also established intracellular Ca2+ stores. Despite their large number, their small size 
means that the total lysosomal calcium concentration is similar in magnitude to that stored in the 
ER ~500µM (Lloyd-Evans, 2016). However, a small Ca2+ release from lysosomes is capable of 
triggering Ca2+ release from the much larger ER and therefore can have a significant impact on Ca2+ 
signalling (Calcraft et al., 2009). Lysosomes also play a role in cell signalling via mechanisms such as 
mTORC1 (Ballabio, 2016). Lysosomal storage disorders are known to primarily affect vulnerable cell 
types such as neurons and this is reported as being due to the signalling events and the lack of new 
cells due to terminal differentiation (Walkley, 2009). 
In the cell, lysosomes are numerous and not static. Position of lysosomes is understood to be linked 
to BORC, a complex of 8 subunits involved in the kinesin dependent movement (Pu et al., 2015). 
Lysosomes are known to travel along microtubules and in some conditions, including lysosomal 
storage disorders, are known to collect at the nucleus (Pu et al., 2016). Interestingly, an increased 
expression of the CLN3 protein has been linked to lysosomes at the perinuclear location in the 
condition of osmotic stress (Getty et al., 2013). Unfortunately, due to the lack of specificity of CLN3 
antibodies, this is difficult to measure (Nelson et al., 2017). However, it is still a finding that would 
be interesting to correlate with other stress conditions, age, Ca2+ activity and finally the size, 
movement and other characteristics of lysosomes themselves. 
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In the heart, autophagic flux has been found to be down regulated with age, associated with an 
increase in waste material such as lipofuscin and damaged mitochondria which in turn is linked to 
the increased weakness and risk of disease in an ageing heart (Shirakabe et al., 2016). Autophagy is 
also closely regulated by changes in the Ca2+ concentration, which is considered an important 
signalling process (Bootman et al., 2018). Autophagosome accumulation has been observed in CLN3 
cerebellar cells and the link between Ca2+ and autophagy is further strengthened by the reversal of 
this accumulation by Ca2+ chelation (Chandrachud et al., 2015). Another study in cerebellar cells 
from the Cln3Δex7/8 mouse model found that an upregulation in autophagy (Cao et al., 2006). 
However, to our knowledge, nobody has so far undertaken a detailed characterisation of the 
autophagic flux in CLN3 cells.  
Mitochondria are organelles found in the cytoplasm, contained within a double membrane and 
containing separate DNA which contributes to encoding mitochondrial proteins. These organelles 
utilise fatty acids and carbohydrates to produce ATP as an energy source for a range of cellular 
activities (Cooper, 2000). Mitochondria are a Ca2+ store and this function is closely linked to 
autophagy; namely that a reduced Ca2+ uptake is known to trigger autophagy (Bootman et al., 
2018). 
Accumulation of mitochondrial subunit c is a well characterised marker of CLN3 disease affected 
cells, as a component of lipofuscin (Kominami et al., 1992). However, in addition to the 
accumulation of defective subunits, a change in mitochondrial function as a whole is implicated in 
CLN3 disease. A decrease of mitochondrial function has been found in CLN3-/- mice (Luiro et al., 
2006). In the CLN3Δex7/8 model, mitochondria were found to be elongated while a decreased level 
of intracellular ATP and increased death as a result of oxidative stress indicates further 
mitochondrial abnormalities (Fossale et al., 2004). 
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2 Chapter 2: Materials and Methods 
 
2.1 Materials 
The materials used in this thesis are detailed in Table 1, including supplier number and application. 
For materials relating to the culture and differentiation of induced pluripotent stem cells, these can 
be found in Chapter 8. 
 
Table 1. Materials: supplier, catalogue number (Cat. #) and application. 
Description Supplier Cat. # Application 
Dulbecco's Modified Eagle Medium 
(DMEM) high glucose, GlutaMAX™  
Fisher/Gibco 61965-026 Cell culture 
Penicillin-Streptomycin (10,000 
U/mL) 
Fisher/Gibco 15140-122 Cell culture 
Fetal Bovine Serum Sigma F7524 Cell culture 
Dulbecco's Phosphate Buffered 
Saline (DPBS) -CaCl2 -MgCl2 
Fisher/Gibco 21600-010 Cell culture 
0.25% Trypsin EDTA (1X) Fisher/Gibco 25200-056 Cell culture 
HBSS (1X) +CaCl2 +MgCl2 Fisher/Gibco 14025-050 Loading/imaging 
FluoroBrite DMEM Fisher/Gibco A18967-01 Loading/imaging 
GlutaMAX -I (100X) Fisher/Gibco 35050-038 Loading/imaging 




Pluronic™ F-127, low UV 
absorbance 
Fisher/Invitrogen P6867 Solvent 
Cal-520 AM AAT Bioquest 21130 Indicator 
Rhod-2, AM, cell permeant Fisher/Invitrogen R1244 Indicator 
LysoTracker™ Red DND-99 Fisher/Invitrogen L7528 Probe 
LysoTracker™ Green DND-26 Fisher/Invitrogen L7526 Probe 
CellLight™ Lysosomes-GFP, 
BacMam 2.0 
Fisher/Invitrogen C10596 Probe 
CellLight™ Lysosomes-RFP, BacMam 
2.0 
Fisher/Invitrogen  C10504 Probe 
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Tubulin Tracker™ Green (Oregon 
Green™ 488 Taxol, bis-acetate) 
Fisher/Invitrogen T34078 Probe 
MitoTracker™ Green FM Fisher/Invitrogen M7514 Probe 
Hoechst  Fisher/ Pierce  62249 Probe 
TMRE  Sigma  87917 Indicator 
ROS Brite™ 570 Stratech 16000-AAT Indicator 
Adenosine 5'-triphosphate 
disodium salt hydrate 
Sigma A2383-10G Treatment 







abcam ab120081 Treatment 
tert-butyl hydroperoxide (TBHP) abcam  ab113851 Treatment 
Hydrogen peroxide solution 30 % 

















EGTA-AM Fisher/Invitrogen E1219  Treatment 
Paraformaldehyde (PFA) Sigma 158127 Immunostaining 
Methanol Fisher  11367996 Immunostaining 
Triton X-100 Sigma T9284-100ML Immunostaining 
Tween 20 Sigma P5927-500ML Immunostaining 
Glycine (powder) Fisher  10061073 Immunostaining 
Bovine Serum Albumin Powder, 
Fraction V 
Fisher  11403164 Immunostaining 
VECTASHIELD® HardSet™ Antifade 
Mounting Medium with DAPI 
Vector 
Laboratories 
 H-1500-10 Immunostaining 
VECTASHIELD® HardSet™ Antifade 
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Alexa Fluor® 568 goat-anti-mouse 
IgG (H+L) 
Fisher/Invitrogen A11031 Immunostaining 
 
The medium and buffers that were used in cell culture and experiments are described in Table 2.  
 
Table 2. Buffer and medium: components and application. 
Buffer/medium Supplementation/formulation Application 
Dulbecco's Modified 
Eagle Medium (DMEM) 
high glucose, 
GlutaMAX™ 
10% FBS and 1% Pen/Strep (100 U/mL) Cell culture 




GlutaMAX (2 mM), HEPES and NaOH (1M 
stock added dropwise to pH 7.3) 
Loading and imaging 
Imaging Buffer 
Distilled water, with NaCl (12.1 mM), KCl 
(0.54 mM), MgCl2 (0.08 mM), CaCl (1.8 
mM), NaHC03 (0.6 mM), EGTA (1 mM), D-
glucose (5.5 mM), HEPES (2.5 mM) and 
NaOH (1M stock added dropwise to pH 7.3) 
Loading and imaging 
HBSS +CaCl2 +MgCl2 NaOH (1M stock added dropwise to pH 7.3) Loading and imaging 
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2.2 Methods 
The experiments were conducted in live or fixed cells and these were cultured according to the 
methods detailed below. 
The details of each individual experiment including the loading of indicators or probes, and the 
treatments of cells, was detailed in the methods section of each chapter. 
 
2.2.1 Cell culture 
All cell culture was carried out in sterile conditions, using a laminar airflow hood and cells were 
screened for mycoplasma at 3 monthly intervals to ensure that there was no undetected 
contamination. The cells were incubated in a 37°C/ 5% CO2 humidified cell culture incubator. 
Neonatal Rat Ventricular Myocytes (NRVMs) were briefly used for analysis in Chapter 4 and these 
were isolated according to (Masoud, 2018). Briefly, neonatal rats aged between 2 – 4 days were 
sacrificed, their hearts immediately removed and placed in ice-cold buffer. The hearts were cut into 
~1 mm3 with a scalpel and then digested in an enzyme solution (pancreatin, DNAse I and 
collagenase). The enzyme solution was exchanged several times and the solution was passed 
through 100 µm cell strainers. After centrifugation and removal of the supernatant, the cells were 
placed in a T175 flask for 1 hour to allow the fibroblasts to adhere and therefore be removed from 
the solution. The final centrifugation and resuspension of the pellet in plating medium resulted in 
a primary NRVM culture which was plated on laminin-coated coverslips and maintained until they 
were used in imaging experiments. 
The culture of induced pluripotent stem cells (iPSCs) is described in full in Chapter 9. Additionally, 
the culture of active and inactive Mouse Embryonic Fibroblasts (MEFs and iMEFs) is detailed in 
Chapter 9, as these were used in the culture of some iPSC lines. 
The methods for the culture of HeLa and fibroblast cell lines (Table 3) are detailed below. 
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Table 3. HeLa and fibroblast cell lines 
Cell type Mutation Source 
HeLa cells 
Wild Type (WT) 






Wild Type (WT) Coriell Institute (GM05399) “apparently healthy individual” 
CLN3Δex7/8 Prof. Mole at University College London (UCL) 
CLN3 D416G Dr Waller-Evans at Cardiff University (originating from UCL) 
 
2.2.1.1 Thawing frozen cells 
To thaw frozen cells, a 15 ml falcon tube was prepared with 9ml of cell culture medium in the hood. 
The cryovials was collected from storage (-80°C freezer or liquid nitrogen) or transport container 
with dry ice upon arrival. The vial was rapidly thawed in a pre-heated 37°C water bath until a small 
chunk of ice remained in the centre of the vial. The vial was then cleaned with ethanol and 
transferred to the cell culture hood, where 1ml of cell culture medium from the pre-prepared 15 
ml falcon was dropped into the vial to thaw the remaining ice. The 2 ml of cell-containing solution 
was then transferred to the 8ml remaining in the falcon and centrifuged at 1200 rpm for 5 minutes. 
The supernatant was carefully aspirated, and the pellet was gently resuspended in cell culture 
medium before transfer to a plate or flask and into the incubator. Cells were monitored for 
attachment and growth, with change or medium or passage as required. 
 
2.2.1.2 Expansion and maintenance of cell culture 
Cell were cultured in flasks or plates to maintain and expand the culture. For the expansion and 
maintenance of the culture, cells were grown in T25 flasks (for routine passaging) and T75 (to 
expand and generate stocks for freezing).  
The cells were passaged when they reached approximately 80% confluency. Media was removed, 
and the cells were gently washed once with 5ml PBS. Immediately after the removal of the PBS, 
0.25% Trypsin-EDTA was added to the flask (1 ml for a T25 or 6-well plate or 3 ml for a T75) which 
was incubated for approximately 2-3 minutes. When the cells had a rounded appearance, observed 
through the light microscope, the cells were detached by tapping the flask against the bench. When 
all cells were in suspension, media was added (5 ml for T25 or 12 ml for T75) to inactive the trypsin. 
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The cell suspension was then divided between flasks for continued growth or plates for 
experimental work, as required. To prepare cells for imaging experiments, they were seeded on 
uncoated glass coverslips of either 16mm diameter for 12 well plates, or 14mm diameter for 24 
well plates, 2 days prior to the experiment. 
 
2.2.1.3 Freezing cells for long term storage 
To prepare cell pellets for long term storage, the cells were detached with trypsin as described 
above, and the suspension was centrifuged at 1200 rpm for 5 minutes. The pellet was then diluted 
in freezing medium (90% FBS, 10% DMSO) and transferred to cryovials in 1ml aliquots and placed 
in a freezing chamber in a -80°C freezer before transfer to liquid nitrogen for long term frozen 
storage. The freezing procedure was carried out rapidly, to minimise the time that the cells were in 
contact with the DMSO at room temperature. 
 
2.2.2 Imaging experiments 
The protocols for the use of specific probes, indicators or treatments are detailed in each chapter. 
Cells were seeded on uncoated glass coverslips of either 16mm diameter for 12 well plates, or 
14mm diameter for 24 well plates, approximately 48 hours before the day of experiment or fixation, 
to allow for growth and recovery from dissociation.   
 
2.2.3 Live cell imaging 
For live cell imaging, the coverslips were transferred to an imaging chamber and maintained in an 
appropriate loading buffer or culture medium as shown in Figure 3. 
 
  
Figure 3. Imaging chamber assembly. The coverslip was sealed into the chamber with Dow Corning 
High Vacuum grease to prevent leaking of imaging buffer. Imaging buffer was added to the chamber 
to prevent cells drying out and to load fluorescent indicators or other compounds. 
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Images were acquired using a Leica DMI 6000 SD fluorescence microscope fitted with the following 
objectives: 5x, 10x, 20x air objectives and a 63x oil immersion objective and the filter cubes shown 
in Figure 4. The numerical aperture of the objective was 1.4. Image capture was carried out using 
the Leica Application Suite software.  
 
 
Figure 4. Filter cubes fitted to Leica DMI6000 fluorescence microscope. Excitation filters with 
bandpass (BP) for excitation wavelength (nm). 
 
All images were saved to the hard drive in LIF (Leica Image File) format and for analysis, imported 
into ImageJ where they were subsequently be stored as a TIF (Tagged Image File) to avoid loss of 




For immunofluorescence, the plated cells were removed from the cell culture laboratory and 
immediately washed with DPBS and fixed using ice-cold methanol. The protocol was carried out as 
detailed in Table 4. All stages were carried out at room temperature (unless otherwise stated) and 
the plates were incubated on a plate shaker. From the secondary antibody (Ab) stage onwards, the 
coverslips were protected from light with a foil covering. If a fluorescent probe (such as CellLight) 
was present prior to the fixation, all stages were performed in subdued light conditions and 
protected from light during incubation. After the final wash stage, the coverslips were removed 
from the plate and mounted to glass microscope slides using mounting medium. The mounting 
medium contained DAPI, and for one experiment in Chapter 4, mounting medium with phalloidin 
was used. The coverslips were dried for an hour at room temperature and either imaged 
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Table 4. Immunofluorescence protocol 
Stage Time  Solution 
Wash 3x DPBS 
Fixation 15 min (on ice) Methanol 
Wash 3x Washing solution: 0.1% Tween-20 in DPBS 
Block 45 min Blocking solution: 1% BSA in DPBS 
Primary Ab 60 min LAMP2 1/500 in blocking solution 
Wash 3x Washing solution 
Secondary Ab 45 min Goat anti-mouse 1/500 in blocking solution 
Wash 3x Washing solution 
Mounting 1 hour + VECTASHIELD mounting medium 
 
 
2.2.5 Electron microscopy 
For electron microscopy of heart tissue (Chapter 7), fixed and frozen mouse hearts were kindly 
supplied by Professor Jonathan Cooper.  The sections were prepared for electron microscopy by Dr 
Igor Kraev and Dr Radka Gromnicova in the Electron Microscopy Suite at The Open University. The 
images were collected using the Transmission Electron Microscope (JEM 1400) and analysed in 
ImageJ. The tissue samples were processed for TEM imaging according to (Gromnicova et al., 2013). 
 
 
2.3 Summary of statistics 
Defining the n number for statistical analysis was depended upon the experiment being carried out. 
Replicates were typically either: 
• Multiple images of several regions (Figure 5A) per coverslip, with multiple cells (Figure 5B). In 
this case, N is the average value per cell and equals the number of cells analysed. This definition 
was used for the analysis carried out in Chapter 6 and Chapter 8.   
• One experiment per coverslip, with multiple cells in a single region (Figure 5B) 
The raw data from quantified images or regions was collected and stored in Excel, with basic 
calculations such as average of multiple replicates, background subtraction carried out in Excel. 
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Figure 5. Selection of regions for imaging and analysis. (A) Cells were grown on glass coverslips 
and imaged in chambers (live cells) or on slides (fixed cells). (B) Images of cells were taken across 
regions on the coverslip. (C) A whole cell or region of interest (ROI) within a cell was selected for 
quantification. 
 
The statistical analysis and graphical presentation of the data was carried out using GraphPad 
PRISM 9 using the tests set out in Figure 6. Initially, outlier analysis was carried out to remove any 
outliers from the dataset with the exception of the lysosome movement analysis in Chapters 4 and 
5. To determine whether the data was normally distributed, the D’Agostino & Pearson test and 
Shapiro-Wilk tests were carried out, with the latter being useful for the assessment of small 
datasets. The comparison of 2, or ≥3 datasets was carried out using the appropriate parametric or 
non-parametric test as set out in Figure 6. 
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Figure 6. Flow diagram of statistics applied to each dataset. All statistical tests were carried out in 
GraphPad Prism 9. *Outlier analysis was not applied to the data for lysosome movement (chapters 
4 and 5).  
 
For some experiments, additional analysis was carried out using GraphPad Prism. These included: 
simple linear regression, slope, and area under the curve for XY plots such as signal over time. 
Where these additional analyses provided additional readouts, the replicates were plotted in a 
Column table and analysed using the appropriate test as in Figure 6.  
Data was typically presented as charts in which the bar represents the mean and the error bar 







ROUT Q = 1%
exclusion of outliers*
Normality and Lognormality Tests

















2 data sets 
≥ 3 data sets 
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3.1.1 Lysosomes in CLN3 disease 
In Chapter 1, CLN3 disease was introduced as a lysosomal storage disorder, caused by a mutation 
of the CLN3 gene resulting in expression of a mutant form of the CLN3 protein. The CLN3 protein is 
reportedly expressed on lysosomes (Kyttala et al., 2006). A major characteristic of CLN3 disease is 
the accumulation of lipofuscin within affected cells, which has been described as a likely failure in 
the interaction between lysosomes and autophagosomes during autophagy (Marani et al., 2009). 
Although lysosomes play an essential part in autophagic catabolism, they also have an 
acknowledged role in cellular signal transduction pathways, such as calcium signalling (Walkley, 
2009, Ballabio, 2016, Lloyd-Evans, 2016). Many of the normal lysosome activities, including Ca2+ 
signalling and autophagy, were recognised as defective in a study of CLN3 disease (Chandrachud et 
al., 2015). 
Given the location of the CLN3 protein and the documented effects of CLN3 disease on lysosome 
function, the ability to image lysosomes with fluorescence microscopy was critical to this project. 
There are several currently available options for fluorescent lysosome probes, with differing 
fluorescence characteristics and mechanisms of organelle labelling. The two most commonly used 
approaches for labelling lysosomes are to exploit the distinctive low pH of these organelles to cause 
probes to accumulate and/or fluoresce, or to genetically target probes to the lysosome. The 
following criteria were essential considerations in the selection of a lysosome probe in this study: 
• Whether a probe could be used for live-cell imaging, with fixed cells, or for both live and 
fixed cells.  
• Confirming that a probe was specific for lysosomes was crucial for analysis of lysosome 
activity based on the imaging experiments.  
• The fluorescence properties of a probe, particularly the excitation and emission 
wavelengths, intensity, and stability of signal. 
 
3.1.2 Comparison of lysosome probes for fluorescence microscopy 
To image lysosomes with fluorescence microscopy there are a range of commercially available 
lysosome probes with varying mechanisms of labelling: 
• LysoTracker Green DND-26 (LysoTracker green)   
• LysoTracker Red DND-99 (LysoTracker red)   
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• CellLight Lysosomes-GFP BacMam 2.0 (CellLight green)    
• CellLight Lysosomes-RFP BacMam 2.0 (CellLight red)    
• Anti-LAMP2 antibody + Alexa Fluor® 568 (anti-LAMP2 antibody) 
 
The lysosome-associated membrane proteins 1 and 2 (LAMP1 and LAMP2) are glycoproteins found 
in abundance on the lysosome membrane (Eskelinen, 2006). Immunostaining for LAMP proteins is 
widely considered to be a valid method for examining the location of lysosomes. However, a major 
limitation of antibody staining is the necessity for cells to be fixed, which means that this approach 
cannot be used for dynamic measurements with live cells. In this study, endogenous LAMP proteins 
were used as the standard for lysosome labelling to examine the specificity of the LysoTracker and 
CellLight lysosomal probes.  
The LysoTracker probes exploit the low pH of the lysosome to achieve specific lysosome labelling 
(ThermoFisher, 2021b). The fluorescence of these synthetic probes increases to detectable levels 
when the fluorophore is protonated in the acidic compartment of the lysosomes. The CellLight 
baculovirus constructs lead to the expression of fluorescently-tagged LAMP1 in living cells 
(ThermoFisher, 2021a). Unlike the LysoTracker stains, the fluorescence of fluorescently-tagged 
LAMP1 is pH independent. Furthermore, as shown in this chapter, the expressed fluorescently-
tagged LAMP1 protein is retained post permeabilisation and fixation, which makes the CellLight 
method potentially more versatile than LysoTracker. On the other hand, the baculovirus-based 
probes rely upon successful transduction of the cells, which can have variable efficiencies in 
different cell lines. Further potential disadvantages of the CellLight approach are the many hours 
required for the fluorescence to develop, and that the over-expressed fluorescently-tagged LAMP1 
protein may be incorrectly targeted or may interfere with the normal function of native LAMP1 in 
the cell.    
As stated above, this study utilised the immunofluorescence of endogenous LAMP proteins, 
identified via a specific antibody, to assess the specificity of lysosome labelling. With the 
appropriate controls (including ‘secondary antibody only’ to rule out non-specific binding), LAMP2 
immunostaining delineated the specific subcellular localisation of the LAMP2 protein without 
requirement for overexpression and provided the means to validate the use of other lysosomal 
probes for dynamic measurements in living cells.  
 
Aim 1: to identify a specific probe for imaging of lysosomes in living cells.  
Objectives: 
• Establish protocols for LysoTracker, CellLight, and LAMP2 labelling in fibroblasts and HeLa cells. 
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• Characterise the specificity of the probes using co-localisation. 
Aim 2: to characterise the specific lysosome probes for their use in live cell imaging experiments 
Objectives:  
• Establish efficient image processing to remove or reduce background signals from fluorescence 
images. 
• Characterise the photostability of the probes in live-cell imaging experiments. 
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3.2 Methods 
The methods for cell culture, details of fluorescence imaging, and the preparation of chambers for 
fluorescence imaging of live cells and slides for fixed cells are described in Chapter 2. All solutions 
containing fluorophores (e.g. LysoTracker and secondary antibody solutions) or cells labelled 
with/expressing fluorophores (such as LysoTracker, CellLight or immunofluorescence) were 
handled in subdued light conditions to avoid photobleaching.  
 
3.2.1 Loading or expressing lysosome probes in live cells 
The names, sources, and functional properties of the lysosomal probes used in this study are shown 
in Table 5. 
Table 5. Details of lysosome probes. 
Probe name Supplier (Catalogue #) Mechanism of labelling Wavelength 
LysoTracker™ Green 
DND-26 
Invitrogen™ (L7526) Accumulation of probe in 
lysosomes leading to 
enhanced fluorescence 
through protonation of 




Invitrogen™ (L7528) 577/590 nm 
CellLight™ Lysosomes-
GFP BacMam 2.0 
Invitrogen™ (C10507) 
Transduction with 





RFP BacMam 2.0 








Alexa Fluor® 568 goat-








The LysoTracker probes were loaded into living cells 30 minutes prior to imaging. LysoTracker was 
stored as small aliquots of a 1 mM stock solution to avoid frequent freeze-thaw cycles. Immediately 
prior to loading, an aliquot was thawed and diluted in imaging buffer (warmed to room 
temperature) to achieve the working concentration of 50 nM. A coverslip coated with cells at 
approximately 70% confluency was removed from a 12-well plate and placed in an imaging 
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chamber. The coverslip was washed gently with room temperature imaging buffer to remove traces 
of cell culture medium, and the LysoTracker solution was subsequently added to the chamber to 
start the incubation. The imaging chamber was incubated at room temperature, protected from 
light, for 30 minutes. Subsequently, the LysoTracker solution was exchanged for fresh imaging 
buffer and the chamber was immediately placed on the microscope stage to commence imaging. 
 
3.2.1.2 CellLight 
The CellLight probes were introduced to the cells via transduction with baculovirus to induce 
expression of GFP- or RFP-tagged LAMP1. Cells were grown to approximately 70% confluency on 
imaging coverslips placed in 6-well plates. The virus particles were diluted in cell culture medium 
to the required titre before being added to the cells. A 6-well plate was retrieved from the incubator 
and the virus-containing solution was gently added to the medium surrounding the cells. The 6-well 
plate was then returned to the incubator to allow expression of the fluorescently-tagged protein. 
At a specific time, the solution containing the virus particles was aspirated from the cells and 
replaced with fresh medium. The cells were then returned to the incubator. Immediately prior to 
imaging, a coverslip from the virus-treated 6-well plate was placed in an imaging chamber and 
gently superfused with room temperature imaging buffer to remove the cell culture medium. 
 
For co-loading of LysoTracker and CellLight, cells expressing CellLight were loaded with LysoTracker 
as detailed above. LysoTracker Red was combined with CellLight GFP, while LysoTracker Green was 
combined with CellLight RFP. 
 
3.2.1.3 Anti-LAMP2 antibody 
To label cells with the anti-LAMP2 antibody, immunostaining was carried out following the protocol 
described in Chapter 2. The secondary antibody was selected for species reactivity, with the 
corresponding Alexa Fluor that did not overlap in excitation/emission wavelengths with the 
lysosomal probes being examined. A control for non-specific binding of the secondary antibody was 
included each time an immunostaining experiment was performed. After immunostaining, the 
coverslips were mounted on slides for imaging. 
 
For comparison of CellLight and LAMP2 antibody staining, coverslips expressing CellLight were 
fixed, permeabilised and immunostained. CellLight GFP was used in combination with a secondary 
antibody conjugated with Alexa Fluor® 568.  
 
3.2.2 Imaging lysosome probes with fluorescence microscopy 
Imaging was performed using a Leica DMI600 fluorescence microscope and a 63x oil immersion 
objective. The LysoTracker probes were imaged with an exposure time of 20 - 50 ms, while the 
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CellLight probes were imaged with an exposure time of 100 - 150 ms. The differences in exposure 
time reflect the fact that the BacMam-based labelling was not as intense as the LysoTracker probe 
and required more excitation for an optimal signal. 
The lysosomal probes used in this study were imaged using typical ‘green’ or ‘red’ filter sets as 
depicted in Table 6. To co-localise the signals from two probes within the same cell, the probes 
were imaged as a green/red pairs in order to detect each probe in separate channels. This method 
relied upon fluorophore detection at the expected channel and an absence of bleed-through to the 
other channel, which would interfere with the results. 
 
Table 6. Excitation and emission wavelengths of the fluorophores of each lysosomal probe. The 
excitation/emission reported by the manufacturers are listed for each probe, in the column 
referring to the respective channels of the Leica fluorescence microscope used for detection. 
 Green channel Red channel 
LysoTracker™ Green DND-26 504/511 nm No signal 
LysoTracker® Red DND-99 No signal 577/590 nm 
CellLight™ Lysosomes-GFP 488/510 nm No signal 
CellLight™ Lysosomes-RFP No signal 555/584 nm 
Secondary Ab Alexa Fluor® 568 No signal 578/603 nm 
 
Since a key aim of this work was to compare the cellular distribution and utility of lysosomal probes, 
it was necessary to perform co-localisation experiments using green and red pairs of the indicators. 
Table 6 depicts the imaging channels with which the various lysosomal probes should optimally 
correspond with. Any fluorescence emission that is detected in the non-expected channel could 
interfere with co-localisation analyses. To ensure that the light emitted by the fluorophores was 
not detected outside of the expected wavelengths, the probes were imaged with both green and 
red channels. The expected outcome was that the fluorescence would be detected in one channel 
and absent on the other (denoted ‘expected channel’ and ‘empty channel’, respectively). For this 
analysis, the probes were loaded individually into cells on coverslips and imaged using both 
channels to determine whether there was any fluorescence bleed through into the empty channel. 
To image the empty channels, an exposure time of 150 ms was used. This was the maximal exposure 
time used in this study, and it was required for the least bright probe (CellLight Lysosomes-RFP). 
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Using a relatively long exposure time of 150 ms increased the likelihood of detecting any apparent 
bleed through. 
The lysosome probes used in this study were selected to represent a range of mechanisms to label 
lysosomes and were not all compatible across live and fixed cell experiments.  While both 
LysoTracker and CellLight were loaded into live cells, antibody staining required fixed and 
permeabilised cells. An attempt was made to use both LysoTracker and CellLight probes with 
LAMP2 immunocytochemistry. LysoTracker fluorescence was detrimentally affected by fixation and 
lost during permeabilisation. Whereas, CellLight retained its signal after fixation and 
permeabilisation. Therefore, the most versatile probes for staining live, fixed and permeabilised 
cells was CellLight, as shown in 7. 
 
 
Table 7. Summary of the utility of different lysosomal probes for live and fixed cell experiments. 
LysoTracker and CellLight can be readily used to label living cells. Only CellLight is suitable for both 
living cell and fixed cell experiments. 
Probe 
Live cells Fixed & permeabilised cells 
Labelling Imaging Labelling Imaging 
LysoTracker ✓ ✓   
CellLight ✓ ✓  ✓ 
Anti-LAMP2   ✓ ✓ 
 
 
Fluorescence imaging was carried out by collecting a series of images for a specified duration. The 
interval between subsequent images in a series was set to the minimal value possible (to obtain the 
most rapid sequence) unless otherwise stated. 
 
3.2.3 Methods for the analysis of lysosome images 
Analysis of the fluorescence images was carried out using tools and plugins within ImageJ. Data 
obtained from the images were transferred to Microsoft Excel for additional calculation, if 
necessary, and to GraphPad Prism for statistical analysis and presentation. The example panels 
shown in Figure 8 and Figure 11 were created using a combination of ‘Split Channels’ and ‘Merge 
Channels’ and the relevant images were saved as .jpeg files for import to Corel Draw. To plot the 
fluorescence profile across the cell images, the ImageJ ‘line’ tool was used to specify a line across 
the diameter of cells, and intensity of the pixels along the line was measured using the ‘Plot Profile’ 
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tool. The profile intensity data was transferred to GraphPad Prism, with the independent variable 
being distance (pixels) and the dependent variable being pixel intensity (gray value). Distances 
reported in pixels were subsequently converted to µm. 
To measure the specific fluorescence intensity of lysosomal probes within whole cells in a field of 
view, the ‘background signal’ observed in non-cellular areas was subtracted from the fluorescence 
intensity recorded from the image area containing cells. For this, the mean gray value was 
measured for a small extracellular area of the image. The cells within the image were outlined by 
tracing around their circumference and duplicated using the ImageJ ‘Polygon selections’ tool. The 
area outside of the traced cell was removed (set to 0 intensity) with ‘Clear Outside’ function. The 
mean gray value was measured for the entire area of each cropped cell.  
Co-localisation analysis was used to determine the extent to which two probes overlapped within 
cells. For this, the images collected using the red and green channels were separated from the stack 
with the ImageJ plugin ‘Split Channels’. To quantitate co-localisation of the lysosomal probe 
fluorescence, the ‘Just Another Co-localisation Plugin’ (JACoP) for ImageJ was used. This plugin 
returned the Pearson’s co-efficient, which is directly proportional the degree of co-localisation. 
Photobleaching analysis was carried out using ‘Intensity v Time Monitor’ plugin within ImageJ and 
exported, with time as the independent variable and the mean gray value of cellular fluorescence 
as the dependent variable.  
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3.3 Results 
3.3.1 Optimisation of loading conditions 
 
LysoTracker had a straightforward loading protocol, achieved within the parameters suggested by 
the manufacturer. Conversely, CellLight required considerable optimisation for each cell line, as 
recommended by the manufacturer. On initial testing, the GFP form of the BacMam expression 
vector construct showed a brighter and clearer signal than the RFP version. Therefore, optimisation 
was carried out with CellLight Lysosomes-GFP to achieve good transduction efficiency and good 
signal to noise. The signal to noise ratio refers to the difference between the signal from the 
fluorophore, localised to its intended target (signal) and the background fluorescence (noise). For 
the optimisation of CellLight, signal to noise was assessed in a qualitative manner, based on the 
appearance of fluorescence signal in the images. Initially, the protocol recommended by the 
manufacturer was tested with fibroblasts, but no fluorescence was observed during imaging. 
Thereafter, the viral transduction protocol was sequentially altered, and several different 
conditions were tested (Table 8).  
 
Although the manufacturer suggested that CellLight viral particles had “minimal toxicity”, it was still 
considered beneficial to reduce the length of time during which the cells were exposed to the 
particles. Since the principal purpose of this study was to characterise lysosomes within individual 
cells, the quality of lysosome staining within each cell was more important than the total number 
of cells transduced. The CellLight reagent was a single particles, so there were no separate negative 
controls for associated reagents. 
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Table 8. Optimisation of CellLight protocol. Manufacturer recommended conditions, range of 
testing and results for optimal expression of CellLight to indicate lysosomes. The CellLight stock 




Range of conditions tested for 
optimisation of CellLight expression 
Concentration of 
viral particles 
0.2 µl/ 1,000 cells 0.1-5 µl/ 1,000 cells 
Cell seeding density <70% 50-80% in 96- and 12-well plates 
Volume of medium N/A 0.05-0.1 ml (96-well) 0.5-1 ml (12-well) 
Incubation times 16 hr with particles 
8-16 hours with particles, followed by  
18-42 hours in fresh medium 
Plate shaking N/A No shaking, 15 minutes or 1 hour RT 
 
The most relevant parameters for improved fluorescence signal and image clarity were found to be 
the concentration of viral particles and incubation time, as illustrated in Figure 7. At 18 hours post-
addition of the viral particles, a relatively strong signal was observed in cells that had been exposed 
to the highest concentrations of particles (Figure 7A – C). However, for the cells at 42 hours post-
addition of viral particles, there was a detectable signal at even the lowest viral particle 
concentration (Figure 7D – F). Moreover, there was a greater image clarity with the longer 
incubation time; the lysosomes were more easily resolvable compared to the more diffused 
fluorescence observed with 18 hours’ incubation.  
While the cells appeared to have a healthy morphology and normal growth with extended exposure 
to the particles, the particles did not need to be present for the entire duration of incubation to 
improve expression. Therefore, the particles could be incubated overnight (~8 - 12 hours), washed 
off using fresh culture medium, and the cells incubated for a further day and a half (~30 - 34 hours) 
before imaging. These timings were used to reduce the exposure of the cells to the viral particles 
with no evident detriment to GFP-expression, indicating that the cells were able to rapidly take up 
the particles, and once internalised the majority of the incubation time was required for the vector-
encoded protein to be expressed. 
 
Page 31 of 264 
 
 
Figure 7. Optimisation of CellLight™ Lysosomes-GFP, BacMam 2.0 loading. Fibroblast cells were 
grown on glass coverslips in 96-well plates as described in Chapter 2. The cells were transduced 
with CellLight™ Lysosomes-GFP using the following conditions: 18-hour incubation (A-C) or 42-hour 
incubation (D-F) with 0.5 µl (A and D), 2.5 µl (B and E), or 5 µl (C and F) of the viral particle stock per 
ml of medium. The CellLight stock solution contained 1 × 108 particles/mL solution. 
 
Table 9 lists that optimised conditions that were established for CellLight™ Lysosomes-GFP 
expression. The key parameters that affect the quality of images were concentration of viral 
particles, incubation time, and the use of plate shaking. The latter may have aided in the dispersal 
of the viral particles as it reduced the appearance of extremely bright, rounded cells that appeared 
to have been overloaded with particles, while the majority of surrounding cells failed to express 
any GFP signal. 
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Table 9. Optimisation of CellLight protocol for fibroblast cells. The CellLight stock solution 
contained 1 × 108 particles/mL solution. 
Parameter 
Range of conditions tested for 
optimisation 
Optimal conditions for high 
quality images 
Concentration of viral 
particles 
0.1-5 µl/ 1,000 cells ≤2.5 µl 
Cell seeding density 
50-80% in 96- and 12-well 
plates 
No visible difference 
Volume of medium 
0.05-0.1 ml (96-well) 
0.5-1 ml (12-well) 
No visible difference 
Incubation times 
8-16 hours with particles 
18-42 hours in fresh medium 
8 hours with particles followed 
by ≤42 hours in fresh medium 
Plate shaking 
No shaking, 15 minutes or 1 
hour RT 
15 minutes RT or, 
2-3 minutes tapping 
 
 
Following the optimisation of CellLight Lysosomes-GFP expression in fibroblasts, the protocol was 
tested in HeLa cells. HeLa cells initially appeared to have significantly better transduction efficiency 
and a stronger signal in a shorter time. However, a challenge associated with these cells was their 
high proliferation rate which meant that the seeding density and incubation time were limited to 
avoid over-confluency.  
The optimal conditions for CellLight Lysosomes-GFP expression in HeLa cells are presented in Table 
10. In essence, the HeLa cell conditions were altered to account for the cell seeding density required 
to maintain a healthy culture up to the point of imaging. While fibroblasts were passaged and 
allowed 24 hours to settle prior to addition of the particles, HeLa cells were seeded and given some 
time to adhere (~4-6 hours) before addition of the particles, which were then allowed an overnight 
incubation before exchange for fresh medium. The HeLa cells were then incubated for a further 24 
hours before imaging. 
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Table 10. Optimisation of CellLight protocol for HeLa cells.  The CellLight stock solution contained 
1 × 108 particles/mL solution. 
Parameter 
Range of conditions tested for 
optimisation 
Optimal conditions for 
high quality images 
Concentration of viral 
particles 
2.5-5 µl/ 1,000 cells 2.5 µl 
Cell seeding density 50-70% 60% 
Volume of medium 0.05-0.1 ml (96-well) 0.5-1 ml (12-well) 1 ml (12-well) 
Incubation time 
8-16 hours with particles 
16-42 hours in fresh medium 
16 hours particles 
≤30 hours medium 
Plate shaking 
No shaking, 2-3 minutes tapping, 
shaking; 15 min or 1hr RT 
15 min RT 
or 2-3 minutes tapping 
 
 
Following the optimisation using CellLight Lysosomes-GFP, the HeLa cells were transduced with 
CellLight Lysosomes-RFP using the optimal conditions detailed in Table 10. In comparison to 
CellLight Lysosomes-GFP, the RFP signal was less intense and therefore required a greater exposure 
time to visualise the lysosomes, but the expression otherwise replicated that of the GFP vector. 
Fixed cells were stained for LAMP2 using a specific antibody and a fluorescently-tagged secondary 
antibody (Table 5) as described in Chapter 2. Essentially, immunofluorescence was carried out using 
methanol fixation and permeabilisation in a single step, with clear LAMP2 staining achieved with a 
1/500 dilution of the primary and secondary antibodies. 
 
3.3.2 Testing for imaging channel specificity 
As described above, the lysosomal probes (Table 5) were detected using a fluorescence microscope 
with the relevant red or green channel being selected depending upon their excitation and emission 
wavelengths (6). Due to the broad excitation and emission spectra of some fluorophores, there is a 
possibility with fluorescence imaging that signals may not be solely restricted to one channel. This 
is commonly referred to crosstalk or referred to as ‘bleed-through.’ Alternatively, an apparent 
fluorescence signal could be obtained through other means such as background fluorescence from 
the buffer or autofluorescence from the cells, or noise from the imaging system. 
Since bleed-through between fluorescence channels can confound the interpretation of 
colocalization analysis, it was important to determine whether there was an issue with the 
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lysosomal probes used in this study. The potential for bleed-through was examined through 
loading/expressing individual lysosomal probes, followed by quantitative and qualitative analyses 
of images obtained using both red and green channels. For example, LysoTracker red was loaded 
into cells using standard conditions, and the cells were imaged using both green and red channels 
(Figure 8). The expected outcome was the presence of significant signal in the red channel 
associated with the excitation and emission wavelengths of the probe. The key unknown was the 
amount of fluorescence evident in the green channel.  
Typical images acquired from cells expressing the different lysosomal probes using both green and 
red channels are shown in Figure 8. The LysoTracker Red probe fluorescence was evident in both 
green and red channels, with a punctate appearance in both channels that is consistent with 
labelling of lysosomes. In contrast, fluorescence from the red secondary antibody used for LAMP2 
detection displayed a punctate appearance in the red channel, but a diffuse signal in the green 
channel. The diffuse signal observed in the green channel when imaging the red secondary antibody 
did not resemble lysosome staining and may have resulted from a high background fluorescence 
caused by the immunostaining protocol. The CellLight transduction expressed the cleanest signals, 
with no evident bleed-through between the channels. Additionally, the LysoTracker Green probe 
did not display bleed-through to the red channel, unlike the red variant of the product. While 
images such as those shown in Figure 8 provide qualitative guidance about channel bleed-through, 
they are not quantitative because sensitive imaging cameras are able to detect modest signals and 
the electronics of an imaging system can enhance the signals for display purposes.  
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Figure 8. Images showing HeLa cells loaded with LysoTracker, expressing CellLight, or 
immunostained with LAMP2 antibody. Images of HeLa cells labelled with each probe were 
captured with green and red channels, as illustrated alongside the merged images. The scale bar is 
10 µM on all images. 
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Images such as those shown in Figure 8 were quantified to measure the fluorescence intensity 
within both the green and red channels for each lysosome probe. The quantification shown in 
Figure 9 compared the fluorescence recorded by the green and red channels when cells were 
loaded with the probes in pairs (Figure 9A) or individually (Figure 9B). Figure 9A shows that each 
pair of probes has similar levels of fluorescence signal under the conditions used. The parity of 
signal between the various probes is helpful in ensuring that co-localisation analysis is meaningful. 
Whilst there was some variation in the fluorescence intensity, each channel had a mean gray value 
of between 50 to 150 and there was no significant difference between the paired channels when 
loaded.  
 
Whilst the data shown in Figure 9A indicate similar levels of fluorescence arising the in the green 
and red channels when pairs of probes are used, they do not inform about any potential bleed 
through between channels. The quantitation of each probe on its own is required to determine 
bleed through (Figure 9B). As anticipated, substantial fluorescence intensity was observed with the 
‘expected channel’ that matched a lysosomal probe’s specified excitation and emission 
wavelengths, and this was significantly greater than that in the ‘empty channel’. The mean gray 
values of the empty channels were between 4 and 10 for all lysosomal probes, except for the red 
secondary antibody used for LAMP2 detection, where the empty green channel had a mean gray 
value of 25. Nonetheless, in each case, the fluorescence intensity of the expected channel was 
significantly greater than in the paired empty channel. This was even true for LysoTracker Red, 
which visually appeared to show bleed-through to the green channel (Figure 8). These data indicate 
that although there was some bleed through between the green and red channels for all the probes 
tested (Figure 8 and Figure 9B), it was a small fraction of the signal observed when pairs of probes 
were used together (Figure 9A).  
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Figure 9. Fluorescence intensity of lysosome probes in HeLa cells when imaged using the green 
and red channels of the Leica microscope. The fluorescence in images of cells labelled with each 
lysosome probe is shown for the green channel (green bars) and red channel (red bars). The cells 
were labelled with: (A) multiplexed probes, or (B) individual probes. These data were analysed with 
a Mann-Whitney test where **** indicates p ≤ 0.0001 and n = 27 images per condition (9 images 
from 3 coverslips, on 3 days).  
 
A negative control that was always imaged alongside the anti-LAMP2 antibody staining was cells 
permeabilised and fixed cells incubated with the secondary antibody only. For every 
immunostaining that was carried out, additional coverslips were treated as a negative control in 
which the only deviation from the immunostaining protocol was the absence of the primary 
antibody, which was replaced with diluent only (blocking buffer) during the primary antibody stage. 
The images achieved from this negative control showed weak fluorescence signals in the green 
channel and the absence of any discernible intracellular structures in the red channel (Figure 4). 
The weak green fluorescence obtained from imaging the red-labelled secondary antibody-only cells 
is likely to reflect cellular autofluorescence (Figure 10). 
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Figure 10. Images of HeLa cells labelled with the anti-LAMP2 secondary antibody only (red 
secondary antibody). The fixed, permeabilised and immunostained cells were imaged using the 
green and red channels of the Leica microscope. The scale bar is 10 µm. 
 
3.3.3 Co-localisation of lysosome probes to assess specificity 
With LysoTracker being lost from cells after permeabilisation, and the anti-LAMP2 antibody 
requiring permeabilisation for staining, CellLight represented a lysosome probe that was available 
as a comparison for both live and fixed cells. 
Experiments were undertaken in which cells were co-labelled with LysoTracker and CellLight to 
explore their subcellular distributions. However, whereas LysoTracker loaded into in all the cells on 
a coverslip, CellLight only caused fluorescently-tagged LAMP1 expression in relatively fewer cells 
that were successfully transduced. Figure 11 shows a field of cells that was transduced with 
CellLight Lysosomes-GFP and subsequently incubated with LysoTracker Red. All of the cells were 
observed to have punctate red fluorescence consistent with LysoTracker Red labelling the 
lysosomes, but fewer cells were found to show green fluorescence. Merging the green and red 
fluorescence images yields yellow pixel colouration for those cells in which CellLight Lysosomes-
GFP was expressed. Similarly, transducing cells with CellLight Lysosomes-RFP and subsequently 
incubating with LysoTracker Green produced yellow pixels in those cells where both probes were 
evident. 
These data indicate that lysosomal probes of different colours can be multiplexed and can either 
identify the lysosomes in all the cells in a field of view (LysoTracker probes) or relatively fewer 
transduced cells (CellLight). Moreover, the clear single-colour staining of the LysoTracker-only cells 
shows that there was little bleed-through between the green and red channels in these 
experiments.  
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Figure 11. HeLa cells on coverslips loaded with LysoTracker and transduced with CellLight. Left: 
CellLight Lysosomes-GFP was expressed by some cells on the coverslip, while all cells were loaded 
with LysoTracker red, resulting in a population of partially yellow (labelled with CellLight and 
LysoTracker) and partially red (LysoTracker only). Right: LysoTracker green was loaded in all cells on 
the coverslip, while some cells expressed CellLight Lysosomes-RFP, resulting in a population of 
partially yellow (labelled with LysoTracker and CellLight) and partially green (LysoTracker only). 
 
To quantify the co-localisation of the probes, LysoTracker green was compared against CellLight 
Lysosomes-RFP and LysoTracker red was compared against CellLight Lysosomes-GFP. The CellLight 
probes lead to the significant LAMP1 protein translation, which means that they carry a risk of 
incorrect localisation associated with protein over-expression. Therefore, the CellLight probes were 
also compared against the immunofluorescence staining of the endogenous LAMP2 protein. This 
was carried out using CellLight Lysosomes-GFP and immunostaining of an anti-LAMP2 antibody with 
a red (Alexa Fluor® 568) secondary antibody (hereafter denoted ‘LAMP2 red’). For each pairing, the 
green and red channels, alongside the composite image, are displayed in Figure 12. Additionally, 
the fluorescence profile was plotted along a line drawn through the cells (depicted on each 
composite image). The peaks indicate the greater fluorescence of a labelled lysosome and the 
overlapping peaks across the profile showed that the lysosomes were at the same location in each 
red and green image.  
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Figure 12. HeLa cells co-labelled with lysosome probes: green, red, and merged images with 
plotted fluorescence profile. The combinations are: LysoTracker green with CellLight red, CellLight 
green with LysoTracker red, and CellLight green with LAMP2 antibody (red secondary). The 
fluorescence profile of each channel was plotted using the yellow line depicted in the merged 
image. The scale bar is 10 µm. 
 
The co-localisation of lysosome labelling was assessed using Pearson’s co-efficient, where a value 
of 1 represents a perfect co-localisation of the above-background pixels between the images, and 
0 indicates no overlap of fluorescent signals in the images. Pearson’s coefficient was calculated 
from images of cells labelled with each probe: (1) individually, in cells on separate coverslips, and 
(2) multiplexed, in pairs, using the green and red channels of the Leica microscope for both (1) and 
(2). The rationale for analysing Pearson’s coefficient in cells with a single probe as well as with 
multiplexed probes was to examine potential for miscalculation of colocalization due to bleed-
through or background signals. As discussed earlier, the lysosomal probes were each designed to 
be detected within a single microscope channel based upon the associated fluorophore (6), and 
therefore, any apparent co-localisation occurring when cells contained only a single probe could be 
attributed to bleed-through or background fluorescence. As such, the analyses of cells containing a 
single probe represented a negative control to investigate the influence of potential extraneous 
signals. 
The Pearson’s co-efficient for the lysosomal probes when they were singularly present within cells 
is shown in Figure 11. It is evident that there was some difference in the apparent co-localisation 
Page 41 of 264 
 
of these lysosomal probes. LysoTracker Green, CellLight green, and CellLight red were found to have 
the least apparent co-localisation.  
 
Table 11. Analysis of apparent co-localisation of the lysosome probes in HeLa cells. The Pearson’s 
co-efficient was calculated by individually loading (LysoTracker), expressing (CellLight), or 
immunostaining (LAMP2) each lysosome probe, followed by imaging the cells using the green and 
red channels of the Leica microscope. 
Lysosome probe Pearson’s co-efficient (mean ±S.E.M.) 
LysoTracker Green 0.16 ± 0.02 
LysoTracker Red 0.45 ± 0.03 
CellLight green 0.14 ± 0.01 
CellLight red 0.11 ± 0.01 
LAMP2 with red secondary antibody 0.44 ± 0.02 
 
 
Co-localisation was quantitated for the following multiplexed pairings: LysoTracker Green with 
CellLight red (Figure 13A), LysoTracker Red with CellLight Green (Figure 13B) and CellLight green 
with LAMP2 immunostaining (Figure 13C). The Pearson’s coefficients determined by imaging cells 
containing these lysosomal probe pairings are plotted alongside the quantification of the 
corresponding negative controls taken from Figure 11. The pairing of LysoTracker Green and 
CellLight red yielded a Pearson’s co-efficient of 0.76 ± 0.02, which was significantly greater than 
that observed with either probe alone (Figure 13A and Figure 11). The significant difference in co-
localisation between the images of cells containing individual probes and those of the multiplexed 
probes suggested that the co-localisation reflected a high proportion of vesicles labelled by both 
probes. The quantitation of co-localisation for CellLight green in combination with LysoTracker Red 
indicated a significantly greater co-localisation between the multiplexed probes (Pearson’s co-
efficient of 0.80 ± 0.02) compared to either probe alone (Figure 11). LysoTracker Red probe had a 
notably higher apparent co-localisation by itself (Pearson’s co-efficient of 0.45 ± 0.03), suggesting 
some signal bleed-through associated with the probe (as noted in Figure 8) present in the images 
captured using the green channel wavelength. Nonetheless, the assessment of both LysoTracker 
and CellLight combinations (Figure 13A and B) suggests that the majority of the fluorescent signals 
were present at the same location, indicative of the probes labelling the same structures within the 
cells. 
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The comparison of CellLight green and LAMP2 immunostaining with the red secondary antibody 
yielded the strongest co-localisation with a Pearson’s co-efficient of 0.89 ± 0.01 (Figure 13C), which 
was significantly greater than that observed with either lysosomal probe alone (Figure 13). There 
was a notable apparent co-localisation occurring with LAMP2 staining only, indicating that some 
bleed-through or background fluorescence from the red Alexa Fluor 568-labelled secondary 




Figure 13. Co-localisation of green and red channels with and without lysosome labelling in HeLa 
cells. The probes were loaded individually and in pairs, as indicated.  Each individual probe and pair 
of probes were imaged with both red and green channels to assess for any effect of bleed-through, 
and the corresponding Pearson’s coefficient was calculated. (A) LysoTracker Green (LTg), and 
CellLight red (CLr), (B) LysoTracker Red (LTr) and CellLight green (CLg) and (C) CellLight green (CLg) 
and anti-LAMP2 antibody with red secondary (LAMP2r). These data were analysed with Kruskal-
Wallis test and multiple comparisons, where *** indicates p ≤ 0.001 and **** indicates p ≤ 0.0001 
and n = 27 images per condition (9 images from 3 coverslips, on 3 days). 
Given that LAMP2 is expressed on lysosomal membranes (Schwake et al., 2013). The LAMP2 
immunostaining observed in this study provides the best marker for validation of lysosomal 
labelling by the other probes. The significant Pearson’s coefficients observed when LAMP2 
immunostaining was compared with the CellLight indicators (Figure 13 and Table 12) validates the 
BacMam probes as lysosomal indictors. In turn, the significant Pearson’s coefficients observed 
when CellLight indicators were compared with the LysoTracker probes (Figure 13 and Table 12) 
validates the acutely-loaded LysoTracker reagents as lysosomal indicators. 
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Table 12. Analysis of co-localisation of the lysosome probes in HeLa cells. The Pearson’s co-
efficient was calculated by co-loading (LysoTracker), co-expressing (CellLight), or immunostaining 
(LAMP2), followed by imaging the cells using the green and red channels of the Leica microscope. 
Lysosome probe pair Pearson’s co-efficient (mean ±S.E.M.) 
LysoTracker Green/CellLight red  
 
0.76 ± 0.02 
CellLight green/LysoTracker Red  
 
0.80 ± 0.02 
CellLight green/LAMP2 (red 
secondary antibody)  
0.89 ± 0.01 
 
 
3.3.4 Assessment of background fluorescence associated with the LysoTracker and 
CellLight lysosome probes  
With their specificity for lysosomes confirmed, both the LysoTracker and CellLight probes were 
considered to be appropriate for use in lysosome imaging experiments. The specificity of the probes 
was crucial in order to reliably analyse lysosomes. However, specificity was not the only 
consideration when selecting a probe for lysosome imaging experiments: the quality of the images 
obtained with each probe could influence the analysis, especially when analyses were automated 
with the use of software such as ImageJ.  
 
Fluorescent probes such as LysoTracker and CellLight have different characteristics which may 
influence the resulting image quality. These can include: 
• Bleed-through, which was examined in Figure 8. 
• Intensity of fluorescence, as illustrated in Figure 9. 
• Background signal, referring to fluorescence not associated with the lysosomes, which may 
originate from various sources such as unbound fluorophores in the buffer solution, or even 
enhanced background introduced by the labelling method (e.g., cell fixation). 
• Noise, which is generally a property of an imaging system, and can appear as a random, frame-
by-frame grainy or speckled texture in the background of an image. Noise can be more 
profound for indicators with limited brightness. 
A key part of the analysis and quantification of images is the selection of regions, or segmentation 
of cells, or intracellular structures. Manual analysis has a number of drawbacks including the risk of 
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human error or subjectivity, as well as the inability to generate a high number of replicates in a 
short period of time, compared to that achieved with automated processing and analysis. 
Therefore, software-driven automated analysis, such as through the use of ImageJ plugins is highly 
desirable, although this comes with its own complications. For example, a noisy background that 
contains regions of a bright pixels that encompass a similar area and shape to lysosomes may be 
incorrectly identified by automated segmentation algorithms and included in the analysis. 
Erroneous segmentation associated with automated analysis can be considerably reduced if the 
images being processed are of high quality (i.e., good resolution and signal intensity), with minimal 
background noise, and consistent labelling. The use of automated image analysis is discussed in 
greater depth in Chapter 4.  
Prior to quantification, images of cells with labelled lysosomes were processed with the ImageJ 
function ‘Subtract Background.’ Removal of background signal from the images enhanced the 
automated segmentation of the lysosomes. The effect of background subtraction on an original 
image of LysoTracker fluorescence within a HeLa cell is shown in Figure 14. The original image 
evidently has numerous discrete lysosomes, but the image also had an elevated background signal 
which was most prominent in the cloudy appearance in the centre. The ‘Subtract Background’ 
function in ImageJ was used to clean the background with minimal impact on the lysosome 
fluorescence. This plugin was based on the removal of background signal in relation to the size of 
the object to be detected, originally described by (Sternberg, 1983). Therefore, it was important 
that lysosome size was considered when removing background and this was achieved through 
careful observation of lysosomes in the images and adjustment of the ‘rolling ball radius’. A rolling 
ball radius of 100 or 50 pixels reduced the background to an extent but did not entirely eliminate 
the cloudy background. With a rolling ball radius of 1, 5 or 10 pixels, the cloudy background was 
fully eliminated. However, a rolling ball radius 1 pixel was considered too extreme as the size and 
shape of the lysosomes was impacted. Ultimately, a rolling ball radius of 5 pixels was used as the 
appropriate radius for the background subtraction in this study, as this method eliminated the 
background signal while retaining the clearest lysosome signal. 
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Figure 14. Background subtraction applied to an image of a LysoTracker labelled HeLa cell. 
Background subtraction was performed using the ImageJ rolling ball plugin with the rolling ball 
radius set to 100, 50, 10, 5 or 1 pixels (px). The scale bar is 10 µm. 
 
To compare the image quality achieved with the use of LysoTracker and CellLight, the probes were 
loaded or expressed in HeLa cells on separate coverslips and were imaged using the fluorescence 
microscope. From these images, regions of lysosome signal or non-lysosome background were 
selected, and the fluorescence intensity measured as mean gray value (Figure 15). In all of the 
images of cells labelled with LysoTracker or CellLight, the pixels had a significantly greater 
fluorescent signal (mean gray value) localised to the lysosomes than found in the background 
regions. As the background fluorescence was comparatively low, this was plotted separately on an 
expanded scale (Figure 15B) to more clearly illustrate the comparison of background signals 
associated with each probe. While the background signals observed with LysoTracker and CellLight  
were not statistically significant, the background signal was noticeably lower in the images of 
LysoTracker-loaded cells than in those expressing CellLight (Figure 15B). 
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Figure 15. Fluorescence intensity of labelled lysosomes and background regions in sample images. 
(A) Lysosome and background fluorescence (mean gray value) plotted from the images of cells 
labelled with LysoTracker or CellLight.  These data were analysed using a Kruskal-Wallis test with 
multiple comparisons, where ** = p ≤ 0.01 and n = 5 regions of lysosome or background 
fluorescence from 5 images. (B) Fluorescence intensity of background signal measurements only. 
The data are presented as mean ± S.E.M. with individual values plotted.  
 
Figure 15 illustrates that there was a robust and consistent fluorescence from lysosome with both 
LysoTracker and CellLight indicators that was substantially greater than the background signal. 
However, despite the relatively low background signal when using these lysosomal probes, an issue 
became apparent due to noise. This was particularly prominent in the recordings of lysosome 
movement, which are further discussed in Chapter 4. 
To visualise the noise in the images, background regions were sampled from images of cells loaded 
with LysoTracker or CellLight, as shown in Figure 16. The images of these background regions 
initially looked similar, but increasing the contrast using ImageJ revealed a clear difference, as 
shown in Figure 16B and Figure 16D. The fluorescence profile depicted in Figure 16E represents the 
pixel intensities along a diagonal line from the bottom left to the top right corners of each 
background image, to capture the variation in signal in a quantitative manner. The number of peaks 
represented the frequency of variation in the signal across the distance measured, while the height 
highlighted the intensity of the signal. The plotted profile across the background of the image from 
LysoTracker-loaded cells had few peaks or troughs with little height, on an otherwise flat baseline 
(Figure 16). Comparatively, the background in the image from CellLight-expressing cells had a far 
greater number of peaks of considerable height.  
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Figure 16. Example background signals from HeLa cells labelled with LysoTracker (red) or 
CellLight-GFP, after background subtraction with rolling ball radius set to 5 pixels. The top panels 
show regions of background from images of LysoTracker loaded or CellLight expressing cells; with 
both original and contrast-enhanced versions of each. The scale bar represents 1 µm in all images. 
The fluorescence profile was plotted using a line drawn across the images diagonally (a distance of 
10 µm) to illustrate the relative variation in the gray value between the images of each indicator. 
 
The data in Figure 16 clearly show that LysoTracker-treated coverslips had the least variable 
background signal, after the rolling ball background subtraction had been applied. Whilst the 
average background pixel intensity for both LysoTracker and CellLight is low compared to the 
lysosomal fluorescence of both probes, the variation in background noise seen with CellLight raises 
an issue with lysosome segmentation. Specifically, it became apparent that variable background 
noise, such as that shown in Figure 3E, was the reason for the random detection of ‘lysosome-like’ 
particles by the segmentation algorithm in cells labelled with CellLight. This is further discussed in 
Chapter 5, in the context of the automated segmentation and tracking of lysosomes.  
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3.3.5 Photostability of fluorescent lysosome probes during imaging 
In addition to the specificity and quality of fluorescence staining, the stability of the signal is an 
important criterion for live cell imaging, particularly for experiments using time series imaging. The 
stability of the fluorescent signal from probes such as LysoTracker and CellLight was partially 
dependent on the rate of photobleaching during exposure to the microscope light source. The 
exposure time set to capture an image, and the number of images in a series, were both factors in 
the rate of photobleaching. The probes with a weaker signal require a longer exposure time per 
image to achieve good signal-to-noise. For time series experiments, such as recording lysosome 
movement (discussed further in Chapter 4), the probes were subject to repeated exposure. 
Images of LysoTracker displayed a strong signal with minimal background, but the intensity of the 
signal reduced rapidly during exposure, as shown in Figure 17. The lysosome fluorescence in cells 
expressing the CellLight probe required a greater exposure time than those loaded with 
LysoTracker. The signal associated with CellLight did not have the same dramatic reduction in signal 
over time as observed with LysoTracker (Figure 17), suggesting that the CellLight probes were more 
resistant to photobleaching. To test the suitability of the lysosome probes for rapid recording, they 
were subject to ‘minimised’ imaging and the fastest frame rate achievable with the microscope 
settings. LysoTracker provided images of sufficient quality for lysosomal tracking with an exposure 
time of 40 ms, yielding an imaging rate of 7.4 frames/second. Whereas, CellLight, which is not as 
bright as LysoTracker, required an exposure time of 100 ms, thereby providing an imaging rate of 
5.2 frames/second. 
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Figure 17. Photobleaching of LysoTracker (red) and CellLight-GFP during 60 seconds of rapid 
imaging. HeLa cells were imaged for 60 seconds using the minimised system settings for fastest 
possible recording. (A) LysoTracker fluorescence (B) CellLight fluorescence shown at 0 seconds, 30 
seconds (and 60 seconds.  (C) The plotted data are presented as average fluorescence intensity 
(mean gray value) over time, with error bars ±S.E.M. and n = 3 cells. 
 
 
The data presented in Figure 11 show cell images and fluorescence intensity prior to background 
subtraction using the rolling ball method. Therefore, to appropriately capture the photobleaching 
of the probes solely localised to lysosomes, the mean fluorescence of the rolling ball-processed 
images was plotted in Figure 18. As expected, the signal of both probes reduced dramatically when 
background fluorescence was subtracted from the mean gray value. The photobleaching of 
LysoTracker was less pronounced in the background-subtracted images, but LysoTracker continued 
to have a distinct drop in fluorescence in the first 20 seconds of imaging. With the background 
removed, this analysis represented the fluorescence of the vesicles and confirmed that there was 
still an initial decrease in fluorescence associated with LysoTracker. However, the fluorescence 
intensity of the LysoTracker and CellLight vesicles was closer in Figure 18 than in Figure 17 in which 
the background fluorescence was included, consistent with the data presented in Figure 9. The 
significant drop in signal following the rolling ball processing indicates how necessary it is to 
perform background correction on fluorescence images. 




Figure 18. Photobleaching of LysoTracker (red) and CellLight-GFP during 60 seconds of rapid 
imaging, calculated from background-subtracted image series. HeLa cells were imaged for 60 
seconds using the minimised system settings for fastest possible recording. Data presented as 
average intensity (mean gray value) error bars ±S.E.M. where n = 3 cells. 
 
3.3.6 Summary of results  
• LysoTracker can be used to label lysosomes as per manufacturer’s instructions, but CellLight 
indicators require cell-specific method refinement for successful transduction (Figure 7, 
Table 9 and Table 10). 
• Lysotracker and CellLight probes show significant cellular co-localisation with endogenous 
LAMP2 (Figure 11, Figure 12 and Figure 13). 
• The availability of Lysotracker and CellLight probes with different excitation and emission 
wavelengths allow for multiplexed experiments (Figure 9, Figure 11 and Figure 12).  
• The lysosomal probes show variable levels of bleed through. They were all brighter in the 
expected red or green imaging channel, but also show signals in the empty channel (Figure 
8 and Figure 9).  
• The red-shifted indicators show the highest amounts of bleed through (Figure 8, Figure 9 
and Figure 13). 
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• There are significant levels of background signal when using any of the lysosomal probes 
(Figure 17 and Figure 18). 
• Rolling ball subtraction can be used to minimise background (Figure 9), whilst preserving 
lysosome fluorescence (Figure 14, Figure 15 and Figure 18). 
• Despite rolling ball background subtraction there is an uneven distribution of background 
pixels observed with CellLight probes compared to LysoTracker (Figure 16). 
• Under the imaging conditions used in this study, the CellLight and LysoTracker probes 
displayed photobleaching with half-times in minutes (Figure 18). 
 
Overall, the results showed that LysoTracker and CellLight probes were comparable to the ‘gold 
standard’ of lysosome immunostaining with the LAMP2 antibody. Therefore, it could be 
inferred that LysoTracker and CellLight are both specific probes for lysosomes and appropriate 
for use in lysosome assays. However, the differing quality of the images and challenges such as 
fluorescence bleed-through and photobleaching, meant that the choice of probe was best 
weighed up against the requirements of the imaging experiment (Table 13). 
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Table 13. Summary of properties of lysosome probes. LysoTracker Green and Red, CellLight 
green and red, and anti-LAMP2 antibody with red secondary antibody. 
 
LysoTracker CellLight Antibody 
Green Red Green Red Red 
Specificity 
Figure 13 
Good ✓ ✓ ✓ ✓ ✓ 
Poor      
Loading/imaging  
Figure 7 
Live ✓ ✓ ✓ ✓  
Fixed   ✓ ✓  
Permeabilised   ✓ ✓ ✓ 
Distribution 
Figure 11 
All cells ✓ ✓   ✓ 
Sub-population   ✓ ✓  
Signal intensity 
Figure 8, Figure 9 
Good ✓ ✓ ✓  ✓ 




Good ✓ ✓    
Poor   ✓ ✓ ✓ 
Bleed-through 
Figure 8, Figure 9, 
Figure 13 
Good ✓  ✓ ✓  
Poor  ✓   ✓ 
Photostability 
Figure 17, Figure 18 
Good   ✓ ✓ 
N/A 
Poor ✓ ✓   
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3.4 Discussion 
3.4.1 Lysosome probes for fluorescence microscopy 
The first aim of this chapter was ‘to identify a specific probe for imaging of lysosomes in living cells.’ 
The probes were LysoTracker and CellLight, which were suitable for use in live cells (7). The third 
probe was the anti-LAMP2 antibody, used to immunostain for lysosomes using a fluorescently 
tagged secondary antibody. The immunostaining of LAMP2 is a highly specific means of labelling 
lysosomes and therefore this was used as a comparison to validate the localisation of the live cell 
indicators. 
According to the manufacturer, LysoTracker accumulates within lysosomes and fluoresces at the 
distinctive low pH of lysosomes in cells. The LysoTracker probes are loaded into live cells and 
suffered a disruption to fluorescence upon fixation, followed by a loss of signal upon membrane 
permeabilisation. Conversely, the immunostaining of LAMP2 requires fixation and permeabilisation 
of cells and therefore this could not be compared directly to LysoTracker as fluorescence of the 
latter would be lost during the immunostaining protocol. 
Live cells transduced with CellLight express Lysosome Associated Membrane Protein 1 (LAMP1) 
tagged with a fluorescent marker. Unlike LysoTracker which was detrimentally affected by fixation 
and permeabilisation, the CellLight fluorescent marker was expressed as a protein and did not 
disperse after permeabilisation. Therefore, CellLight was suitable for co-labelling with either 
LysoTracker or anti-LAMP2 antibody staining, and this presented an opportunity to compare the 
localisation of lysosome signal across multiple probes. 
The use of LysoTracker, CellLight and the LAMP2 antibody enabled a robust comparison of three 
different methods of lysosome staining. However, before the co-localisation experiments were 
conducted, it was important to ensure that each indicator was performing correctly, and labelling 
vesicles as accurately and completely as could be achieved with the protocol. 
 
3.4.1.1 Optimisation of CellLight™ Lysosomes-GFP and -RFP, BacMam 2.0 
Although CellLight was a useful probe in terms of versatility, its use was not immediately 
straightforward. The first attempt to express CellLight resulted in no visible signal. While the second 
attempt (with a greater number of particles) resulted in a small cluster of extremely bright cells 
while the rest of the coverslip remained unaffected. Therefore, CellLight was subject to a 
systematic, qualitative assessment until suitable fluorescence was achieved. The four 
manufacturer-recommended parameters for optimisation of CellLight transduction in each cell line 
(concentration, seeding density, volume of medium and incubation time) were crucial. Additionally, 
the observed poor distribution of transduced cells on the coverslip meant that a further shaking 
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step was tested.  The optimisation of CellLight was achieved through careful variation of each of 
the parameters to address the issues of poor signal and low number of cells transduced. 
The poor distribution of transduced cells was observed as a cluster of cells on the coverslip were 
transduced, while the majority beyond this cluster had no detectable fluorescent signal. The 
CellLight solution was handled carefully and mixed carefully with gentle pipetting rather than a 
vortex mixer, to avoid damage to the particles. It was possible that the particles were therefore not 
well distributed if they settled in the solution which was prepared before removing the plates from 
the incubator. The additional steps taken to either shake or tap the plate resulted in a wider spread 
of fluorescent cells on the coverslip, suggesting an improvement to the distribution of particles. 
Gently tapping the plate for 2-3 minutes was sufficient improve distribution. 
In parallel, the number of particles and incubation time were assessed within the range described 
in   
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Table 8. The number of particles was calculated (x µl per 1,000 cells) with the number of cells 
estimated based on the initial seeding density and appearance of confluency. By increasing the 
number of particles, the intensity of the signal increased but this had a cloudy appearance with 
poor clarity of vesicles (as shown in Figure 7). In comparison, extension of the incubation time 
resulted in a greater intensity of signal with a lower number of particles and most crucially an 
improved clarity of vesicle signal. The incubation time was comprised of two parts: (1) addition of 
particles in medium for uptake into the cells and, (2) incubation in fresh medium after particle 
addition for protein expression. Ultimately the strongest and clearest signal was achieved 48 hours 
from particle addition, with the particles removed after the first 16 hours.  
Although the optimisation steps improved the quality of the signal and number of cells transduced, 
CellLight did not achieve 100% transduction (Figure 11). Consequently, there were fewer cells 
available for analysis compared to LysoTracker or antibody staining which was present in all cells 
on the coverslip. For any experiment quantifying a population of cells, the limitation of CellLight 
would be considerable. However, for experiments in which a single cell was analysed in detail (such 
as the tracking of lysosome movement, described in Chapters 4 and 5) the number of transduced 
cells was of less consequence for analysis. 
Regardless, the selectivity of cells based on their effective transduction introduced a potential 
selection bias to the experimental sample. Additionally, exposure to the baculovirus particles, or 
LAMP1-GFP or -RFP expression within the cell may have had potentially induced unknown effects 
which would have added a possible confounding variable to the data. For analysis of LysoTracker 
images, cells were typically selected based on brightfield images to avoid any bias in choosing either 
a region to image or a cell to analyse. This was not possible with CellLight images, as not all cells 
were positive and therefore the cells had to be selected based on those which were expressing 
CellLight. 
3.4.2 Lysosome probe signal and specificity for lysosomes (co-localisation) 
Working with fluorescent probes, the signal is expected to be visible at distinct wavelengths 
depending on the fluorophore, such as GFP (488/510 nm) in the green channel and RFP (555/584 
nm) in the red channel of the microscope. However, as with all fluorescence probes, there is a risk 
of florescence bleed through beyond the wavelengths specified into additional channels. 
Furthermore, some of the processing such as the immunostaining and mounting of coverslips, may 
have introduced additional background fluorescence. This bleed through has implications for 
analysis being conducted with co-loaded probes, such as the co-localisation analysis. 
The co-localisation of the probes was assessed within the constraints of the loading and imaging 
conditions for each probe (live, fixed, or fixed and permeabilised). The comparisons were: 
LysoTracker/CellLight and CellLight/LAMP2 immunostaining. Imaging of the paired probes was 
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achieved through selection of fluorophores of distinct excitation and emission wavelengths; to be 
detected by the green and red channels separately. The co-localisation analysis of this paired 
loading could have been influenced by any signal bleed through. Therefore, it was important to 
confirm that the co-localisation was not a result of signal bleed through.  
When the probes were imaged individually, the fluorescence of each one was far greater in the 
channel corresponding to their expected wavelength than in the empty channel, as shown in Figure 
9. When assessing the fluorescent signal outside of the expected channel, the greatest signal was 
found in the green channel after immunostaining LAMP2 and a red secondary antibody. This was 
illustrated in Figure 8 in which a uniformly higher background cell fluorescence can be seen in the 
green channel; suggesting that there was background interference rather than a distinct bleed-
through of the lysosome signal specifically.  
The co-localisation of vesicles labelled with the LAMP2 antibody only in Figure 13 had a higher value 
than expected if there was no fluorescence in the green channel. However, this was still significantly 
lower than the co-localisation of vesicles labelled with both CellLight green and the LAMP2-
antibody. 
Similarly, there was an unexpected signal detected in the green channel when LysoTracker red was 
loaded individually (Figure 8). However, unlike the LAMP2 immunostaining, the fluorescence had a 
clear punctate staining which indicated bleed-through rather than a fluorescent cell background. 
The bleed-through was not reflected in the quantification of fluorescence intensity (Figure 9) due 
to the relatively low signal, however the calculation of co-localisation calculation is not based on 
intensity of signal, but location. Therefore, the effect of bleed-through was present in the co-
localisation analysis, which showed a greater co-localisation of LysoTracker red to the green 
channel than expected from the individually loaded control (Figure 13). In comparison, the green 
version of LysoTracker and both CellLight probes had very low co-localisation to the other channels 
when loaded individually, which suggested minimal bleed-through and reliability in the co-
localisation analysis. 
In addition to acting as a control for the co-localisation, the signal bleed-through was an important 
finding by itself. For experiments utilising the co-loading of lysosome probes, LysoTracker red and 
anti-LAMP2 antibody staining would have needed to be used with utmost caution, or ideally 
swapped for LysoTracker green or either of the CellLight probes. However, where lysosome probes 
were imaged only in a single channel, the fluorescence beyond this wavelength would not influence 
the data.  
Ultimately, these controls showed that there was some bleed through associated with LysoTracker 
red and a high background associated with immunostaining of LAMP2, but the resulting co-
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localisation was still significantly lower than when the vesicles were co-labelled with multiple 
probes. Furthermore, the LysoTracker green and the CellLight probes did not have any evidence of 
bleed-through or other fluorescence outside of the expected channel. Therefore, it was still possible 
to use these probes in combination to assess the co-localisation and therefore indicate the 
specificity of labelling achieved with each one. 
The was a high co-localisation of labelling when the composite images of co-loaded probes were 
quantified (Pearson’s co-efficient, Figure 12), which suggested that the probes were predominantly 
labelling the same population of vesicles within the cells. The vesicles were expected to be 
lysosomes based on the similarity of staining across all methods of labelling: pH dependent loading, 
LAMP1 expression and particularly the LAMP2 antibody staining. 
Despite the positive identification of the vesicles as lysosomes, some may be late endosomes due 
to the similarity of structure and protein composition of these vesicles. Hereafter, “lysosomes” 
refers to the vesicles positively identified by lysosome probes, with reasonable confidence that the 
population is representative of lysosomes but may include some late endosomes. 
 
3.4.3 Characterisation of lysosome probes for live cell imaging experiments 
As the probes were determined to be lysosome-specific, the next aim of this chapter was ‘to 
characterise the specific lysosome probes for their use in live cell imaging experiments.’ 
The characterisation comprised of a number of parameters connected to the quality of the images 
obtained and their appropriateness for analysis in accordance with the requirements of the imaging 
experiments. The capacity for bleed-through has already been discussed in the context of co-
localisation analysis. Additional parameters for the quality of LysoTracker and CellLight labelling 
included the extent and uniformity of background fluorescence and the photostability of the 
lysosome signal. 
3.4.4 Quality of fluorescence background 
Ideally, lysosome images should have a bright and clear signal localised to the lysosomes with the 
rest of the image displaying a minimal, uniform background in the cell and extracellular spaces. 
However, the use of fluorescent probes generally comes with a risk of obtaining background signal 
within the images. Background signal can be present for various reasons, such as autofluorescence 
in the cells, fluorescent interference from the buffer or accumulation of unbound indicator in the 
cell. 
A powerful tool for the removal of background from images of cells labelled with lysosome probes 
is ‘Subtract Background’ in ImageJ, utilising the ‘rolling ball radius’ method of image processing. 
When the rolling ball radius set to 5 pixels, Subtract Background removes areas of fluorescence 
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larger than lysosomes (as shown in Figure 14) from the background without affecting lysosome 
signal.  
To investigate the quality of the images of LysoTracker or CellLight labelled cells, a small study of 
lysosome fluorescence compared to background fluorescence (after background subtraction) was 
carried out with LysoTracker red and CellLight green, plotted in Figure 15. The background 
fluorescence was significantly lower than the indicator in both cases, as expected. Comparing the 
background of the images of each probe directly, there was a significantly higher fluorescence 
associated with CellLight, but again this was still relatively low. 
As well as the overall intensity of the signal, the uniformity of any background florescence was 
important to consider, particularly when running automated methods of analysis. While the 
background may have appeared similar on the screen to the human eye, there was a possibility that 
images analysis tools within ImageJ may have picked up on a more subtle variation. The difference 
in apparently similar images was illustrated in Figure 16, which showed that increasing the contrast 
revealed a different variability in the background of LysoTracker and CellLight images. The plotted 
profile illustrated the relative difference between the background of these two indicators. 
Manual image analysis carried out by a person would require vesicles to be bright enough to identify 
by eye, but the mean gray value across the image would not need to be viewable on screen for an 
algorithm to detect shapes. Therefore, there is a risk that an algorithm may segment non-lysosome 
regions in cases where the background is particularly noisy. This was further explored in Chapter 4, 
in relation to segmentation and tracking of lysosomes throughout time series imaging. 
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3.4.5 Photostability of fluorescent lysosome indicators during imaging 
The photostability of the signal was the final criteria for the lysosome probes examined in this 
chapter, as a comparison between LysoTracker and CellLight for live cell imaging. 
An analysis of photobleaching as change in fluorescence intensity (mean gray value) over time, set 
out in Figure 17 showed that LysoTracker had a higher initial signal which rapidly reduced within 
the first 10-15 seconds of continuous imaging. Conversely, the signal from CellLight was lower but 
remained more stable for the duration of imaging. This initial analysis took into account the images 
as a whole, including any background within the cells. As shown in the example images in Figure 
17, many of the cells had a cloudy background which would have increased the fluorescence 
quantified and may have been subject to a different rate of photobleaching to the labelled 
lysosomes. 
To accurately represent photobleaching of lysosome fluorescence rather than background, the 
intensity of the images was plotted after background subtraction in Figure 18. This analysis showed 
that the overall signal was reduced, as expected after the removal of background signal. Notably, 
LysoTracker was still subject to an initial drop in fluorescence but this appeared to be somewhat 
less pronounced and the signal from both LysoTracker and CellLight was more similar. This was 
most likely as when determining the exposure time on the microscope, the aim was for the 
lysosome fluorescence of LysoTracker and CellLight to have a reasonable clarity and intensity. The 
relevance of photobleaching and time series imaging was further investigated and discussed in 
relation to the segmentation and tracking of lysosomes in Chapter 5. 
 
3.5 Conclusions 
The results in this chapter provide valuable insight for the selection of an appropriate lysosome 
probe, based on the requirements of the experiment. Additionally, these data support the 
hypothesis that the lysosome probes have a high degree of overlap in labelling vesicles within a cell, 
which confirms that LysoTracker does specifically label lysosomes and late endosomes. 
LysoTracker has the advantage of rapid loading, with no protein over-expression which could 
potentially influence normal cellular functions with unknown consequences. The LysoTracker signal 
was present in all cells, with a good clarity and uniform background which was removable with the 
use of Subtract Background. LysoTracker green did not have the bleed-through issue experienced 
with LysoTracker red, making it a useful tool for co-localisation experiments. However, the 
LysoTracker probes were rapidly photobleached during imaging and therefore may not be suitable 
for extended time series recordings. This is discussed further in Chapter 5. 
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CellLight was the most versatile for imaging under live or fixed and permeabilised cells. The probe 
was pH independent, with a good stability during imaging. Although CellLight red had a relatively 
weak signal compared to the other probes, CellLight green had a brighter signal and therefore could 
be imaged with a lower exposure time. Regardless of these benefits to CellLight, there were several 
limitations including the extended time of particle incubation prior to imaging (raising practical 
difficulties in maintaining an appropriate confluency during cell culture) and the limited number of 
cells expressing the labelled protein. Finally, the unknown consequence of protein overexpression 
in cells could influence the study of CLN3 disease in unpredictable way, particularly as the CLN3 
protein is a lysosome membrane protein with its function and interactions still to be fully 
understood. 
On the whole, LysoTracker and CellLight had distinct advantages and disadvantages, but both were 
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3.6 Future work 
This chapter presented an assessment of lysosome probes which were selected to represent 
different methods of labelling lysosomes, in order to compare the specificity across the group. The 
natural expansion of this work would be the comparison of a greater number of probes, especially 
with the inclusion of any newly emerging technology which may become available.  
LysoTracker was selected as a widely used live cell lysosome probe from one of the largest brands 
to represent the family of indicators which load by accumulation within lysosomes. Alternative 
products include: Cytopainter LysoOrange Indicator (ab138895) from Abcam and LysoBrite™ 
(22645) from AAT Bioquest. As these probes all label lysosomes through accumulation and pH 
gradient, they therefore had no immediately obvious advantage over the well-established 
LysoTracker probes. However, the subtle differences between these probes may have distinguished 
them in other ways and therefore may justify a further assessment in future. In particular, as 
observed with the different extent of bleed-through from LysoTracker green and red, the properties 
of the fluorophore can differ between probes. 
The CellLight probe was chosen primarily for its versatility and lysosome labelling through 
expression of a lysosome membrane protein. Additionally, the relatively good safety profile of 
baculovirus makes this a more practical alternative than others such as adenovirus. Another option 
for lysosome staining is transfection to express a fluorescently tagged protein at the lysosome. All 
of these options would certainly be of interest for a more depth future analysis. However, it would 
be useful to determine that extent of any possible interference to normal lysosome function from 
transduction or transfection and this would need to be carefully considered before use in sensitive 
experiments.  
Finally, antibodies can be used as a highly specific manner of labelling structures when 
immunostaining is carried out correctly. The LAMP2 antibody was selected for its specificity to 
Lysosome Membrane Associated Protein 2, a common marker for lysosomes alongside Lysosome 
Associated Membrane Protein 1 (LAMP1). An interesting future study would be the comparison of 
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4 Development of an assay to analyse lysosomal positioning and 
movement 
4.1 Introduction 
Lysosomes are motile organelles that carry out numerous functions, as discussed in Chapter 1. The 
ability of lysosomes to move to new positions is directly linked to their function (Pu et al., 2016). 
The importance of analysing lysosomes in the study of CLN3 disease has already been discussed in 
Chapter 1.  The importance of selecting an appropriate lysosome indicator for imaging experiments 
was discussed in Chapter 3. 
The movement of lysosomes can be observed during live cell imaging, but quantification of this 
movement is not straightforward; especially with the aim of quantifying a large number of 
lysosomes with a high degree of accuracy. To achieve this aim, the quantification of lysosome 
movement required the following: 
• Segmentation: identification of lysosomes within an image 
• Tracking: plotting the location of each segmented lysosome on each frame 
• Calculation: measuring the parameters of lysosome movement based on the location 
 
4.1.1 Image Analysis and Quantification 
There were several possible approaches for image analysis to obtain lysosome movement data, 
which were dependent upon the nature of the images and the parameters to be quantified. The 
images captured during the experiments discussed in this chapter included: 
• Single images – allowing measurements such as number and size of lysosomes  
• Image sequences (time series) – allowing tracking of lysosome movement over time 
Based upon there being single images or image sequences, and the type of data to be quantified, 
there were a number of tools and plugins within ImageJ that presented options for the 
quantification. These tools allowed for manual, automated or combination approaches for analysis: 
• Manual analysis - quantification carried out by a person (henceforth referred to as ‘analyst’), 
such as visually identifying lysosomes in an image and counting the total number present. 
• Automated analysis – repeatable, software-driven segmentation and measurement, in which 
there is minimal input from the analyst once the relevant settings were established. 
For the lysosome analysis described in this chapter, even manual methods employed tools in ImageJ 
to improve speed and accuracy. However, these are still comparatively manual as the ultimate 
decision to identify, count or measure, a lysosome was determined by the analyst and not the 
software settings.  
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4.1.2 ImageJ plugins 
The ImageJ plugin from MOSAIC, Particle Tracker 2D/3D, henceforth referred to as ‘Particle Tracker’ 
was used to track lysosome movement in an automated manner (Sbalzarini and Koumoutsakos, 
2005). This was first introduced in Chapter 4, which detailed the settings and application of this 
plugin. The quality of the data was dependent upon good clarity of images to correctly segment 
lysosomes and the ability to track these segmented vesicles throughout each frame of a series.  
 
Aims and objectives 
Aim 1: to quantify the number of regions of lysosomes in images of cells loaded with LysoTracker 
Objectives:  
• Compare the manual (Cell Counter) and automated (Nucleus Counter) methods of lysosome 
counting 
 
Aim 2: to establish an assay to track lysosome movement in live cells 
Objectives: 
• Determine whether the photobleaching of LysoTracker fluorescence affects the ability to track 
lysosomes over time 
• Establish suitable imaging conditions for the cells, especially buffer and temperature 
• Compare lysosome tracking with the Particle Tracker plugin to an alternative method to 
measure lysosome movement (Frame Overlay)  
• Utilise the Frame Overlay method to measure movement of gross cell structures during imaging 
• Assess the extent to which the cells move during imaging and how this movement might affect 
the measurement of lysosome movement 
 
Aim 3: to examine lysosome movement and quantify the plotted trajectories 
Objectives: 
• Directly compare lysosomes with visually distinct ‘long’ and ‘short’ trajectories 
• Quantify the lysosome movement to examine: 
o The movement frame-to-frame movement of lysosomes (sum of distance) 
o The total directional distance moved by a lysosome in the cell (maximum distance) 
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Aim 4: to investigate nocodazole as a treatment to depolymerise microtubules  
Objectives: 




4.2.1 Treatment and labelling of cells 
This chapter details a number of experiments carried out using HeLa and fibroblast cell lines, which 
were cultured on glass coverslips using the methods described in Chapter 2. The buffers and 
solutions for imaging are detailed in and Table 14 and their formulations are given in Chapter 2. 
The lysosome probes, LysoTracker and CellLight were used as previously discussed in Chapter 3. 
LysoTracker loading was carried out for the majority of these experiments. For the assessment of 
buffer temperature on lysosome movement, the cells were equilibrated at room temperature or 
37°C in FluoroBrite DMEM or imaging buffer. The subsequent imaging experiments used 
FluoroBrite DMEM and all loading and imaging was carried out at 37°C. The maintenance of 37°C 
was ensured by using a cell culture incubator located close to the microscopes. The imaging 
chambers and solutions were warmed in the incubator prior to use to minimise any drop in 
temperature, and the coverslips with attached cells were incubated in the imaging chamber within 
the incubator during LysoTracker loading. After loading, the LysoTracker solution in the imaging 
chamber was exchanged with fresh warmed buffer and the imaging chamber immediately 
transferred from the incubator to the microscope in order to start an experiment. The microscope 
was already set to the approximate z-location for imaging so minimal focusing was required and 
imaging was completed in less than 3 minutes (30 s per region x 5 regions = 2.5 minutes). 
To transduce the cells with CellLight, the particles were incorporated into the cell culture medium 
surrounding the cells for 8 hours. The medium was exchanged to remove the particles and the cells 
were incubated for a further 48 hours to ensure that expression was achieved. The coverslips on 
which CellLight-expressing cells were growing were subsequently removed from the plates and 
placed in imaging chambers with care to avoid exposure to light. Apart from the viral transduction 
procedure, the cells were treated in the same manner as those loaded with LysoTracker. 
The methods for the loading of each indicator are briefly summarised in Table 14. Full details of the 
methods, including the preparation of stock solutions, are available in Chapter 2. For the cell 
movement experiments, the probes WGA and Hoechst were used to label cell membranes and 
nuclei respectively. Finally, Tubulin Tracker was used to label microtubules. 
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Table 14. Methods for the labelling and treatment of cells.  
Probe/Treatment Conditions for cell loading or treatment 
LysoTracker 50 nM (1 in 10000 dilution) in FluoroBrite DMEM for 30 minutes 
CellLight 
2.5 µl (1x108/ml) for 8 hours in GlutaMAX DMEM at 37°C and 48 hour 
incubation at 37°C in fresh GlutaMAX DMEM 
WGA 1 in 200 dilution for 15 minutes at room temperature 
Hoechst 1 in 2000 dilution for 15 minutes at room temperature 
Tubulin Tracker 1 in 2000 dilution for 1 hour at room temperature 
Nocodazole 20 µm (1/1000 dilution) solution in FluoroBrite DMEM for 30 minutes 
DMSO vehicle 
control 
1/1000 DMSO in FluoroBrite DMEM for 30 minutes 
 
For many of the lysosome movement experiments, cells were treated with nocodazole to 
depolymerise the microtubules. A solution containing either 20 µm nocodazole or DMSO was 
prepared in FluoroBrite DMEM and added to the cells for 30 minutes. Nocodazole was dissolved in 
DMSO to prepare the stock solution and therefore the DMSO vehicle control solution was prepared 
at 1 in 1000, to match the volume of DMSO in the nocodazole solution. After incubation, the control 
or nocodazole solutions were exchanged for Tubulin Tracker (Figure 45), or immediately fixed with 
15 minutes in 4% PFA and mounted to slides with Vector Shield containing Phalloidin (Figure 46).  
The imaging experiments described in this chapter all used the Leica DMI6000 fluorescence 
microscope and subsequent image analysis was carried out using ImageJ. Details of the specific 
plugins and image analysis methods are explained in full below. 
 
4.2.2 Image analysis and quantification 
The methods for counting and measuring lysosomes are set out in Figure 19. The ‘Cell Counter’ 
method refers to the visual identification of each lysosome in an image by the analyst, while the 
‘Nucleus Counter’ method refers to the software-driven segmentation of lysosomes within an 
image. Despite their names, these plugins were not used specifically for cells or nuclei in this study. 
Rather, the Nucleus Counter methods was calibrated to 5 to 100 pixels in order to segment 
lysosomes in cells loaded with LysoTracker. Both of the counting methods were used in this chapter 
but in the subsequent data presented in Chapter 5, only the Nucleus Counter method was used. 
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Figure 19. The steps for manual and automated counting of vesicles using ImageJ plugins.  
 
 
4.2.3 Cell size (area, µm2) 
As each cell was measured on an individual basis, there was little advantage to the development of 
an automated analysis of cell size. Instead, the measurement of approximate cell size was carried 
out by drawing a line around the circumference of cells in ImageJ with the ‘Freehand Selections’ 




Open image in ImageJ
Outline cell region
and 'Clear Outside'
Apply 'Grid' to the image
Run 'Cell Counter' and manually 
click on each vesicle
Record final count from Results
Nucleus Counter (automated)




set to 5.0 pixels
Run 'Nucleus Counter'
set to min. 5, max. 100
Select all labels in
'ROI Manager'
Record count from Summary
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Figure 20. Measurement of cell size, size of segmented lysosome regions and number of lysosome 
regions. The cell area was measured using the ‘Freehand Selections’ tool (represented by the yellow 
outline in the images). ‘Clear Outside’ and ‘Subtract Background’ were applied to process the image 
before measurement with ‘Nucleus Counter’ with the results of segmentation shown in the Region 
of Interest (ROI) Manager. The scale bar is 10 µm. 
 
4.2.4 Size (area, µm2) and number of segmented lysosome regions 
Following the measurement of cell size, the image was processed to clear the extracellular staining 
(particularly lysosomes in surrounding cells) and subtract the background, as shown in Figure 20.  
The automated measurement of size and number of segmented lysosome regions utilised the 
‘Nucleus Counter’ method as set out in Figure 19. The ImageJ function ‘Clear Outside’ was used to 
remove staining beyond the cell outline, in surrounding cells. This limited the quantification of 
lysosomes to each cell individually. As described previously in Chapter 3, images were processed 
with ‘Subtract Background’ set to 5 pixels rolling ball radius in order to remove any background 
signal. Finally, the ‘Nucleus Counter’ plugin (set to 5 - 100 pixels) was used to segment the 
lysosomes, presenting data such as average lysosome area (µm2) and number of segmented 
regions. Each of these steps is shown in Figure 20. The segmented regions were added to the ROI 
manager which could then apply labels to the image (shown in the final panel of Figure 20) which 
was useful to visually inspect and verify the segmentation. 
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4.2.5 Lysosome movement: Tracking 
The analysis of lysosome movement was carried out by identification of lysosomes as described 
above, followed by tracking their frame to frame movement throughout a series of images taken at 
equal intervals.  With the exception of Figure 24, all lysosome recordings were carried out with the 
most rapid achievable frame rate of 0.2 seconds per image, for 30 seconds in total. For the 
photobleaching experiment shown in Figure 24, the frame rates used are specified and the total 
imaging time was 60 seconds.  
The two methods for analysis of lysosome movement are summarised in Figure 21. With the ‘Frame 
Overlay’ method, the fluorescence images at the start and end of the recording time (30 seconds) 
were duplicated, pseudo-coloured red and green, and merged. The contrasting red and green 
colours revealed two distinct borders when movement had occurred, with the distance between 
the two colours being measurable with the line tool in ImageJ. In contrast, the use of the Particle 
Tracker method allowed for lysosomes to be tracked as a continuous pathway (‘trajectory’) on a 
frame-by-frame basis throughout the recording. The stages for this method included processing the 
image (i.e. clear outside and subtract background) before running the Particle Tracker plugin to 
generate the tracking data. 
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Figure 21. 'Frame Overlay' and 'Particle Tracker' methods for lysosome tracking. 
 
 
The settings for Particle Tracker were selected using trial and error and constant cross-referencing 
with the ‘visualise trajectories’ output to ensure that lysosomes were optimally identified and 
tracked throughout a recording.  
The lysosomes were identified in the image based on a combination of parameters: 
• Radius - approximate size of lysosomes for detection (pixels) 
• Cutoff - value calculated by the Particle Tracker algorithm to determine ‘non-particles’  
• Percentile - the fluorescence profile of the image was calculated as a percentile and the top 2% 





Open series in ImageJ
Select region and duplicate the
two frames of interest
Recolour images using the lookup table
to contrast (e.g. red and green)
Merge channels
Duplicate the regions for measurement 
and increase zoom to 600%
Use straight line tool to measure between 
edges of alternative colours
Particle Tracker




set to 5.0 pixels




Link Range  1
Displacement  5
Dynamics  Brownian
Open 'Visualise All Trajectories'
and 'All Trajectories to Table'
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The settings related to the tracking of lysosomes through subsequent images included: 
• Link Range - the number of frames used to identify individual lysosomes based on their relative 
positions  
• Displacement - the maximum expected distance moved by a particle between frames 
• Dynamics - lysosome trajectories do not have a straight, linear path and therefore fit the 
Brownian motion dynamics 
The results from Particle Tracker were presented as: (1) the ‘visualised trajectories’ illustrating each 
lysosome pathway within an image series and, (2) a data table with coordinates corresponding to 
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4.3 Results 
4.3.1  Measurement of lysosomes with Nucleus Counter 
The results in this section detail some preliminary work, establishing the quantification of vesicles 
in live cell images. The vesicles, in this case autophagosomes, were labelled with the Cyto-ID kit and 
represented structures of a similar size and shape to lysosomes. The analysis was carried out using 
neonatal rat ventricular myocytes (NRVMs). 
The quantification of number of lysosomes was carried out using ImageJ. As previously described, 
the Cell Counter method was based upon a manual count of lysosomes while the Nucleus Counter 
method utilised an automated software-driven segmentation and quantification. 
To assess the manual method in detail, five images of vesicles (labelled with CytoID) were 
duplicated and analysed three times by two different people, as shown in Figure 22A. The 
comparison revealed that there was some variation in the count of the same image by the same 
analyst and that between analysts there was a difference in the count of Image E, but this was not 
significant overall. This represents the degree of human error which is associated with manual 
measurement. A number of factors could contribute to variation from a single analyst, such as the 
length of time spent on the task and the environment which could introduce variables of tiredness 
and distraction. Additionally, while automated analysis of images takes into account their numerical 
values such as pixel intensity, the display visible to an analyst was partially dependent on the screen 
display. This was represented in Figure 22B, in which the spread of data can be seen to vary from 
image to image with repeats on three different display screens. Even when the same screen was 
used by the same analyst, there was some variable, which may be attributed to human error as 
previously stated. However, another consideration may be that each individual screen could be 
influenced by different lighting. For example, at different times of day or dependent on weather, 
such as sunlight through an adjacent window, which may create glare.  
  





Figure 22. Comparison of the results of manual vesicles counting. Autophagosomes in NRVMs 
were labelled with CytoID and imaged using the fluorescence microscope. (A) The number of 
vesicles in two images (A and E) counted three times by two different analysts (Person 1 and Person 
2). These data were analysed with an unpaired t-test and n = 3 counts per person, per image. (B) 
Scatter plot to show replicates of 5 images (A – E) counted 3 times on different display screens. 
 
The manual and automated methods of vesicle counting were compared directly: the manual count 
was an average of three analysts and the automated count was carried out using Nucleus Counter. 
There was no significant difference between these methods, suggesting that on average the data 
from either manual or automated analysis was reliable. 
 
 
Figure 23. Number of autophagosomes counted manually and using automated analysis in 
NRVMs loaded with Cyto ID. These data are presented as a mean ±S.E.M. and show no statistically 
significant difference when using an unpaired t-test. n = 5 regions on 5 coverslips. The replicates of 


























Page 73 of 264 
 
 
The analysis presented in Figure 22 and Figure 23, in which NRVMs were labelled with CytoID, was 
not further developed in this thesis. The NRVMs were not used as a cell model for further study, 
nor was CytoID used in additional experiments. However, these data present an assessment of the 
methods of vesicle counting which are applicable to the measurement of lysosomes in other cell 
types. The use of the automated Nucleus Counter method had a number of clear advantages over 
the manual Cell Counter method, although the result of the count was comparable between the 
methods indicating a reasonable level of accuracy applicable to both. Regardless, the Nucleus 
Counter method was more rapid and enabled a measurement of the area of each segmented region 
in addition to the total number. Therefore, Chapter 5 details the results of analysis carried out using 
the automated Nucleus Counter method. 
 
4.3.2 Tracking and analysis of lysosomes with Particle Tracker 
4.3.2.1 Particle Tracker settings 
As set out in Chapter 3, the careful selection of lysosome probes was important in the planning of 
imaging experiments to ensure that high quality images could be obtained for appropriate analysis. 
For the experiments investigating lysosome movement, live cells loaded with a lysosome probe 
were imaged rapidly to create a time series. The clarity of LysoTracker signal and ability to label 
lysosomes without protein over-expression made it a strong candidate for use in the tracking 
experiments. However, the photobleaching of LysoTracker (Chapter 3) could have a detrimental 
effect on the tracking.  
To test whether photobleaching influenced the data obtained using Particle Tracker, fibroblast cells 
were loaded with LysoTracker and imaged for 60 seconds. The imaging was caried out at the three 
frame rates set out in Table 15, which also illustrates the number of images recorded and the 
number of frames when reduced to half the total number in the series, which is applicable to the 
analysis in Figure 24C. The ‘reduced frames’ were essentially the removal of every other frame in 
an image sequence. This removal of frames was used as a way of seeing whether Particle Tracker 
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Table 15. Imaging speed and number of images per 60 seconds (s) recording. 
Frame rate 
(time per image; s) 
Number of images 
recorded in 60 s 
Number of frames 
taken from an image 
sequence (half) 
0.2 303 152 
0.5 120 60 
1.0 60 30 
 
 
The most rapid recording rate achievable was 0.2 s per image, due to the limiting factors of 
exposure time and microscope hardware. 1.0 s represented relatively slow imaging and therefore 
slower photobleaching, as shown in the panels of Figure 24A. The influence of the frame rate on 
photobleaching is shown in Figure 24A, in which the rapid imaging of 0.2 s and 0.5 s per frame are 
associated with a visible loss of lysosome signal shown in the comparison of first and last frames in 
image sequences. However, with an rate of 1.0 s per image the lysosome signal was still evident in 
the images. The comparative effects of different imaging rates on photobleaching is depicted in 
Figure 24B, which shows a steep decline in fluorescence when imaging at 0.2 s or 0.5 s compared 
to 1.0 s. 
To determine whether the photobleaching affected lysosome tracking, series of images recorded 
at each frame rate were measured using Particle Tracker. The image series were quantified by 
calculating the number of lysosomes identified in the first frame and the percentage of these 
organells that were sucessfully tracked throughout the 60 second imaging period (Figure 24C). As 
shown in Table 15, the imaging frame rate altered the number of images that were obtained within 
the 60 s imaging time. To detemine whether the number of frames in an image series had an impact 
on the tracking even number frames (2, 4, 6 etc.) were removed from a copy of the recordings to 
reduce the number of frames as described above, while retaining the photobleaching effect 
throughout the series. The quantificaton of lysosomes successfully tracked for each frame rate is 
shown in Figure 24C.  Data obtained using the original image series with all frames (solid bar, ‘all’ 
frames) is plotted alongside the results seen with reduced frames (striped bar, ‘half’ number of 
frames). There was no significant difference in tracking with altered imaging speed, photobleaching 
or number of frames in an image series.  
Therefore, the Particle Tracker was clearly able to continuously track lysosomes, even when the 
signal was significantly reduced by photobleaching. A large number of lysosomes were not tracked 
throughout all frames, but this was observed to be a result of events such as lysosomes passing in 
close proximity as previously discussed. The large numbers of lysosomes lost from the tracking was 
partially a consequence of the setup of the link range and displacement. In order to avoid incorrect 
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linking between neighbouring lysosomes and therefore an artificially elevated distance, the linking 
and displacement were set very low. The strict settings dramatically improved confidence in the 
measurements, but elevated the number of incompletely tracked lysosomes when the tracker was 
unable to link the frames in which a lysosome was temporarily lost. 
 
 
Figure 24. Photobleaching, frame rate and particle tracking. (A) The first and last frames of image 
series are shown to illustrate how imaging speed influenced photobleaching. LysoTracker images 
were acquired at 0.2, 0.5 and 1.0 seconds per frame over a 60-second imaging period. (B) The 
LysoTracker fluorescence intensity at each imaging speed was plotted over time. (C) The percentage 
of lysosomes tracked from first to last frame was plotted for each imaging frame rate, with tracking 
across all, or a reduced set, of the original frames. These data are plotted as mean ± S.E.M. and 
analysed with a Kruskal-Wallis test, with multiple comparisons. 
 
The results shown in Figure 24 suggest that the photobleaching of LysoTracker did not compromise 
lyososme tracking in comparison to a condition with less photobleaching. Additionally, the speed 
of imaging and number of frames did not significantly influence the tracking outcome. Taken 
together, these findings indicate that LysoTracker is a suitable probe for labelling lysosomes in these 
experiments and that the most rapid imaging speed can be used.  
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As there was no apparent detriment to lysosome tracking caused by changing imaging frame rate, 
the photobleaching of LysoTracker was of apparently little consequence. Therefore, LysoTracker 
was selected for the bulk of lysosome tracking experiments in this study. Furthermore, with 
comparable tracking across multiple imaging speeds, the most rapid imaging rate (0.2 s/frame) was 
used in order to capture the maximum detail of lysosome movement. The ability of Particle Tracker 
to continually segment and track lysosomes despite the considerable loss of LysoTracker 
fluorescence meant that this plugin was well suited to the assay. 
 
4.3.2.2 Loading and imaging of lysosome movement: buffer and temperature 
The choice of lysosome probe was not the only consideration for the tracking assay setup. The use 
of LysoTracker meant that cells could be imaged within 30 minutes of removal from cell culture. 
However, even within 30 minutes it was possible that the change of environment could influence 
lysosome movement and affect the results of this sensitive assay, the choice of solution used for 
LysoTracker loading and imaging was investigated. The extracellular solutions used in this study 
were Imaging Buffer (IB) and FluoroBrite DMEM (FB) (each solution was formulated and 
supplemented as described in Chapter 2). IB was a simple pH buffered solution, while FB was a 
supplemented medium more comparable to the cell culture medium.  
In addition to the formulation of the buffer, the effect of temperature was investigated. The 
optimum temperature for cell culture is 37°C, as maintained by cell culture incubators to mimic 
physiological body temperature. The room temperature (RT) of the laboratory was maintained at 
around 20°C. To assess whether there was an effect of temperature on lysosome movement, cells 
maintained at either RT or 37°C (as close as realistically possible) were recorded and analysed. Cells 
were incubated at RT, using buffer which had been equilibrated to RT, whilst others were incubated 
in the 37°C cell culture incubator located close to the microscopes in the imaging room. The analysis 
of lysosome movement in cells exposed to different conditions, i.e., combinations of buffer (IB or 
FB) and temperature (RT or 37°C), was plotted in Figure 25. 
Initially, the distances travelled by lysosomes during imaging was plotted by percentile (i.e., plotting 
the distance moved by a lysosome versus its relative mobility in the whole population). Plotting 
lysosome movement by percentile allows visualisation of the proportions of lysosomes with 
different degrees of motility.  As shown in Figure 25A, the majority of lysosomes moved only a small 
distance, which was similar between all temperature and buffer conditions below the top 25%. In 
the 25%, the data for lysosome movement in the different conditions began to deviate. These data 
were re-plotted on an expanded x-axis to illustrate the differences between the imaging conditions 
more clearly. The lysosome movement distance increased substantially in the top 25%, and a larger 
number of lysosomes moved a greater distance in the cells incubated at 37°C, compared to those 
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at RT. There were a greater number of lysosome movement trajectories with ‘intermediate to long’ 
distances in the cells incubated with FB, compared to cells incubated with IB in which the majority 
of trajectories were short with a sharp increase at around the top 5% to the longer trajectories. 
The mean lysosome movement distances were plotted in a bar graph in Figure 25B, with all 
replicates shown as scatter points on each bar. As the vast spread of data masks the differences 
between the means, the bars were also plotted in Figure 25C, to show the comparison more clearly. 
Lysosomes in cells incubated at 37°C had a greater distance of travel in comparison to those 
incubated at RT. There was no significant difference in lysosome movement between the cells at 
37°C when IB or FB was used. The average distance of lysosome movement was lowest in the cells 
in FB at RT, which was significantly lower than when IB was used at RT.  
Overall, analysis of the mean lysosome movement (Figure 25C) showed a significant reduction in 
lysosome movement at RT compared to 37°C. While the buffer did not immediately impact the 
results at 37°C, there was a difference between them at RT. However, looking at the upper 
percentiles where the lysosome movement distances begin to deviate for each condition, it would 
appear that there are a greater number of lysosomes travelling further in the cells with FB at 37°C 
compared to IB.  
  




Figure 25. Lysosome movement in fibroblasts equilibrated with different temperature and 
buffers. The experimental temperature for imaging was 37°C or room temperature (RT) and buffer 
was either FluoroBrite DMEM (FB) or imaging buffer (IB). (A) Lysosome movement plotted by 
percentile of least to most distance covered. (B) All individual replicates plotted on the bars. (B) 
Bars without replicates to show relationship between means. All data were plotted as mean ± 
S.E.M. and analysed with Kruskal-Wallis test with multiple comparisons where * indicates p ≤ 0.05, 
*** indicates p ≤ 0.001 and **** indicates p ≤ 0.0001. n = 470 ± 55 lysosomes from 5 cells per 
condition.  
 
With the greatest difference in distance travelled by lysosomes occurring between the upper 
percentiles of the data (Figure 25A), the lysosomes falling into the top 25% of movement were 
analysed separately, as shown in Figure 26.  The individual data points plotted in Figure 26A 
illustrated the spread of lysosome movement distances within the top 25% most motile lysosomes, 
and highlighted the pattern as seen in the percentile plots of Figure 25. As expected, analysis of 
these data taken from the top 25% most motile organelles of each dataset presented a more 
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pronounced statistical difference in lysosome movement between the imaging conditions, 
especially the effect of temperature. However, a surprising outcome was the loss of significance in 
lysosome movement between the two datasets at RT, which indicated that the difference in 
lysosome movement from these cells lay in the lower lysosome movement percentiles of the 
dataset. These analyses illustrate that lysosomes travelling a greater distance were more common 
in cells at 37°C, with FB as the buffer of choice for loading and imaging. For all subsequent 
experiments, the buffer of choice was FluoroBrite, cells were incubated at 37°C, and care was taken 




Figure 26. Comparison of the effect of imaging conditions on the most motile lysosomes 
(lysosome distances of the 75-100%). The comparative mobility of lysosomes in the top 25%. (A) 
All data were plotted with replicates as scatter points and, (B) as mean ± S.E.M. and analysed with 
a Kruskal-Wallis test with multiple comparisons where *** indicates p ≤ 0.001 and **** indicates p 
≤ 0.0001. n = 1167 ± 14 and 47 ± 6 lysosomes representing the top 25% most motile lysosomes, 
respectively, from 5 cells per condition. 
 
4.3.2.3 Establishing and verifying the ‘Frame Overlay’ and ‘Particle Tracker’ measurements of 
movement 
Having determined which lysosome probe to use and the most appropriate imaging conditions for 
tracking, the next stage was to look more closely at the lysosome movement. As presented in Figure 
25, the majority of lysosome movement (appearing to be at least 75%) covered relatively low 
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distances. These limited lysosome movements raised the possibility that the Particle Tracking assay 
may be sensitive to any background movement, originating from the cells or microscope stage.  
To address the critical question of whether cells moved during imaging experiments and thereby 
influenced the tracking of lysosomes within them, movement of cells was measured. However, 
although Particle Tracker worked well for tracking lysosomes and similar vesicles, an alternative 
method was required to look at cells. This section discusses the results of the alternative method 
that was established for the purpose of measuring the potential movement of gross cell structures. 
The results obtained with this alternative method were compared to those obtained for lysosome 
movement with Particle Tracker. 
The alternative measurement approach that was used to record movement of gross cell structures 
was the ‘Frame Overlay’ method (described in Figure 21). Cellular structures were labelled with 
fluorescent probes: WGA was used to label cell membranes, Hoechst for nuclei, and LysoTracker 
for lysosomes. Following labelling, the cells were imaged under identical conditions. Frames 
acquired at two time points during the imaging were duplicated and pseudo-coloured red and green 
to provide contrasting colours. The red and green pseudo-coloured images were then merged. If 
there was no movement, the cell structures would appear as uniform yellow pixels resulting from 
the merged red and green pseudo-colours (Figure 27, left hand panel). If there was visible 
movement, distinct red and green pixels would be evident with a measurable space in between 
(Figure 27, right hand panel). To achieve an overall measurement of movement, the labelled 
structures (nuclei or cell membranes) were measured on a minimum of three sides and the average 
measurement was taken to represent total movement. Alternatively, for lysosomes a line was 
drawn from the centre of these spherical organelles to mark their start and end locations within a 
cell. 
To track movement of the cell membrane, cells were stained with WGA and recorded for 30 
seconds, as shown in Figure 27. On the left-hand side panel of Figure 27, the cell had no visible 
movement as shown by the uniform yellow colour of the cell staining and clear border. In this 
particular example, a small piece of cell debris floated through the image and can be seen as 
distinctly red or green at its start and end locations. This debris presented a helpful contrast against 
the apparently static cell, for illustrative purposes. On the right-hand side of Figure 27, the example 
cell had clearly moved, as shown by the very distinct green and red pixels of the cell edge. The 
yellow line in this image is the ImageJ line tool which was used to quantitate the distance.  
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Figure 27. Illustration of gross movement of a fibroblast cell membrane, depicted as change in 
WGA staining colour using the Frame Overlay method. Example cells with no visible movement 
(left) and substantial movement (right). The brightness and contrast of the images was enhanced 
equally for clarity. 
 
The majority of cells had limited movement as shown on the left hand side in Figure 27, while the 
example of visible movement is from an experiment in which the cell moved due to the imaging 
chamber being incorrectly seated on the microscope. Where visible movement was present, 
recordings would be stopped, and the chamber readjusted to ensure that there was no movement 
in the final image series to be analysed. 
For a direct comparison of the Frame Overlay and Particle Tracker methods, the Frame Overlay 
method was used with a slight modification. As mentioned earlier, the lysosome movement was 
measured from the centre of the lysosome in each frame rather than the edge, as this is most 
comparable to Particle Tracker, which also measured movement from the centre of the organelles, 
as shown in Figure 28. 
Images series with examples of lysosomes with varied trajectory lengths were selected and 
duplicated in ImageJ. One copy of the image series was processed according to the Frame Overlay 
method described above (i.e., start and end frames were pseudo-coloured red and green, and then 
merged). The other copy of the image series was analysed using Particle Tracker. Using these 
approaches, it was possible to directly compare the movement of the same lysosomes using the 
Frame Overlay and Particle Tracker methods. An example of this paired analysis is shown in Figure 
28A. The line indicating lysosome movement that was measured using the Frame Overlay method 
is depicted in Figure 28A (left-hand panel). The corresponding trajectory of the same lysosome 
recorded using Particle Tracker is shown in Figure 28A (right-hand panel). The quantified data 
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presented in Figure 28B showed no significant difference in lysosome movement for the Frame 
Overlay and Particle Tracker measurements. 
 
 
Figure 28. Comparison of Frame Overlay and Particle Tracker measurement of lysosome 
movement. These data were mean ± S.E.M. and analysed with a paired t-test, n = 9 lysosomes. The 
scale bar is 1 µm. 
 
The comparison of the two methods to measure the lysosome movement over time, as shown in 
Figure 10, provided important corroboration of the Frame Overlay and Particle Tracking assays. For 
the tracking of populations of lysosomes, Frame Overlay was not a practical solution as each 
lysosome would need to be measured individually. Furthermore, it is evident from the lysosome 
movement trajectories shown in Figure 28A that the Frame Overlay could not be used to resolve 
subtle frame-by-frame movements. The Frame Overlay approach is only practically applicable to a 
single measurement of the full distance that lysosomes traverse over a period of imaging. In 
comparison, a large number of lysosomes could be tracked simultaneously using Particle Tracker 
with precise measurements even for very small frame to frame positional shifts. The advantage of 
Page 83 of 264 
 
the Frame Overlay method was that it could be used to measure movement of much larger regions, 
such as the cell membrane.  
 
4.3.2.4 Assessment of whole cell ‘background’ movement and comparison to lysosome 
movement 
To study the extent of any background cell movement that could affect the lysosome tracking data, 
fixed markers were required. As many organelles of similar size to lysosomes, such as mitochondria 
or endoplasmic reticulum, were neither discrete particles nor static within the cell they were not 
suitable as fixed markers. Therefore, to determine the extent of cell movement, nuclei and cell 
membranes were chosen. The nuclei were labelled with Hoechst, as shown in Figure 29, and cell 
membranes were labelled with WGA, as previously shown in Figure 27. The Frame Overlay method 
described above was used to examine gross movements of these cell structures. 
The nucleus illustrated in Figure 29 shows a Hoechst-labelled nucleus that was imaged for 30 
seconds as a time series using the fluorescence microscope and processed using the Frame Overlay 
method. Four fixed points (labelled with a cross and number) are indicated around the 
circumference of the nucleus, each of which was examined closely under an increased 
magnification for the presence of red or green pixels, which would indicate movement. 
Enlargement of points 1 and 2 show the subtle movement that occurred (slight green and red tinge 
to the right-hand images in Figure 29). The distance between the red and green pixels in these 
regions were measured with the ImageJ line tool. 
 
 
Figure 29. Example of a nucleus (Hoechst-stained) analysed for movement using the Frame 
Overlay method. A whole nucleus with four points of measurement is depicted. In brief, two images 
of the same nucleus were taken 30 seconds apart. One image was pseudo-coloured green, and the 
other was pseudo-coloured red. The two images were then overlaid, as described in the text. Where 
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the pixels in the red and green images overlap, the resulting merged image will appear yellow. 
Movement is shown by presence of non-overlapping green and red pixels at the edges of the 
nucleus. The scale bar is 10 µm and the enlarged images are 2x magnified. 
In order to compare the background movement (represented by nuclei and membranes) to 
lysosomes, 9 cells were labelled with LysoTracker and recorded for 30 seconds. Lysosome 
movement was plotted as distance moved by the organelles (Figure 30A), organised by percentile 
as shown earlier. The average movement of cell membranes and nuclei are shown in Figure 30A as 
straight lines intersecting the lysosome data. The right-hand panel in Figure 30A shows the distance 
moved by the least motile 20% of the lysosomal population on an expanded scale, and indicates 
that the movement of the cell membranes and nuclei intersected lysosome movement at 1.4% and 
1.5%, respectively.  
To quantify the cell movement alongside the average lysosome movement, the mean distance 
moved by lysosomes, cell membranes and nuclei were plotted in Figure 30B. The movements of the 
cell membranes and nuclei were significantly lower than that of the lysosomes. Importantly, there 
was no significant difference between the movements of the cell membranes and nuclei, which 
would be expected for fixed reference points. 
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Figure 30. Comparative analysis of the movement of lysosomes, cell membranes and nuclei 
during 30 seconds of recording. (A) Example movement of lysosomes, cell membranes and nuclei, 
with all lysosomes plotted by percentile and lines indicating the movement of cell membranes and 
nuclei respectively. (B) Data are presented as ± S.E.M. and analysed with a one-way ANOVA with 
multiple comparisons. n = average measurements of lysosomes from 9 cells and cell membranes or 
nuclei from 18 cells each. 
 
Visual inspection alone during imaging experiments is not sufficient to draw firm conclusions about 
potential movements of cells that may confound tracking of organelles. For this, an objective assay, 
such as the one using the Frame Overlay method described here, is required. The use of the cell 
membrane and nucleus as fixed reference points with the Frame Overlay method indicated that 
gross cell movement during imaging would have a negligible influence on the lysosome movement 
data. The results presented in Figure 30 indicate that >98% of the lysosomes within a cell moved 
more than the cell membrane or nucleus. Therefore, the assessment presented in Figure 30, and in 
particular the direct comparison of fixed cellular reference points with lysosome movement, was 
helpful in drawing the conclusion that there was little influence of background cellular movement 
on the results of this study. 
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4.3.3 Trajectory illustration 
Since the measurement of lysosome movement using Particle Tracker had been verified with an 
alternative method (Frame Overlay; Figure 28) and the influence of potential variables, such as 
photobleaching (Figure 24) and background movement of the cell (Figure 30) were found to be 
negligible, the plotted lysosomal trajectories obtained using Particle Tracker were considered to be 
reliable. The key outputs from Particle Tracker consisted of ‘Visualise Trajectories’ (i.e. a graphic 
showing lysosome movement during an image series; Figure 31) and a data table in which each 
lysosome’s trajectory was plotted as coordinates on a frame by frame basis. A unique identifier 
provided by Particle Tracker enabled every lysosome’s visual trajectory to be matched to the 
relevant coordinate data in the table.  
 
 
Figure 31. Example of lysosome movements displayed in the ‘Visualise Trajectories’ output from 
Particle Tracker. Lysosome movement was recorded during 30 seconds of imaging of a LysoTracker-
loaded HeLa cell. The scale bar is 10 µm. 
 
Some lysosome movement could be clearly observed during live cell imaging in HeLa and fibroblast 
cells, which was far more noticeable upon replaying the recording at a more rapid imaging speed, 
or, jumping between the first and last frame to see the extent of movement. Using the visual output 
from Particle Tracker, it was possible to observe movement in the entire population of tracked 
lysosomes with a greater clarity. 
There were several key observations with regard to lysosome movement: 
• Lysosomes continuously moved 
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• The majority of lysosomes hovered at a fixed point (‘short’ trajectories) 
• Some lysosomes had an extended, directional trajectory (‘long’ trajectories) 
Relating to those with the extended (long) trajectories: 
• Lysosomes did not travel in perfectly straight lines 
• The trajectories of different lysosomes did not generally move in parallel, even when the 
organelles were closely located 
• Extended movement was often in short bursts, with organelles stopping to hover before 
moving again 
 
In summary, lysosomes were shown to exhibit an array of movement patterns with the greatest 
distinction falling between the ‘short’ and ‘long’ trajectories. Figure 32 shows the trajectories of 
two lysosomes from the same recording of a single cell, highlighting the variation between the short 
(lysosome number 37) and long (lysosome number 306) trajectories. The total distance of the 
lysosome trajectory was 4.4 µm for lysosome 37 and 8.18 µm for lysosome 306. This indicates a 
clear difference between the movement profile of these two lysosomes. However, given that 
lysosome 37 did not move far across the cell, it is somewhat surprising that its frame-to-frame 
movements summated to over half that of lysosome 306.  
The very compact trajectory of lysosome 37 showed that although the lysosome was observed to 
be continually moving, it was potentially tethered to another structure or otherwise anchored in 
place or awaiting an interaction that would enable it to reposition within the cell. Conversely, 
lysosome 306 appeared to be travelling within the cell in a relatively linear manner, possibly along 
a microtubule. Although lysosome 306 travelled in relatively straight direction, the trajectory did 
deviate somewhat and exhibited some drift and hovering at various points. To investigate the 
extent to which lysosome movement was constant in distance (and therefore velocity) between 
frames, the trajectories of the example lysosomes 37 and 306 were divided into either three 10-
second periods, or ten 3-second periods, as illustrated in Figure 33 - Figure 36. 
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Figure 32. Plotted trajectories of lysosomes that had a short (‘37’) and long (‘306’) travel distances 
in a cells during 30 seconds of imaging. Recordings were captured during 30 seconds of rapid 
imaging of LysoTracker-loaded cells and the lysosome trajectories were mapped by Particle Tracker. 
The scale bar is 1 µm. 
 
Beginning with the lysosome that displayed a short trajectory (lysosome 37), the frame-to-frame 
movement over a 30-second imaging period was calculated and plotted for 0 - 10 s, 11 - 20 s and 
21 - 30s segments (Figure 33). The bars plotted in Figure 33 had variations in their height, and which 
indicated that lysosome 37 did not move a consistent distance throughout the three time segments. 
Additionally, within each bar there was a noticeable split in the data points for the frame-to-frame 
movements suggesting that the distance lysosome 37 moved varied from about 0.00 - 0.05 µm to 
0.10 - 0.15 µm throughout the recording. However, as shown in the Figure 33, and discussed above, 
there was no substantial change in the location of lysosome 37 within the cell.  
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Figure 33. Analysis of the movement of lysosome 37 in 10-second intervals over a 30-second 
imaging period. The frame-to-frame movements of lysosome 37 were calculated using Particle 
Tracker over a 30-second imaging period. For this plot, the frame-to-frame movements were 
grouped into 10-second intervals and plotted as mean ± S.E.M. The individual frame-frame 
movements of lysosome 37 are displayed as scatter points.  The scale bar represents 1 µm.  
 
To investigate the movement of lysosome 37 in greater detail, the same data shown in Figure 33 
was re-plotted using 3-second intervals, as shown in Figure 34. The deviation in the height of the 
bars in this Figure 16 shows a clearer picture of the changes in movement of lysosome 37, with a 
noticeable drop in movement between 3 - 13 seconds. Intriguingly, even separating the plot into 3-
second intervals there was a noticeable grouping of shorter (0.00 - 0.05 µm) and longer (0.08 - 0.17 
µm) movements. The exceptions to this variable movement were the three bars covering 3 - 13 
seconds, in which the longer movements were not evident. The decrease in movement during this 
3 - 13 second period was not obvious from visual inspection of the recording of lysosome 37’s 
movement, or when using longer imaging intervals (Figure 15), emphasising the need to employ an 
assay that can adequately resolve rapid, sub-micrometre positional changes. 
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Figure 34. Analysis of the movement of lysosome 37 in 3-second intervals over a 30-second 
imaging period. The frame-to-frame movements of lysosome 37 were calculated using Particle 
Tracker over a 30-second imaging period. For this plot, the frame-to-frame movements were 
grouped into 3-second intervals and plotted as mean ± S.E.M. The individual frame-frame 
movements of lysosome 37 are displayed as scatter points.  The scale bar represents 1 µm.  
 
The next pattern of movement analysed was that of lysosome 306 (Figure 32), which displayed a 
long trajectory. Similar to the approach used with lysosome 37, the trajectory of lysosome 306 was 
grouped into three 10-second intervals (Figure 35). The yellow, red and blue boxes drawn over the 
trajectory of lysosome 306 in Figure 35 show the distance travelled by the lysosome in each of the 
10 second windows. It is evident that the lysosome travelled less distance overall in the first 0 - 10 
seconds compared to the following two 10-second periods. This is also reflected by the bar graph, 
plotted below the trajectory. As previously seen with the short trajectory of lysosome 37 (Figure 
33, Figure 34), there were noticeable groupings of data points showing shorter (0.00 - 0.06 µm) and 
longer (0.08 - 0.24 µm) movements of lysosome 306 for each of the 10-second intervals.    
Page 91 of 264 
 
 
Figure 35. Analysis of the movement of lysosome 306 in 10-second intervals over a 30-second 
imaging period. The frame-to-frame movements of lysosome 37 were calculated using Particle 
Tracker over a 30-second imaging period. For this plot, the frame-to-frame movements were 
grouped into 10-second intervals and plotted as mean ± S.E.M. The individual frame-frame 
movements of lysosome 306 are displayed as scatter points.  The scale bar represents 1 µm. 
 
To examine the long trajectory of lysosome 306 with greater detail, the data shown in Figure 17 
were re-plotted with 3-second intervals, as shown in Figure 36. It was interesting to note that there 
was no interval in which the frame-to-frame distances were all reduced (as shown previously with 
lysosome 37; Figure 34). However, there were still noticeable groupings of data points showing 
shorter (0.00 - 0.06 µm) and longer (0.08 - 0.24 µm) movements of lysosome 306 for each of the 3-
second intervals. However, the distinction between the data points showing shorter and longer 
movements was less pronounced than with lysosome 37.  
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Figure 36. Analysis of the movement of lysosome 306 in 3-second intervals over a 30-second 
imaging period. The frame-to-frame movements of lysosome 306 were calculated using Particle 
Tracker over a 30-second imaging period. For this plot, the frame-to-frame movements were 
grouped into 3-second intervals and plotted as mean ± S.E.M. The individual frame-frame 
movements of lysosome 306 are displayed as scatter points.  The scale bar represents 1 µm.  
 
These analyses indicated that were similarities in the patterns of movement of lysosomes 37 and 
306 despite the differences in overall distance moved and their linear/non-linear trajectories. In the 
30-second imaging periods, the trajectories of both lysosomes showed some fluctuation in the 
distance moved between frames. Lysosome 37 had an approximately 10-second period in which its 
movement appeared to be reduced. 
As the grouped data shown in Figure 33 - Figure 36 still presented some questions about the overall 
fluctuation in the movement of the lysosomes, the data points for the frame-to-frame movement 
were plotted as a simple scatter plot (Figure 37). In addition, to illustrate the movement of the 
lysosomes in greater detail, the frame-to-frame movements of the lysosomes in the first and last 5 
seconds of the 30-second imaging period were plotted on an expanded scale.  
The plot for both lysosomes in Figure 37 clearly shows the groupings of data points showing shorter 
and longer movements. For lysosome 37, these movements occurred approximately within two 
bands spanning 0.00 - 0.025 µm and 0.08 - 0.17 µm (as shown in Figure 33 and Figure 34). For 
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lysosome 306, the groupings of shorter and longer movements were slightly less distinct, and the 
plotted distances were more broadly grouped within 0.00 - 0.06 µm and 0.08 - 0.24 µm (as shown 
in Figure 35 and Figure 36). The dashed lines shown in the right-hand panels of Figure 19 emphasise 
that there appeared to be rapid reversible transitions between the shorter and longer frame-to-
frame movements for both lysosomes. However, lysosome 306 displayed more of the longer frame-
to-frame movements throughout the 30-second recording. The scatter plots in Figure 37 show a 
clear differentiation between the movements of lysosomes 37 and 306; with lysosome 306 
frequently covering greater distances between frames than lysosome 37. Whilst these analyses 
show clear differences between movements of lysosomes 37 and 306, it is notable that this did not 
represent the most striking visual difference between them, which was the relative linear, 
directional movement of lysosome 306. 
 
 
Figure 37. Analysis of the movement of lysosomes 37 and 306 over a 30-second imaging period. 
The frame-to-frame movements of lysosome 306 were calculated using Particle Tracker over a 30-
second imaging period and are displayed as scatter plots. The first and last 5 seconds of the scatter 
plots are shown on expanded scales in the right-hand panels. The scale bar represents 1 µm.  
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The two examples, lysosome 37 and lysosome 306, presented an opportunity to assess the 
similarities and differences between two visually contrasting lysosome trajectories. Whilst the 
outcome from the frame-by-frame analysis indicated that there were differences in the movement 
of the organelles throughout the recordings, it left open the question of whether their trajectories 
could be differentiated by another form of analysis. Specifically, the frame-by-frame analysis of 
lysosomal movement indicated that lysosomes could undergo short and long movements, and that 
lysosome 306 that had more long movements that summated into a greater overall distance moved 
(8.18 µm). However, lysosome 37, which stayed in the same cellular region, completed a total 
movement of 4.4 µm.  
 
4.3.4 Analysis and interpretation of lysosome trajectories with Particle Tracker 
The analysis of frame-to-frame movement was extended by developing a method to quantitate the 
directionality of lysosome trajectories using Particle Tracker. A graphical summary of the method 
for quantification and presentation of lysosome trajectories using Particle Tracker is illustrated in 
Figure 38. The top panels in Figure 38represent two lysosomes (red and blue circles) tracked over 
three frames (Figure 38A). The panels show a frame-by-frame movement of the red and blue 
lysosomes. The overall trajectories of the lysosomes are shown in Figure 38B, with the 
corresponding co-ordinates relating to the movement listed in Figure 38C. In essence, Particle 
Tracker was able to provide a similar graphical representation of lysosomal movement as indicated 
in Figure 38B (‘Visualise Trajectories’; see Figure 31), and a table of the cellular coordinates of the 
lysosomes on a frame-by-frame basis, similar to that shown in Figure 38C.  
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Figure 38. Example representation of lysosomal trajectories and tracking. (A) Position of 
trajectories 1 and 2 in three separate frames. (B) Paths illustrating trajectories and, (C) coordinates 
obtained as raw data output. 
 
The coordinates obtained from Particle Tracker provided the details of location of the lysosomes in 
any particular image frame, but not specifically movement. To interpret these data further, 
additional calculations were required, and the outcomes of the analysis were planned as follows: 
• Sum: total length of the lysosome trajectory, calculated as the cumulative frame-by-frame 
movement (as shown in the analysis above) 
• Maximum: the widest span travelled by each lysosome within the cell (not necessarily the 
starting position to final location as lysosomes could travel back on themselves; see below)  
• Velocity: speed of lysosome movement calculated as distance (sum) moved over time (µm/s) 
The basic calculations were the ‘maximum distance’ (Figure 39A) and the ‘sum of distance’ (Figure 
39B). The velocity was subsequently calculated as the sum of distance divided by time. The 
illustrations in Figure 39 detail the transformation of the coordinates to a measurement of the 
distance between them, using x and y (the given coordinates) to calculate z (the distance).  
 




Figure 39. Calculation of ‘maximum distance’ and ‘sum of distance’ movements based on 
coordinates. (A) Maximum distance represents the travel between the two furthest points and (B) 
sum of distance to represents the cumulative distance of the trajectory. 
 
The aim of ‘maximum distance’ was to differentiate between lysosomes that had a relatively linear 
and elongated cellular trajectory, and those that hovered at a fixed cellular point. Conversely, the 
‘sum of distance’ (henceforth referred to as ‘sum’) is the method by which the movement between 
each frame is calculated and summated, in order to measure the total length of the trajectory. The 
sum did not take into account whether a lysosome had repositioned within a cell, but instead 
determined the overall movement of a lysosome (whether linear or hovering), which can also be 
divided by time to calculate the velocity of movement.  
Since not all lysosomes are tracked over the entirety of an imaging series (Figure 24), the first step 
in the trajectory analysis was to remove lysosomes that had not been fully tracked from the dataset. 
The number of frames per trajectory was added to the dataset and those which did not match the 
expected total number of frames in the series were filtered out. The remaining trajectories were 
then quantified based on the calculations as follows: 
1. Known ‘x’ and ‘y’ per lysosome, per frame. 
a. Maximum: x and y coordinates of the ‘minimum’ and ‘maximum’ values in the series 
b. Sum: x and y coordinates from all frames in the series 
2. Calculation of z = √ ( x2 + y2 ). 
a. Maximum: single z, distance between minimum and maximum coordinates 
b. Sum: total of each z distance between frames 
Finally, the distances were transformed from pixels to microns (distance in µm = distance in pixels 
* 0.146).  
Page 97 of 264 
 
The desired output from the maximum distance calculation was a representation of the length of 
the trajectory within the cell – the distance travelled, potentially coming into contact with other 
organelles. Therefore, the ‘minimum and maximum’ distance was used to locate the outer points 
of the area in which the lysosome travelled. An assessment of the start and end point of tracking 
would not necessarily capture the full extent of movement if a lysosome crossed back on its own 
pathway, as illustrated in Figure 40.  
 
 
Figure 40. Calculation of ‘maximum distance’ and ‘sum of distance’ movements based on 
coordinates. (A) A lysosome with a relatively linear trajectory in which the maximum distance can 
be calculated from the first and last positions of the organelle. (B) A lysosome with a more complex 
trajectory where the maximum distance cannot be calculated from the first and last positions of 
the organelle.  
 
Returning to the example movements of lysosomes 37 and 306 (Figure 41A), the results of 
maximum and sum distance were plotted for each lysosome. In Figure 41B, the sum was plotted as 
cumulative distance, indicating that lysosome 306 had a consistent and steady movement during 
the imaging period, ultimately travelling a greater distance in comparison to lysosome 37. The 
period when lysosome 37 showed only short frame-to-frame movements (Figure 34) can be seen 
in Figure 41 as the part of the cumulative distance line with a shallow incline. The sum and 
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maximum calculations for each lysosome were plotted in Figure 41C. As expected, the sum 
calculations (represented by the darker bars) were greater than the maximum. The difference 
between the two trajectories was far more pronounced when calculating the maximum distance; 




Figure 41. Analysis of the trajectories of lysosomes 37 and 306. (A) Illustration of lysosome 
trajectories for lysosomes 37 and 306. The scale bar is 1 µm. (B) The cumulative distance moved by 
lysosomes 306 and 37 The line of best fit (straight lines) represent the correlation coefficient 
(r2=0.93 and r2=0.99 for 37 and 306 respectively). (C) A quantitative comparison of the sum and 
maximum (max) distances for the two lysosomes. 
 
Additional lysosomes, from the same cellular image, were analysed for sum and maximum 
movements (Figure 42). The analysis presented in Figure 42 shows 5 lysosome trajectories that 
were considered to be long (lysosomes 306, 261, 033, 232 and 147), and 5 lysosome trajectories 
that were considered to be short (lysosomes 256, 173, 252, 037 and 185).  
The maximum distances presented in Figure 42B show a clear separation between the long and 
short lysosomal trajectories. Lysosome 232 is an example of an organelle that exhibited a great 
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amount of movement within the cell, which would not have been represented by the calculation 
based upon the first and last frame of recording. The lysosomes were organised on the graph in 
order of greatest to least maximum distance. 
This same order was retained for the distances calculated as sum of movement (Figure 42B) and 
these revealed that the variation in trajectory length was not as great as expected throughout the 
dataset. Furthermore, lysosome 252, which appeared to be hovering, had a greater total trajectory 
length than lysosome 306 which had a long trajectory.   
 
 
Figure 42. A comparison of maximum and sum distances travelled by ten lysosomes within the 
same cell. The example lysosomes in the top panel were all taken from a single recording of a 
LysoTracker loaded fibroblast cell. The scale bar is 1 µm. (A) The distances travelled by lysosomes 
calculated as maximum distance (µm). (B) The distances travelled by lysosomes calculated as sum 
distance (µm). 
 
To further examine the relationship between the sum and maximum calculations, the distances 
were plotted as a scatter chart (Figure 43A). The chart indicated a weak relationship (r2 = 0.477) 
between the points, which supported the interesting finding that a trajectory with a greater sum of 
movement did not necessarily travel a greater distance within the cell. The maximum and sum 
distances were plotted together per lysosome. The most comparable maximum and sum distances 
were in trajectory 306, which also had the most linear appearance of all, although it also had the 
shortest sum distance of all of the long trajectories.  
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Figure 43. A comparison of maximum and sum distances travelled by ten lysosomes. (A) Scatter 
plot and, (B) bar chart, showing the maximum (max) and sum of distance measurements. 
 
As the maximum distance appeared to differentiate between these examples, but the sum of the 
trajectory path was less distinctive, the examples were grouped by long and short, as shown in 
Figure 44A. The mean cumulative distance (Figure 44B) of the short and long trajectories (sum) 
showed that overall, the longer trajectories had a steeper slope and greater average distance 
achieved in 30 seconds of imaging. This was quantified as a comparison of the slope of these 
cumulative curves showed that the longer trajectories had a significantly greater slope than the 
shorter ones (Figure 44C).  
 
Page 101 of 264 
 
 
Figure 44. Comparison of example trajectories grouped by 'short' and 'long' appearance.  The 
scale bar is 1 µm. (B) The mean cumulative distance of the trajectories calculated as the sum of the 
path. (C) The comparison of the slope of each cumulative trajectory distance. These data are plotted 
as mean ±S.E.M. and analysed with an unpaired t-test where ** indicates p ≤ 0.01 and n = 5 
lysosomes per group from 1 cell.  
 
The maximum calculation showed a clearer distinction between the long and short movement 
groups and it was possible to find a significant difference. Therefore, in a much larger data set with 
the hundreds of lysosomes per cell accumulated into a data set, the distinction may be clearer if 
there was an overall change in the movement of the lysosomes. Nonetheless, there is reason to 
utilise both calculations in a thorough study of lysosome trajectories in order to systematically 
investigate both the trajectory pathway and the maximum distance of movement within a cell. 
The more interesting readout from the sum of movement was the transformation to distance over 
time to represent the velocity of movement. Therefore, the analysis would capture distance moved 
within the cell (maximum distance) to establish whether a lysosome may be tethered in place or 
under control of a motor protein, and the velocity of the overall movement of the lysosome.  
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4.3.5 A pharmacological control treatment to induce a change in lysosome movement 
The example lysosome trajectories thus far have been selected based on their appearance from a 
single cell, for the purposes of comparison. The next step was to determine whether lysosome 
movement could be influenced by a treatment to induce a phenotype in the cell, primarily to test 
the sensitivity of the assay and act as a control. 
Lysosomes travel along microtubules in order to reposition in the cell (Pu et al., 2016). Therefore, 
the disruption of microtubules is a reasonable experimental approach to reduce lysosome 
movement. This was achieved through treatment of cells with nocodazole, the effect of which is 
shown on fibroblast cells in Figure 45. The microtubules were labelled with Tubulin Tracker, and 
there was a clear loss of fluorescence in cells treated with 20 µm nocodazole for 30 minutes. This 
was quantified as the fluorescent signal (mean gray value) and shows a significant reduction in the 
signal indicating that the Tubulin Tracker fluorescence, and therefore the microtubules, were 
disrupted. The fluorescence signal was not completely removed, but no longer had the distinctive 
appearance of microtubules as the nocodazole treatment depolymerised the structure.  
 
 
Figure 45. Depolymerisation of microtubules with nocodazole treatment. Microtubules were 
labelled with TubulinTracker and imaged after 1 hour of DMSO vehicle treatment (untreated) or 20 
µm nocodazole treatment. The scale bar is 10 µm. Quantification of fluorescence of TubulinTracker 
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in untreated or nocodazole treated fibroblasts (mean gray value). These data are ±S.E.M. and 
analysed with an unpaired two tailed t-test, where * indicated p ≤ 0.05 and n = 3 coverslips. 
 
To determine whether the nocodazole treatment also influenced actin, fibroblast cells were 
treated, immediately fixed, and placed on slides in a mounting medium containing phalloidin. Three 
replicates were carried out and there was no difference between the labelling of untreated and 
nocodazole treated cells. Images of phalloidin labelled fibroblasts are shown in Figure 46 (untreated 
and nocodazole treated). 
 
 
Figure 46. Actin labelled with phalloidin in fixed fibroblast cells: untreated (left) and treated with 
nocodazole (right). The scale bar is 10 µm. 
 
The nocodazole treatment appeared to successfully depolymerise the microtubules with 20 µm 
nocodazole for 30 minutes. The effect of this microtubule depolymerisation on lysosome 
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4.3.6 Summary of results 
• The quantification of the number of lysosomes per cell was carried out using Cell Counter 
(manual method) or Nucleus Counter (automated method). 
• A variation in the total number of manually counted lysosomes was found between replicates, 
between analysts and dependent upon the display screen. Figure 22  
• Comparable results were achieved with Cell Counter and Nucleus Counter, indicating that 
either method was applicable. Figure 23  
• The Nucleus Counter method included both the number and size of segmented regions and this 
is used for the analysis described in Chapter 5. 
  
• The quantification of lysosome movement was carried out with Particle Tracker. 
• The photobleaching of LysoTracker was found to have no significant impact on the ability to 
track lysosomes with Particle Tracker. LysoTracker was selected as the preferable probe for 
subsequent imaging experiments. Figure 24  
• The number of frames and frequency of imaging did not detrimentally affect lysosome tracking 
with Particle Tracker. Therefore, lysosomes were imaged as rapidly as possible, to capture a 
high level of detail in their movement. Figure 24  
• The movement of lysosomes was influenced by a combination of buffer and temperature. 
However, the difference was most pronounced in the population of lysosomes travelling the 
greatest distances. Figure 25 and Figure 26  
• There was a larger population of lysosomes travelling greater distances (top 25%) in the cells 
which had been incubated at 37°C compared to room temperature. Figure 25 and Figure 26  
• Lysosomes in FluoroBrite DMEM at 37°C travelled a greater distance in comparison to those in 
Imaging Buffer, however the reverse was true at room temperature. Figure 25 and Figure 26  
• As the combination of 37°C and FluoroBrite DMEM most closely represented the physiological 
conditions for the cells, this condition was used for future lysosome tracking experiments. 
• To analyse lysosome movement with a second method, the manual Frame Overlay method was 
described and compared against the automated Particle Tracker. Figure 28  
• The Frame Overlay method enabled the measurement of the background cell movement, 
represented by the cell body and the nucleus which could be relatively static in comparison to 
the lysosomes. The movement of these two markers was significantly lower than that of the 
lysosomes, comparable to the lowest 1.5% of lysosome movement. Figure 30  
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• Lysosomes with characteristically different movement ‘long’ and ‘short’ pathways were 
compared in detail to assess the continuity of their movement. The short trajectory was found 
to have noticeable reduction in movement during a 10 second period out of 30 seconds. Both 
trajectories had the appearance of two bands of movement, with the distance changing from 
the high or low band between successive frames. Figure 33, Figure 34, Figure 35, Figure 36, and 
Figure 37  
• The interpretation of lysosome movement was based upon the ‘maximum distance’ and ‘sum 
of distance’ (with velocity of travel being a transformation of the latter over time). Figure 39   
• The relationship between ‘maximum’ and ‘sum’ distances was not linear. Figure 40, Figure 41, 
Figure 42 and Figure 43  
• An assessment of the ‘long’ and ‘short’ trajectories showed that despite the poor correlation 
between sum and max, on average the population of long trajectories did have a longer 
trajectory (cumulative sum). This was reflected by a significantly greater slope of distance over 
time for the cumulative movement of the longer trajectories compared to the shorter ones. 
Figure 44  
• Nocodazole treatment appeared to depolymerise microtubules, represented by a significant 
reduction in Tubulin Tracker fluorescence. However, nocodazole treatment did not have the 
same effect on actin, which was labelled with Phalloidin. Figure 45 and Figure 46 
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4.4 Discussion 
The experiments detailed in this chapter establish and compare methods for the analysis of 
lysosomes in live cells. These include the measurement of number and size of lysosomes regions, 
and the tracking of lysosome movement over time. Lysosomes were labelled with LysoTracker and 
imaged using the Leica fluorescence microscope. The methods for the quantification of these 
images was a key focus of this chapter.   
 
4.4.1 Manual vs automated analysis  
Image analysis was carried out using ImageJ, which has a number of tools available to facilitate the 
quantification of various parameters within the image. For simple quantification, functions such as 
the rectangle, straight line, or freehand selection tools can be used to measure distance, area, 
fluorescence intensity and amongst other readouts. More specific tools, such as the combination 
of Grid and Cell Counter to assist with the manual counting of lysosomes. These methods all rely on 
input from the analyst, such as drawing a line to measure the length, or the individual selection of 
each lysosome to count their total number. As the final value is determined by the analyst input, 
these methods are described as ‘manual.’ although a clearer definition may be ‘semi-automated’ 
due to the assistance of the ImageJ tools.  The Nucleus Counter and Particle Tracker plugins apply 
a software-driven segmentation to the images based on pre-determined parameters. Therefore, 
there is little input from the analyst and these methods can be described as ‘automated,’ although 
it is worth considering that a degree of input was required to initially set the parameters for 
analysis. 
Manual methods of analysis have the benefit of the enhanced decision making that a human analyst 
has over even complex algorithms. However, the same human decision making is open to error, 
subjectivity, and bias. Automated methods are highly repeatable, as a large number of images can 
be analysed with identical settings, reducing the variation associated with manual decision making. 
Furthermore, automated image analysis is carried out using the numerical data comprising the 
image, and therefore bypasses any influences such as the clarity of the display on screen.  Finally, 
the use of automated methods allows for a far greater number of replicates to be analysed 
compared to more time consuming manual approaches. 
 
4.4.2 Quantification of lysosome labelling: number and size of segmented regions of 
lysosomes 
Measurement of the number of lysosomes was carried out with both manual and automated 
analysis. However, only the automated segmentation using Nucleus Counter allowed for a 
measurement of the size of the lysosome regions. Therefore, the comparison of these methods was 
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based upon the number of lysosomes, or segmented regions of lysosome staining, which were 
counted.  The basic findings suggested that while considerable error was introduced in manual 
counting by different analysts and using different screens, the average count was comparable to 
that of the automated method. This served two purposes: to verify that the methods were 
comparable and to suggest that the variation in the manual count did not make a significant 
difference to the average when compared to the automated counting. Both methods appear to be 
comparable, and the benefits of the automated counting include its rapid application, high 
repeatability, and the measurement of size.  
The measurement of the size of segmented regions is of interest to analyse their potential 
clustering, which is discussed further in Chapter 5. Ideally, lysosomes would be counted and 
measured individually to represent the absolute number and size per cell. However, there are three 
major challenges with this: Firstly, the segmentation of individual lysosomes in a population where 
many lysosomes were closely grouped. Secondly, the diffusion of the fluorescence signal. Finally, 
the three dimensional structure of the cell and which could result in lysosomes offset from the 
plane of imaging. Each of these factors could influence the measured size of the lysosomes. 
The measurement of lysosomes based on segmentation is influenced by the number of clusters of 
lysosomes. If cells had a greater clustering of lysosomes, the number of segmented regions may be 
reduced, with the size of these increased. Therefore, while this analysis is not necessarily a reliable 
measurement of the absolute number and size of lysosomes, it presents an opportunity to assess 
regions of lysosome staining and determine the extent of lysosome clustering based upon the size 
of the regions. This was applied to the study of lysosome clustering, which is discussed in Chapter 
5. 
The diffusion of the signal associated with fluorescence imaging means that fluorescently-labelled 
structures such as lysosomes can lack a sharp boarder and may appear larger than their true size. 
If this was equally true of all lysosomes in all images, the relative size would still be useful for 
comparison purposes. However, as illustrated in Figure 47, lysosomes do not necessarily all align 
with the plane of imaging. The example lysosomes A, B and C are offset from the plane of imaging 
to different degrees and  their appearance in the image is represented below. 
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Figure 47. Cartoon to illustrate lysosome measurements. The blue line represents the plane of 
imaging (z-location), while the red structures are representative of lysosomes and the black lines 
denote measurement of these from the two dimensional image. 
 
4.4.3 The optimal conditions for imaging lysosome movement  
After lysosome counting and measurement, the second and more complex analysis of lysosomes 
relates to aims 2, 3 and 4: the tracking of lysosome movement. To establish this assay, the 
conditions first had to be optimal for imaging lysosome movement in live cells. This included the 
choice of lysosome probe to achieve high quality images that would be suitable for segmentation 
and tracking.  
As LysoTracker was the preferred probe and this was associated with a high rate of photobleaching, 
it was important to test whether the loss of signal caused a loss of lysosome tracking during analysis. 
To determine the influence of the photobleaching on the tracking, the number of lysosomes tracked 
to final frame was plotted in, comparing 0.2 s, 0.5 s and 1.0 s. The process of tracking lysosomes 
involves the identification and labelling of each lysosome per frame by the Particle Tracker plugin.  
Segmentation was driven by a number of factors. The most significant of these for photobleaching 
is the ‘percentile’ which relates to the percentile of the fluorescence profile which is considered to 
be a labelled structure, in this case LysoTracker fluorescece. Tracking lysosomes using the Particle 
Tracking plugin meant that lysosomes had to be identified in each frame of the series in order to 
plot their location throughout. If the plugin was unable to identify lysosomes due to a loss of 
fluorescence over time caused by photobleaching, this would be unsuitable. However, the results 
of Figure 24 clearly show that photobleaching did not deterimentally affect the tracking of the 
lysosomes. This may be because the photobleaching effect was constant and universal across the 
image, so the top percentile remained relative.  
Lysosomes trajectories were not always complete, but for the purposes of analysis, the trajectories 
of interest are those plotted from the first to the final frame. The data was filtered after tracking to 
remove any incomplete trajectories and therefore all data was comparable for the full 30 second 
imaging period. 
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4.4.4 Buffer and temperature 
The next stage of the assay setup was to detemine the optimal conditions for imaging, to ensure 
that the tracked lysosome movement was representative of cells in physiological conditions. The 
influence of conditions such as starvation on processes related to lysosome movement meant that 
all loading and imaging was carried out in conditions as close to cell culture as possible. For many 
experiments, live cell indicators are loaded at room temperature, in a simple imaging buffer (IB). 
For lysosome tracking, loading was carried out in the 37°C incubator and FluoroBrite DMEM (FB) 
was used in place of imaging buffer. The medium was selected for its lack of phenol red to minimise 
background fluorescence and supplemented with GlutaMAX. The medium was partially complete, 
as no serum was added to minimise the background fluorescence and avoid interference during 
loading and imaging. The lack of serum raises the possibility that the cells were subject to 
starvation, but this is likely to be minimal within the rapid 30 minute loading and 3 minutes of 
imaging. Furthermore, all cells were incubated in the same formulation, so this was not introduced 
as a variable.  
Amongst the different combinations of buffer and temperature, it was temperature that appeared 
to have the most significant impact on lysosome movement. The greatest distances were travelled 
by lysosomes in the cells incubated in FB at 37°C, followed by those incubated in IB at 37°C. 
Conversely, between the two conditions at RT, lysosomes travelled a greater distance in the cells in 
IB compared to FB. It is possible that the formulation of FB did not perform correctly at RT, as this 
is a cell culture medium designed for use within an incubator. However, the FB was pH adjusted 
and stabilised with HEPES to regulate pH independently of the C02 incubator and the pH of the 
medium was stable upon checking after completion of experiments, so it is unlikely that this was 
responsible.   Although the mean distance travelled by lysosomes was significantly different overall 
(Figure 24) the percentile plots showed that the greatest effect of temperature and buffer appeared 
to be in the lysosomes travelling the furthest (Figure 25). Analysing the top percentile of movement 
from lysosomes in the cells strengthened the significant differences between the conditions (Figure 
26).  
 
4.4.5 Background movement of lysosomes 
The Frame Overlay method was used to measure distance between structures within images taken 
at a set time apart. This was useful for: (1) the verification of Particle Tracker measurements and, 
(2) the tracking of background cell movement, which could not be analysed using Particle Tracker. 
Background movement from the cell was not expected to be the underlying cause of the measured 
lysosome movement, as the lysosome trajectories plotted by Particle Tracker clearly travelled in 
multiple dimensions. If the cell had drifted, it might be expected that all lysosomes would be 
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measured as travelling in a single direction. Regardless, any cell movement could still be enough to 
interfere with the very sensitive and detailed frame by frame measurements of lysosome 
movement.  
 
4.4.6 Characteristics of lysosome movement 
4.4.6.1 Trajectory illustrations 
The observed trajectory illustrations revealed two distinct movement patterns: ‘short’ trajectories 
which hovered at a fixed point and ‘long’ trajectories which travelled within the cell. The majority 
of lysosomes appear to have short trajectories and the difference between the movement patters 
is of interest due to its potential biological importance. As lysosomes are motile organelles, the 
ability to reposition within the cell, transport material and closely interact with other organelles 
(such as fusion with autophagosomes) is a critical part of their function. Therefore, analysing the 
maximum distance of travel is useful to examine the total trajectory length. 
The other readout for lysosome movement was the sum distance (length of trajectory, regardless 
of the directional, linear distance travelled within the cell) which was also transformed to velocity 
(distance over time). These indicated the length and speed of the trajectory overall, without 
specifically differentiating between those travelling over a distance or moving around a fixed point. 
The combination of the study of maximum distance, sum of trajectory path and velocity of 
movement all provide opportunities for the assessment of lysosome dynamics in cells healthy and 
CLN3 disease model cells, which was carried out in Chapter 5. 
The movement of lysosomes in the cell may be driven by motor proteins, or subject to diffusion 
and passive transport within the cell (Bandyopadhyay et al., 2014, Cabukusta and Neefjes, 2018). 
This may include Brownian motion occurring due to the fluid plasma membrane (Saxton and 
Jacobson, 1997). Although the movement of the cell and nucleus were found to be relatively low 
compared to the lysosome, the size of lysosomes compared to the nucleus suggests that these may 
be more suspectable to forces of passive movement such as diffusion which is discussed further in 
Chapter 5.  
The analysis of example lysosomes with long and short trajectories (306 and 37) showed that 
movement was somewhat continuous, although the short trajectory had a period in which 
movement was almost negligible. It was possible that the low level fluctuating movement was a 
result of some instability of the microscope stage which was not picked up by the analysis of total 
background movement (Figure 30). However, as both lysosomes 37 and 306 were from the same 
example, it might be expected that any influence on the cell would be observed in both trajectories 
equally. The reduction in movement of lysosome 37 at around 5 to 15 seconds is not mirrored in 
the same period of time on the plotted distances of lysosome 306.  
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The extremely rapid imaging of these lysosomes means that movement are tracked in a very precise 
and sensitive manner. This is excellent for the study of lysosome trajectories in great detail but also 
leaves the assay vulnerable to over-interpretation or perhaps minor changes from external 
influences. On the other hand, a slower recording would lose much detail of the trajectories and 
given the small size of lysosomes, even a small movement can represent a significant distance 
within the cell and perhaps an exertion of energy in response to stimulation. 
One of the possible influences on the sensitive tracking assay, especially given the extremely small 
distances being measured, is the plane of imaging. This was previously discussed in relation to 
lysosome location and therefore their apparent number and especially their size. However, with 
tracking, a slight misalignment with the plane of imaging could influence the measurements to a 
considerable degree.  
As illustrated in Figure 48, lysosome movement may not be parallel to the frame of imaging. The 
arrows (A, B and C) show differently angled trajectories; if each lysosome moved an equal distance 
in each of those directions, only lysosome B would have an accurate measurement due to being 
parallel to the axis of imaging. Conversely, A and C would appear to have shorter trajectories due 
to their travel on the z-axis. 
 
 
Figure 48. Cartoon to illustrate lysosome movement. The blue line represents the plane of imaging 
(z-location), while the red structures are representative of lysosomes and the black arrows 
represent directional movement.  
 
Two visual clues suggested that the lysosome movement was more likely to be parallel to the plane 
of imaging than perpendicular. Firstly, the appearance of the lysosomes themselves did not show 
an increase in fluorescence which would indicate that lysosomes were travelling towards the plane 
of imaging from another region. The change in LysoTracker fluorescence over time was the 
universal steady decline caused by photobleaching with no rapid drop in individual lysosome 
fluorescence to suggest a lysosome travelling away from the plane of imaging. Secondly, the Tubulin 
Tracker staining indicates that microtubules are arranged in a linear manner along the plane of 
imaging, as illustrated in Figure 49. This cell was grown on a glass coverslip and imaged using the 
fluorescence microscope, the same conditions as used for imaging lysosome movement.  
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Figure 49. Microtubules in a Tubulin Tracker loaded fibroblast cell. The microtubules have an 
organised and elongated appearance which suggests a degree of parallel with the plane of imaging. 
The scale bar is 10 µm. 
 
On the whole, it was very unlikely that the majority of lysosomes exhibiting their hovering 
movement were travelling up and down, perpendicular to the x-axis. Nonetheless, it was certainly 
possible that the trajectories were not all strictly parallel. The results were strengthened by the 
large number of lysosomes tracked per cell, the number of replicates (multiple cells, from multiple 
coverslips across multiple days) and the precise replication of the imaging conditions and analysis 
methods. The assay was carefully carried out to ensure that it was sensitive and robust despite the 
challenges associated with the three dimensional nature of the cells and the limitation of 
fluorescence imaging. 
As explained previously, the ‘link range’ which facilitated tracking of lysosomes over a greater 
distance was harshly reduced to avoid aberrant linkage. Briefly, this was due to the proximity of 
lysosomes in the cell and the high risk of linking separate lysosomes using this alogrithm. As a result, 
a large number of lysosomes were not tracked throughout each frame and this was often where 
lysosomes had come ino very close proximity (likely crossing paths above or below another, with 
the appearance of close contact due to the single z-plane of imaging). The harsh reduction of link 
range reduced the available data, but improved the accuracy of the tracking that was sucessfully 
completed. In addition to loss of segmented lysosomes from the first frame, new lysosome labels 
were added, often in place of a trajectory which had been briefly disrupted. The data was cleaned 
for broken trajectories to represent the full trajectory plotted across 30 seconds.  
The continuity of movement was illustrated through plotting the average distances in 3 or 10 
second intervals within the total 30 second imaging time (Figure 33, Figure 34, Figure 35 and Figure 
36). The plots showed that even by splitting up the frames to sections of 10% of the total imaging 
time (3 seconds) there was distinctive variation represented by the size of the S.E.M. and the 
distribution of the scatter plots representing the distance between each frame. 
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4.5 Future work 
4.5.1 The effect of temperature on lysosome movement 
The finding that temperature had a measurable influence on lysosome movement was an 
interesting result in its own right which could warrant some further investigation.   
This would be best carried out with a microscope with a chamber which would allow for the precise 
control of temperature to determine the full extent to which lysosome movement is sensitive to 
temperature. Additionally, it would be interesting to introduce some more extreme temperatures, 
such as raising the temperature of the cells above 37°C.  
 
4.5.2 The effect of buffer/nutrients on lysosome movement 
The formulation of Imaging Buffer was essentially a pH 7.4 balanced salt solution with minimal 
supplementation such as glucose. As such, Imaging Buffer missed some of the key components of 
cell culture medium such as amino acids and serum. The FluoroBrite DMEM was purchased as a 
clear alternative to cell culture medium. The FluoroBrite DMEM was additionally supplemented 
with GlutaMAX, in order to closely match the formulation of the GlutaMAX DMEM which was used 
in cell culture.  
 
4.5.3 Imaging experiments  
As an assay for lysosome movement, the tracking method has a lot of potential and this is applied 
in Chapter 5 to the study of CLN3 disease. However, in order to learn more about the specific 
dynamics of lysosome movement under normal conditions, it would be interesting to expand the 
imaging to incorporate colocalisation as a means to   
• Cellular structures: microtubules and the nucleus. If the movement of lysosomes is indeed 
along microtubules it would be valuable to plot the trajectories along these tracks in 
confirmation of the microtubule-dependent nature of this movement. The accumulation of 
lysosomes at the nucleus is associated with lysosome function and a response to conditions 
such as starvation (Pu et al., 2016). Therefore, the proximity of lysosomes to the nucleus may 
be an interesting clue to the purpose of their movement. 
• Other organelles: autophagosomes, endoplasmic reticulum and mitochondria. The observation 
that lysosomes often stopped and started their movement at set points makes it extremely 
interesting to determine whether another organelle was present at these locations. 
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Naturally, the challenge with both multiplexed imaging and z-stacks is that these dramatically 
reduce the available imaging speed and increase exposure which would photobleach the 
fluorescent probes. 
Finally, in combination with lysosome labelling, it would be interesting to express markers of early 
and late endosomes in order to compare these populations with LysoTracker-labelled vesicles. The 
extent to which lysosomes overlap with late endosomes was previously discussed in Chapter 4 and 
it would be interesting to determine whether the lysosomes with greatest movement were in fact 
late endosomes, or more structurally similar to these. As endosomes are responsible for 
endocytosis and therefore these are certainly expected to move throughout the cell (Pu et al., 
2016). 
Furthermore, an ideal use for the assay may be in combination with autophagosome labelling and 
the induction or inhibition of autophagy through pharmacological treatment of live cells. Any cell 
model with a defect in autophagy may reveal an alteration in the movement of lysosomes if their 
ability to correctly reposition to undergo autophagy is affected.  
Ultimately, the ability to track lysosomes in large numbers and a high level of detail has great 
potential for: (1) the examination of lysosome dynamics and a greater understanding of their 
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5 Examining putative effects of CLN3 knockout on lysosomal 
positioning and movement  
5.1 Introduction 
Chapters 3 and 4 outlined the empirical steps that determined the choice of lysosomal probe used 
in this study, and the careful setup for assays to analyse the numbers, clustering, and movement of 
lysosomes in live cells. Whilst the previous chapters established the essential methodology, the 
work described in this chapter depicts how the toolkit was applied to study the behaviour of 
lysosomes in cells with and without mutations in their CLN3 gene.  
Chapter 4 also established that depolymerisation of microtubules significantly inhibited lysosomal 
movement. The movement of lysosomes within cells is known to be dependent upon microtubules 
(Pu et al., 2016). Nocodazole is a well-known effector of microtubule depolymerisation in live cells. 
Numerous studies have verified the effect of nocodazole at various doses and incubation times: 10 
µM for 5 hours (Matteoni and Kreis, 1987), 20 µM for 30 minutes (Baravalle et al., 2005) and  20 
µM and 50 µM for 30 minutes (Jahreiss et al., 2008). In Chapter 4, depolymerisation of microtubules 
was demonstrated by a reduction in Tubulin Tracker staining after a treatment of 20 µM nocodazole 
for 30 minutes. Therefore, the treatment conditions were used as a positive control in this chapter 
in the study of lysosome movement in CLN3 cell models. 
 
Aims and objectives 
Aim 1: to measure lysosome clustering in CLN3 cell models 
Objectives: 
• Measure the size (area in µm2) of HeLa and fibroblast cells, to compare the WT and the CLN3 
disease model cell lines.  
• Establish whether there is a relationship between cell size and the number of segmented 
lysosome regions. 
• Measure the size of the lysosome regions segmented by Nucleus Counter (described in Chapter 
4) to determine whether the lysosome clustering effect of nocodazole treatment in HeLa cells 
could be quantified. 
• Measure the size of segmented lysosome regions to determine whether the CLN3 mutation in 
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Aim 2: to measure lysosome movement in CLN3 cell models 
Objectives:  
• Track and quantify lysosome movement in HeLa and fibroblast CLN3 cell models using Particle 
Tracker (described in Chapter 4) 
o Maximum distance of lysosome movement (distance between furthest points) 
o Velocity of lysosome movement (sum of distance over time) 
• Determine whether any changes to the distances moved by lysosomes occur for all lysosomes, 
or solely those travelling in the top 25% of moving lysosomes 




The methods for cell culture and imaging are described in Chapter 2. The methodologies used for 
lysosome counting and tracking are described in Chapter 3. The ‘Nucleus Counter’ method was used 
for segmenting, counting, and measuring the size of areas of lysosome fluorescence. The ‘Particle 
Tracker’ method was used for the tracking of lysosomes, with subsequent calculations carried out 
to determine; (1) maximum distance, representative of the distance travelled by lysosomes within 
the cell and, (2) velocity of movement, as the sum of the lysosome trajectory in a defined period of 
time to represent the overall speed of travel. 
The control cells and cell models of CLN3 disease studied in this chapter are:  
1. HeLa cell lines 
a. WT 
b. CLN3 KO 
2. Fibroblast cell lines 
a. Healthy donor (WT) 
b. CLN3 patient with the Δex7/8 mutation 
c. CLN3 patient with the D416G mutation 
The cells were untreated (DMSO vehicle control) or treated with 20 µM nocodazole for 30 minutes 
to depolymerise microtubules. To image lysosomes, the cells were loaded with LysoTracker and 









5.3.1 Accuracy in the identification of individual lysosomes vs. groups of clustered 
lysosomes 
As discussed in Chapter 4, LysoTracker staining could be quantified using the Nucleus Counter 
plugin. Images were segmented by Nucleus Counter, which recorded the total number and average 
size of these regions (area in µm2), henceforth called segmented lysosomes. Initially, this statistic 
was considered to be useful as a quantification of the approximate number of lysosomes (based on 
regions of LysoTracker staining) and their relative size. However, an observation emanating from 
the use of nocodazole-treated cells led to an additional question: does the segmentation and 
quantification achieved using Nucleus Counter accurately reflect an increase in the size of individual 
lysosomes, or may it report an increase in size because lysosomes cluster together so that individual 
lysosomes can no longer be resolved and distinguished by the segmentation?  
Cells loaded with LysoTracker were treated with nocodazole for the purpose of depolymerising 
microtubules, as first described in Chapter 4. The LysoTracker staining in untreated cells showed 
lysosomes of a similar size, shape, and intensity, distributed throughout the cells (Figure 50A). 
Conversely, the LysoTracker staining in the nocodazole treated cells showed some larger regions 
with an elliptical shape and brighter staining (Figure 50B). To determine whether this effect was a 
true representation of the lysosomes, or an effect on the LysoTracker probe, the treatment was 
repeated in cells expressing CellLight to label lysosomes. As described in Chapter 3, CellLight is a 
pH-independent probe that labels lysosomes through expression of a GFP-tagged lysosomal 
membrane protein rather than via accumulation within the lysosomes. The appearance of larger, 
brighter regions following nocodazole treatment was replicated in cells expressing CellLight, as 
shown in Figure 50. 
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Figure 50. The appearance of lysosomes in untreated and nocodazole treated cells. The panels 
show the appearance of LysoTracker and CellLight probes in: (A) untreated HeLa cells and (B) cells 
after 30 minutes 20 µM nocodazole treatment. The scale bars are 10 µm. 
 
To confirm whether the appearance of the larger, brighter, and unusually shaped regions of 
lysosome staining was caused by enlargement of individual lysosomes, or by clustering of several 
lysosomes that could not be separated using the segmentation, the fluorescence profile of several 
examples was examined (Figure 51).  
Figure 51 shows the fluorescence profiles of two distinct and separate lysosomes (Figure 51A) and 
two other lysosomes that were close in proximity but were still clearly resolved as discrete entities 
(Figure 51B). The traces shown in Figure 51 indicate the fluorescence intensities measured along a 
lines drawn through the lysosomes (yellow line in the images) in Figures 2A and B. Where the 
lysosomes were separate (Figure 51A), each lysosome had a distinct peak in the fluorescence trace. 
The lysosomes in closer proximity (Figure 51B) had two peaks which were almost merged, as the 
fluorescence intensity profile did not return to baseline in between the peaks. These data illustrate 
that lysosome fluorescence profiles may be joined, but each individual lysosome should show a 
peak towards its centre where the signal is strongest.  
 
 
Figure 51. Resolving adjacent lysosomes. (A) Two clearly distinct peaks associated with lysosomes 
that are not touching. (B) Two lysosomes in closer proximity. The fluorescence signal intensity (gray 
value) along the yellow line drawn through the image was plotted in the line traces. The scale bar 
is 1 µm. 
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Examples of both LysoTracker- and CellLight-labelled lysosomes in cells with and without 
nocodazole treatment were examined. In the untreated cells, the majority of lysosomes had a clear 
single peak as shown in Figure 52(A). In cells treated with nocodazole, the distribution of lysosomes 
was less uniform, and cells showed regions with large areas of fluorescence. A profile plotted 
through these larger areas of lysosome staining generally showed multiple peaks signifying that 
these were several individual lysosomes clustering in close proximity Figure 52(B). 
 
 
Figure 52. Comparison of lysosome distribution in untreated and nocodazole-treated cells. 
LysoTracker-loaded HeLa cells: (A) Untreated and (B) nocodazole treated. The plotted fluorescence 
profile (gray value plotted on the y-axis) illustrates the LysoTracker signal along the yellow lines. (A) 
In the top panels, single lysosomes from the image of an untreated cell can be identified in the 
images and by their single peak. (B) In the bottom panels, from the image of a nocodazole treated 
cell, the plotted profiles have a less smooth appearance with two peaks, indicating that two 
lysosomes were in close proximity. The scale bar is 1 µm in all images. 
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The treatment of cells with nocodazole induced a phenotype of lysosome clustering. The 
segmentation attainable with the Nucleus Counter plugin was not able to segment the individual 
lysosomes following nocodazole treatment, but it allowed the clustering phenotype to be 
investigated by measuring an increased area for the segmented regions, as discussed below. To 
indicate that the measured numbers and areas are not necessarily those of individual lysosomes, 
they are henceforth called ‘segmented lysosome regions.’ 
 
5.3.2 Cell size, number of lysosomes and clustering of lysosomes in HeLa cells 
To study if knockdown of CLN3 caused changes in the number of lysosomes or induced a clustering 
phenotype, untreated and nocodazole-treated WT and CLN3 KO HeLa cells, were analysed using 
the Nucleus Counter method. The number of lysosomes in a cell could be affected by the area of 
the cell, with a larger cell potentially having more lysosomes. Therefore, in a first step, cell area and 
number of lysosomes were analysed to establish if there is a relationship between cell area and the 
number of lysosomes.   
There was no significant difference between the average cell area of the WT HeLa and the CLN3 KO 
HeLa cell lines as shown in Figure 53A. Figure 53B and C show a weak relationship between cell area 
and the number of lysosomes for both cell lines. Therefore, the number of segmented lysosomes 
could be compared directly, and did not have to be normalised to cell area. 
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Figure 53. Area of HeLa cell and the relationship with number of lysosomes. (A) Area of HeLa cells 
plotted as mean ± S.E.M. with scatter points representing individual cell area. These data were 
analysed with an unpaired t-test and n = 81 cells from 9 images (from 3 coverslips on 3 days). (B) 
The number of lysosomes per cell plotted against the size of each WT cell. (C) The number of 
lysosomes per cell plotted against the size of each CLN3 KO cell. The lines show the results of a 
linear regression calculation for both data sets and indicates a weak correlation (WT, r2 = 0.36 and 
CLN3 KO, r2 = 0.24). 
 
To test whether the clustering of lysosomes in the nocodazole treated cells caused a significant 
difference in the area of the segmented lysosomes, and if this area was affected by the genotype, 
the area of segmented lysosomes was quantified (Figure 54). There was a significant increase in the 
size of the segmented lysosomes in the nocodazole treated cells. The increased area is interpreted 
as a larger number of clustered lysosomes being present in the cells. The size of the segmented 
regions does not differ between the WT and CLN3 KO cell lines, suggesting no effect of the CLN3 
mutation on clustering of lysosomes.  
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Figure 54. Lysosome clustering in HeLa cells. These data were analysed with an Ordinary one-way 
ANOVA with Tukey’s multiple comparisons test and n = 81 cells from 9 images (from 3 coverslips 
on 3 days). 
 
5.3.3 Cell area, number of lysosomes and clustering of lysosomes in fibroblasts 
Cell size, number of segmented lysosomes and their area were also analysed for the WT, Δex7/8 
and D416G fibroblast cell lines. First, it was established whether the number of segmented 
lysosomes correlated to cell area (Figure 55). No differences were found for the cell area (Figure 
55A), and, like the results in HeLa cells, only a weak correlation of cell area and number of 
segmented lysosomes was found (Figure 55B).  
 
Page 124 of 264 
 
 
Figure 55. Fibroblast cell area and number of segmented lysosome regions. These data were 
analysed with an Ordinary one-way ANOVA with Tukey’s multiple comparisons test for n = 9 cells 
(from 3 coverslips, on 3 days). The lines show the results of a linear regression calculation for each 
data set and indicate a weak correlation (WT, r2 = 0.31, Δex7/8, r2 = 0.10 and D416G, r2 = 0.20). 
 
The comparison of the WT, Δex7/8 and D416G fibroblast cell lines in Figure 56 revealed no 
significant difference between the size of the segmented lysosome regions. This suggests that there 
is no quantifiable clustering of lysosomes within any of the fibroblast cell lines.  
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Figure 56. Lysosome clustering in fibroblast cells. These data were analysed with an Ordinary one-
way ANOVA with Tukey’s multiple comparisons test and n = 9 cells (3 coverslips on 3 days). 
 
5.3.4 Tracking lysosome movement in live cell models of CLN3 disease 
The assay to track and analyse lysosome movement was explained in Chapter 4. The experiments 
described in this section detail the application of the lysosome tracking assay to the CLN3 cell 
models.  
To induce a phenotype of reduced lysosome movement in the cells, the microtubules were 
depolymerised with nocodazole treatment. DMSO was used as a vehicle control. Following these 
treatments, the cells were loaded with LysoTracker and imaged as set out in Chapter 2. The analysis 
and interpretation of the data was carried out according to the methods described in Chapter 4.  
Lysosomal movement was analysed in two ways:  
1) Maximum distance – the widest span travelled by each lysosome within the cell.  
2) Velocity – a transformation of the sum distance (total frame-by-frame movement) over 
time  
  
5.3.5 Tracking Lysosome movement in HeLa cells 
WT and CLN3 KO HeLa cells were used to investigate whether there was a change to lysosome 
movement in this cell model of CLN3 disease. The movement analysed here is the maximum 
distance, which gives an idea if a lysosome moved over a long distance in a cell.  
The movement of lysosomes for individual cells of each cell line (untreated or treated with 
nocodazole) was measured and plotted in Figure 57 to give an idea about the variability of the cells 
within each dataset. The bars represent the mean distance moved by lysosomes per cell, with the 
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scatter points showing the measured distance moved by each individual lysosome. There is some 
variation in the height of the bars which is most pronounced in the CLN3 KO cell lines and indicates 
that the mean of lysosome movement distance was not entirely consistent across the replicates 
(cells) per dataset. 
 
 
Figure 57. The maximum distance travelled by lysosomes in HeLa cells. HeLa cell lines were either 
untreated or nocodazole treated, loaded with LysoTracker and movement of lysosomes was 
recorded for 30 seconds. These data are mean ± S.E.M. per cell, with scatter points representing 
individual lysosome movement within each cell. The y-axis scale is adjusted to clearly present the 
spread of data points relative to the height of the bars for each data set. 
 
To summarise the data, the average distance of lysosome movement was plotted for each condition 
shown in Figure 58. For both the WT and CLN3 KO cell lines, nocodazole significantly reduced the 
distance travelled by lysosomes within the 30 second imaging period. There was no significant 
difference between the WT and CLN3 KO cells, which were comparable in both the untreated and 
nocodazole treated conditions. However, there was a noticeable increase in the S.E.M. of the 
distances travelled by lysosomes in CLN3 KO cell line, particularly in the untreated cells (Table 16). 
The S.E.M. of the data from the untreated cells was lower than the nocodazole treated cells, as the 
treated cells lacked the population of lysosomes travelling greater distances. 
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While nocodazole did still significantly reduce movement in lysosomes in the CLN3 KO cells, the 
significance of this difference was weaker due to the larger S.E.M. of the untreated cells.  
 
   
 
Figure 58. The mean maximum distance travelled by lysosomes in HeLa cells. HeLa cell lines were 
either untreated or nocodazole treated, loaded with LysoTracker and recorded for 30 seconds. 
These data are mean ± S.E.M. per cell, with scatter points representing mean lysosome movement 
per cell. These data were analysed with Kruskal-Wallis with Dunn’s multiple comparisons where ** 
indicates P ≤ 0.01, **** indicates P ≤ 0.0001 and n = mean distance of lysosomes in 9 cells (from 3 
coverslips on 3 days). 
 
The distances travelled by lysosomes were plotted by the percentile in Figure 59. There was a clear 
distinction between the profile of lysosome movement in untreated cells compared to nocodazole 
treated cells: a far greater number of lysosomes travelled further in the untreated cells which is 
represented by the increase of the distances as early as 50% and a very clear increase throughout 
the top 25%. Conversely, the majority of lysosomes in nocodazole-treated cells travelled very little 
and the small increase seen in the top percentiles remained far lower than that of the untreated 
cells, indicating that the directed movement over longer distances was inhibited by nocodazole. 
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Figure 59. The maximum distance travelled by each lysosome in 9 cells per condition, plotted by 
percentile. These data are plotted as distance organised by percentile of approximately 900 ± 100 
lysosomes from 9 cells (from 3 coverslips on 3 days). 
 
To directly compare the different conditions, the percentile plots were combined as shown in Figure 
60. Traces for the WT and CLN3 KO cells showed a high degree of overlap in both conditions. The 
majority of lysosomes do not move appreciably, and only lysosomes in the highest percentiles move 
a longer distance. To test if this ‘directed movement’ over a longer distance is affected in the CLN3 
KO cells, the same analysis was repeated for the top 25% (Figure 60B). However, traces for both 
cell lines still showed a great overlap in each condition.  
Therefore, while Figure 58 showed that the mean movement was comparable, Figure 60 illustrates 
the comparison of lysosome movement in greater detail. The proportion of lysosomes travelling 
different distances was very similar between the cell lines, with microtubule depolymerisation 
inducing the same reduction in lysosome movement.  
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Figure 60. A comparison of the distance travelled by each lysosome in 9 cells per condition, 
plotted by percentile. These data are plotted as distance organised by percentile of approximately 
900 ± 100 lysosomes from 9 cells, per condition. 
 
To analyse the movement of the lysosomes with longest trajectories from each data set in more 
detail, those falling within the top 25% were plotted in Figure 61. The difference in the distance 
moved between the untreated and nocodazole treated cells was more pronounced, but there was 
no significant difference between the WT and CLN3 KO HeLa cell lines. 
 
 
Figure 61. The mean maximum distance travelled by lysosomes in HeLa cells: top 25%. (A) WT and 
CLN3 KO HeLa cell lines were either untreated or nocodazole treated, loaded with LysoTracker and 
recorded for 30 seconds. These data are mean ± S.E.M. per cell and were analysed with Kruskal-
Wallis with Dunn’s multiple comparisons where **** indicates P ≤ 0.0001 and n = mean distance 
of lysosomes in 9 cells (from 3 coverslips on 3 days). (B) The right-hand side figure shows the mean 
values as a bar with distance per lysosome as scatter points on the bars.  
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The velocity of lysosome movement was calculated based on the sum of the distance over time, as 
described in Chapter 4. The sum of the distance reports the cumulative movement, which is a 
different value to the maximum distance that was presented in Figure 57 - Figure 61. The lysosomes 
moved throughout the whole recording, so the sum of the distance moved by the lysosomes divided 
by the duration of imaging yields the average velocity. While the measurement of distance presents 
information on the ability of lysosomes to travel within the cell, the velocity calculation could reveal 
a different phenotype. For example, if lysosomes could travel on microtubules but there was a 
phenotype affecting efficiency, this may be reflected in the velocity of travel.  
To provide an insight into the variability of the velocity between the different cell lines and 
conditions, the mean velocity of lysosomes per cell was plotted in a separate bar, with the velocity 
of each individual lysosome plotted as a scatter point (Figure 62). The distribution of individual 
lysosome velocities illustrates a spread of data, although the mean represented by the bars did not 
appear to be greatly variable. Unlike the measurement of distance plotted in Figure 58, the 
variability of the velocities plotted for the same cells in Figure 62 is less pronounced as all data 
points appear closer to the mean. 
 
 
Figure 62. The velocity of lysosomes in HeLa cells. HeLa cell lines were either untreated or 
nocodazole treated, loaded with LysoTracker and movement of lysosomes was recorded for 30 
seconds. These data are mean ± S.E.M. per cell, with scatter points representing individual lysosome 
movement within each cell. 
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To summarise the data, the average lysosome velocity was plotted for each condition, with the 
scatter points representing the mean distance per cell (Figure 63). This revealed a reduction in the 
movement of lysosomes in nocodazole treated CLN3 KO HeLa cells compared to the untreated WT 
HeLa cells.  
Nocodazole treatment was earlier shown to significantly reduce the maximum distance that 
lysosomes travelled in both, WT and CLN3 KO cells (Figure 58). The fact that the velocity within cells 
from the same genotype was not reduced is important to note and indicates that the sum of 




Figure 63. The mean velocity of lysosomes in HeLa cells. HeLa cell lines were either untreated or 
nocodazole treated, loaded with LysoTracker and recorded for 30 seconds. These data are mean ± 
S.E.M. per cell, with scatter points representing mean velocity of the lysosome movement per cell. 
These data were analysed with Kruskal-Wallis with Dunn’s multiple comparisons where ** indicates 
P ≤ 0.01, and n = mean distance of lysosomes in 9 cells (from 3 coverslips on 3 days). 
 
5.3.6  Tracking lysosome movement in fibroblast cells 
WT fibroblast cell lines were compared to two CLN3 patient cell lines carrying the Δex7/8 and 
D416G mutations, respectively. These cell lines were treated, imaged, and analysed in the same 
manner as the HeLa cells, with a comparison between untreated and nocodazole treated cells.  
To provide an overview of the variability of lysosomal movement in different cells, the replicates in 
Figure 64 show the distance of lysosome movement in each of the conditions, with the scatter 
points showing the distance travelled by individual lysosomes. On first inspection, the profile of 
movement within the untreated WT fibroblasts looks different to that of the CLN3 cell lines and the 
nocodazole treated fibroblasts. The untreated WT fibroblasts show lysosomes moving a far greater 
distance compared to both cell lines with mutations in CLN3 (note the difference in the y-axis 
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scales). The maximum distance lysosomes travel within the untreated CLN3 cell lines is more 
comparable to the reduction seen in the nocodazole treated cells.  
 
Figure 64. The maximum distance travelled by lysosomes in fibroblasts. Fibroblast cell lines were 
either untreated or nocodazole treated, loaded with LysoTracker and lysosome movement was 
recorded for 30 seconds. These data are mean ± S.E.M. per cell, with scatter points representing 
individual lysosome movement within each cell. 
 
To summarise these data, the average maximum distance of lysosome movement was plotted for 
each condition, with the scatter points representing the mean distance of lysosome movement per 
cell (Figure 65). As previously demonstrated in HeLa cells (Figure 58), nocodazole treatment was 
able to significantly reduce the distances travelled by lysosomes in the WT fibroblasts. However, 
this is not true of the two CLN3 patient cell lines (Δex7/8 and D416G) in which there was no 
significant reduction of movement with nocodazole treatment of these cell lines compared to their 
untreated counterparts. 
The data shown in Figure 65 has a greater S.E.M. in the untreated WT cell than any other, which 
indicates that the spread of data was greatest amongst these replicates (Table 17). This reflects 
more variation in the distances travelled by lysosomes in different cells, while all lysosome 
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movement was relatively comparable amongst the nocodazole treated WT cells and in the 
untreated and nocodazole treated CLN3 patient cell lines. 
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The untreated and nocodazole treated Δex7/8 and D416G cells are more comparable to the WT 
fibroblasts which had been treated with nocodazole. There is a significant reduction in lysosome 
movement in the Δex7/8 nocodazole-treated cells and D416G untreated and nocodazole-treated 
cells. While lysosome movement in the untreated Δex7/8 is lower than the untreated WT 
fibroblasts, this is not significant.  
  
 
Figure 65. The maximum distance travelled by lysosomes in fibroblasts. Fibroblast cell lines were 
either untreated or nocodazole treated, loaded with LysoTracker and recorded for 30 seconds. 
These data are mean ± S.E.M. per cell, with scatter points representing mean maximum distance of 
the lysosome movement per cell. These data were analysed with Kruskal-Wallis with Dunn’s 
multiple comparisons where * indicates P ≤ 0.05, ** indicates P ≤ 0.01, *** indicates P ≤ 0.001 and 
**** indicates P ≤ 0.0001 and n = mean distance of lysosomes in 9 cells (one each from 3 coverslips 
on 3 days). 
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The maximum distance of each lysosome’s movement was plotted by percentile in Figure 66, to 
examine the distribution of distances in each condition. There is an immediate difference between 
the untreated WT fibroblasts compared to all other cells and conditions, which exhibits the pattern 
of an increasing number of lysosomes travelling greater distances towards the top percentiles. 
Conversely, the nocodazole treated cells all have relatively flat distribution with the majority of 
lysosomes travelling low distances and very little increase in the top percentiles, indicating that 
lysosomes did not move over a long distance within the cells.  
The lysosome movement in the untreated Δex7/8 and D416G is greater than in the nocodazole 
treated cells and shows a moderate increase in distance of lysosomes in the top percentiles. 
However, there are far fewer lysosomes in the upper percentiles travelling longer distances and 
these do not travel as far as in the untreated WT cells.  
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Figure 66. The maximum distance travelled by each lysosome in 9 cells per condition, plotted by 
percentile. These data are plotted as distance organised by percentile of approximately 1800 ± 600 
lysosomes from 9 cells, per condition. 
 
To better compare the movement between the different genotypes and conditions, the respective 
percentile plots were combined (Figure 67), illustrating that movement of lysosomes in untreated 
WT cells differed greatly to those in the nocodazole treated WT, and both the untreated and 
nocodazole treated Δex7/8 and D416G cells. In WT cells, more cells show movement of lysosomes, 
starting before the 75%, and they travel a greater maximum distance (Figure 67). Plotting only the 
top 25% of value, more lysosomes travel a greater distance in the CLN3 patient fibroblasts without 
nocodazole treatment, compared to all cell lines that were treated with nocodazole.  




Figure 67. A comparison of the distance travelled by each lysosome in 9 cells per condition, 
plotted by percentile. These data are plotted as distance organised by percentile of approximately 
1800 ± 600 lysosomes from 9 cells, per condition. 
 
To compare lysosomes travelling the greatest distances in each condition, the top 25% were shown 
in Figure 68. Earlier it was shown that nocodazole did not reduce the maximum distance travelled 
for the two CLN3 patient cell lines (Figure 65). However, when plotting only the top 25%, there was 
a clear significant difference between all conditions. Nocodazole significantly reduced the 
maximum distance lysosomes travelled in all cell lines, WT, Δex7/8 and D416G. 
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Figure 68. The mean maximum distance travelled by lysosomes in fibroblast cells for the top 25%. 
Fibroblast cell lines were either untreated or nocodazole treated, loaded with LysoTracker and 
recorded for 30 seconds. (A) These data are mean ± S.E.M. per cell and were analysed with Kruskal-
Wallis with Dunn’s multiple comparisons where ** indicates P ≤ 0.01 and **** indicates P ≤ 0.0001 
and n = mean distance of lysosomes in 9 cells (one cell each from 3 coverslips on 3 days). (B) The 
right hand side figure shows the mean value for the maximum distance as bar, with the distance 
per lysosome as scatter points. 
 
As for HeLa cells, after analysing the maximum distance moved, additional analysis sought to 
investigate whether the velocity of the movement changed in fibroblasts of the different 
genotypes, or with nocodazole treatment. To get an impression on the variability of the data, the 
mean velocity of lysosome movement per cell was plotted in bars, with the velocities of individual 
lysosomes displayed as scatter points (Figure 69). The plotted velocities have a smaller ± S.E.M. 
compared to the plotted distances previously shown in Figure 64. There is some variation between 
the cells, which is most noticeable in the Δex7/8 cells, both untreated and nocodazole-treated. 
 




Figure 69. The velocity of lysosome movement in fibroblast cells. Fibroblast cell lines were either 
untreated or nocodazole treated, loaded with LysoTracker and recorded for 30 seconds. These data 
are mean ± S.E.M. per cell, with scatter points representing individual lysosome movement within 
each cell. 
 
To summarise the data, the mean lysosome velocities per cell were plotted (Figure 70). There was 
no significant difference between the velocity of lysosomes in any of the untreated or nocodazole 
treated pairings per cell line. However, the lysosomes in D416G cell line trended towards slower 
overall lysosome movement compared to WT and the nocodazole-treated Δex7/8 cells. The Δex7/8 
and D416G mutations did not appear to impact lysosome velocity to the same extent as their 
maximum distance (Figure 65).  
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Figure 70. The mean velocity of lysosomes in fibroblast cells. Fibroblast cell lines were either 
untreated or nocodazole treated, loaded with LysoTracker and recorded for 30 seconds. These data 
are mean ± S.E.M. per cell, with scatter points representing mean lysosome movement per cell. 
These data were analysed with Kruskal-Wallis with Dunn’s multiple comparisons where * indicates 
P ≤ 0.05, and n = mean distance of lysosomes in 9 cells (one cell each from 3 coverslips on 3 days). 
 
5.3.7 Variation in tracking results by cell type 
In HeLa cells, nocodazole treatment significantly reduced the maximum distance but not the 
velocity of lysosome movement. There was no significant difference between the WT and CLN3 KO 
cell lines in the measurement of either distance or velocity (neither when analysing all cells, nor 
when only analysing the top 25%). Conversely, when analysing all cells, nocodazole treatment was 
only able to induce a significant reduction in the WT fibroblasts, while the Δex7/8 and D416G cell 
lines did not show a significant difference between the untreated and nocodazole treated cells for 
each. One explanation for this could be a reduced maximum distance that lysosomes travelled in 
fibroblasts compared to HeLa cells which was observed when comparing the results of lysosome 
tracking in the two different cell types (Figure 71). 
In the absence of a comparable CLN3 mutation (KO, Δex7/8 or D416G) between cell lines, only the 
WT are compared. The spread of data in Figure 71A showed a very similar distribution of the 
maximum distance lysosomes moved in the HeLa cells compared to the fibroblasts: the majority of 
distances fell within a group at the bottom, with a tapered top representing a small population of 
lysosomes travelling many times greater than the mean. The mean ± S.E.M. plotted Figure 71B 
showed that lysosomes in HeLa cells travelled significantly further overall than in fibroblast cells.   




Figure 71. A comparison of the distance travelled by lysosomes in WT HeLa and WT fibroblast 
cells. (A) The left hand figure includes the individual replicates of the distance travelled by each 
lysosome. (B) These data are mean ± S.E.M. per cell and were analysed with two-tailed Mann 
Whitney test, where **** indicates P ≤ 0.0001 and n = mean distance of lysosomes in 9 cells (from 
3 coverslips on 3 days) per cell type.  
 
The percentile plot of the distances, shown in Figure 72, also illustrated the spread of data and 
shows the greater distances travelled by lysosomes in HeLa cells. Unlike previous figures showing a 
suppressed movement which was most prominent in the top percentiles (nocodazole treatment of 
cells, Figure 60 and Figure 67) this is not the cause of the lower mean distance recorded in 
fibroblasts. When plotted by percentile, HeLa and fibroblast cells have a similar shape of the curve 
in the top 25% but the distances of lysosome travel are far greater in the HeLa cells from a much 
earlier percentile. 
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Figure 72. A comparison of distance travelled by lysosomes in HeLa and fibroblast cells: 
percentile.  These data are plotted as distance organised by percentile of 1009 and 1950 lysosomes 
from 9 HeLa and 9 fibroblast cells respectively. 
 
In order to compare the velocity of lysosome movement in HeLa and fibroblast cells, the values 
found in WT cells were plotted in Figure 73, showing no significant difference between the cell 
types. Therefore, lysosomes in fibroblasts travelling a shorter maximum distance within the cells, 
they were no slower than in the HeLa cells. 
 
 
Figure 73. A comparison of the velocity of lysosomes in HeLa and fibroblast cells. (A) The left hand 
figure includes the individual replicates of the distance travelled by each lysosome. (B) These data 
are mean ± S.E.M. per cell and were analysed with two-tailed Mann Whitney test.  n = mean 
distance of lysosomes in 9 cells (from 3 coverslips on 3 days) per cell type.  
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Summary of results:  
• Counting and measurement of lysosomes were analysed using the assay described in Chapter 
4. 
• Enlarged or clustered lysosomes were observed in nocodazole-treated cells, which was 
consistent when lysosomes were labelled with LysoTracker or CellLight. The fluorescence 
profile of the large regions of lysosome signal had multiple peaks, indicating that these regions 
were indeed clusters of lysosomes. Figure 50, Figure 52 
• There was no difference in cell size between HeLa WT and CLN3 KO, or fibroblast cell lines WT, 
Δex7/8 or D416G. The correlation between cell size and number of lysosomes per cell was 
found to be weak. Therefore, the quantification of segmented lysosome regions was not 
normalised to the size of the cell. Figure 53, Figure 55 
• The effect of clustering after nocodazole treatment was assessed in HeLa cells by segmentation 
and measurement of number and size of segmented regions of LysoTracker staining. In both 
cell lines, nocodazole treatment increased the sizes of the segmented regions. There was no 
difference between the WT and CLN3 KO cell lines. Figure 54 
• The fibroblast cell lines (WT, Δex7/8 and D416G) had no significant difference in the number 
and size of segmented lysosome regions, suggesting that lysosomes were not clustering within 
any of the fibroblast cell lines. Figure 56 
• Lysosome movement was analysed using the tracking assay which was described in Chapter 4. 
• The maximum distance of lysosome movement in HeLa cells was reduced by nocodazole in both 
WT and CLN3 KO cells, and there was no difference between the WT and CLN3 cells. Figure 57, 
Figure 58 
• The reduction in movement was more pronounced when looking at the top 25% of distances 
travelled by lysosomes in the HeLa cells. Figure 61 
• There was no significant difference to velocity of lysosome movement with nocodazole 
treatment in the HeLa cells, although there was a slight reduction in velocity of lysosomes in 
the CLN3 KO cells which resulted in a significant reduction in the nocodazole treated CLN3 KO 
cells compared to the untreated WT cells. Figure 62, Figure 63 
• The maximum distance of lysosome movement in fibroblast cells was reduced by nocodazole 
only in the WT cell line. Conversely, the Δex7/8 and D416G cells already had a reduced lysosome 
movement and nocodazole was not able to further reduce this. Figure 64, Figure 65 
• When analysing only the top 25% of cells showing the longest lysosome movement, nocodazole 
significantly reduced the maximum distance moved in both CLN3 patient cell lines. Figure 68 
• This analysis also showed a reduced maximum distance for lysosomal movement in the 
untreated Δex7/8 and D416G cells compared to the WT fibroblasts.  
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• There was a significant reduction in lysosome velocity in the D416G fibroblasts, compared to 
the WT fibroblasts. This reduction in velocity was not true of the Δex7/8 fibroblasts. Figure 70 
• A comparison of WT HeLa and WT fibroblast cells revealed that lysosomes travelled greater 




The directional movement of lysosomes over longer distances is not a continuous movement, but 
could be described as saltatory, with phases of fast movement, after which the lysosome is static 
(Matteoni and Kreis, 1987). Examples for such movement, and of lysosomes returning to the place 
where they originated were shown in Chapter 4. It was found that this directional movement 
depends on microtubules and could be inhibited by nocodazole treatment.  A small percentage of 
lysosomes in nocodazole-treated cells (4%) still showed movement over shorter distances, 
consistent with Brownian motion (Matteoni and Kreis, 1987).  
The contribution of actin filaments to lysosome movement is less clear. Whilst one study found no 
effect of depolymerising actin filaments or the intermediate filaments on lysosome movement 
(Matteoni and Kreis, 1987), other studies find that lysosomes also move along actin filaments, 
mostly at the cells periphery (Cordonnier et al., 2001).  
The treatment of HeLa cells with nocodazole resulted in a visual and measurable clustering of 
lysosomes Figure 54. The nocodazole treatment was responsible for depolymerisation of the 
microtubules within the cell, therefore impacting the lysosome movement over longer distances. It 
only affected movement over shorter distances to a lesser effect, as shown by the fact that 
nocodazole did not inhibit the maximum distance that lysosomes travelled in WT fibroblasts. 
The clustering of lysosomes is described as a result of movement towards the microtubule 
organising centre (MTOC), where lysosomes interact with a number of other vesicles  (Matteoni 
and Kreis, 1987). This manner of lysosome clustering is an expected function in cells, and is 
proposed to be related to the interaction of lysosomes with other organelles, such as endosomes 
(Ba et al., 2018). 
However, normal lysosome clustering appears to be different to the clustering observed in Figure 
50 of this chapter. Firstly, clustering described in literature predominantly occurs at the MTOC 
(close to the nucleus), while the lysosome clustering seen within the nocodazole treated cells of 
this chapter was showing regions distributed throughout the cell where lysosomes were too close 
together to be segmented with the techniques used. Secondly, based on literature it may be 
expected that the depolymerisation of microtubules would decrease the clustering and increase 
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the distribution of lysosomes throughout the cell (Matteoni and Kreis, 1987). This was not the case, 
and again suggests that the clustering observed in the nocodazole treated HeLa cells was different 
from the clustering of lysosomes at the MTOC.  
To determine whether there was any clustering of lysosomes in the cell models of CLN3 disease, 
the size of segmented lysosome regions were quantified for both HeLa (WT and CLN3 KO) and 
fibroblast cells (WT, Δex7/8 and D416G) in Figure 54 and Figure 56 respectively. There was no 
clustering of the lysosomes in either of the CLN3 disease cell models to suggest a phenotype 
comparable to the inducible clustering observed in response to microtubule depolymerisation with 
nocodazole treatment.  
The disruption of microtubules has been shown with super-resolution microscopy to increase the 
number of pauses in lysosome movement, while decreasing the distances travelled (Mohan et al., 
2018). This published work presents a detailed assessment of a small number of lysosomes and 
regions with microtubule staining. 
The methodology established for a lysosome tracking assay explained in Chapter 4 was here 
implemented in the study of CLN3 disease. This presented an analysis of a large number of 
lysosomes per cell rather than relying on the qualitative assessment of single trajectories, as had 
been done before. In the WT and CLN3 KO HeLa cells, the maximum distance of lysosome travel 
was significantly reduced by depolymerisation of the microtubules with nocodazole.  
However, there was no difference between lysosome movement in the WT and CLN3 KO cells Figure 
58. Conversely, the mean velocity of lysosome movement was not affected by nocodazole 
treatment, although some effect was seen on the treated CLN3 KO HeLa cells in comparison to the 
untreated WT HeLa cells Figure 62. At best, there was a subtle reduction in velocity, but this effect 
was certainly not as pronounced as the measurable impact of maximum distances travelled by 
lysosomes. This apparent discrepancy can be explained by the fact that the velocity was calculated 
based on the sum of the distance lysosomes moved, not the maximum distance.  
In fibroblast cell lines, the WT fibroblasts exhibited a significant reduction in maximum distance of 
lysosome movement after nocodazole treatment Figure 65. However, the CLN3 patient cell lines 
(Δex7/8 and D416G) did not have a significant reduction in maximum distance of lysosome travel 
in the nocodazole treated cells due to an already reduced distance in the untreated cells, that was 
similar to that in nocodazole-treated WT fibroblasts Figure 65. Consequently, when only analysing 
the 25% of fibroblasts in which lysosomes move over the longest distance (Figure 68), nocodazole 
was found to inhibit the lysosomal movement in all fibroblast cell lines. This analysis also showed 
significantly reduced movement in fibroblasts from CLN3 patients compared to the WT.  This 
suggests that the patient cell lines have a reduced lysosome movement phenotype.  
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As previously shown in HeLa cells, nocodazole did not influence the velocity of movement in the 
fibroblast cell lines. While the maximum distance of lysosome movement was significantly affected 
in the CLN3 patient cell lines, this was not mirrored to the same extent in the measurement of 
velocity (Figure 70). However, there was some reduction in the lysosome velocity, which was 
significant in the D416G patient cell lines but not in the Δex7/8 cell lines. 
The relationship between maximum distance moved and the velocity was discussed in Chapter 4 
and found to only have a weak correlation. Therefore, the fact that changes were found to distance 
and not velocity in; (1) nocodazole treated cells and, (2) the CLN3 patient fibroblast cell lines, further 
confirms the poor relationship between maximum distance and velocity. It is important to note that 
the velocity calculation here was based on the sum of the distance, which includes the movement 
over short distances with less clear direction.  It might be suggested that this type of velocity of 
lysosomes is less dependent on microtubules and their associated motor proteins and that the 
speed of movement is dependent upon other factors. Lysosomes may be subject to diffusion by 
Brownian motion within the cell, which could go some way to explaining the baseline ‘hovering’ 
movement of lysosomes lacking the elongated, directional manner of travel (Robson et al., 2013, 
Bandyopadhyay et al., 2014).  
As the reduced lysosome movement phenotype in CLN3 patient fibroblasts was comparable to the 
nocodazole induced microtubule depolymerisation in WT cells, this could suggest that the 
phenotype is microtubule dependent. However, there was no appearance of lysosome clustering 
within any of the CLN3 cell models, which might also be a microtubule dependent process based 
on the observation and quantification in Figure 50 and Figure 54 respectively. 
Finally, the use of both HeLa and fibroblast cells in this chapter revealed that the results in the 
fibroblast patient cells were not directly comparable to the CLN3 KO HeLa cells. A comparison of 
the WT of each cell line showed that HeLa cells had a significantly greater maximum distance of 
lysosome movement overall compared to the fibroblast cells Figure 71. The change in mean 
lysosome distance was previously shown (with nocodazole treatment, or in the case of fibroblasts, 
the CLN3 mutations) to be predominantly a reduction in the top percentile of lysosome distance. 
However, when looking at the percentile plot of lysosome movement HeLa and fibroblast cells,  
(Figure 72) it was clear that rather than a loss of lysosome travelling the furthest, there were simply 
fewer of them in the fibroblast cell lines.  
As CLN3 disease is known to predominantly affect sensitive cells with less proliferation (as described 
in Chapter 1) it is possible that the HeLa cells were a less suitable model for assessing the effects 
with the sensitive lysosome movement assay than fibroblasts. Further investigation with a greater 
number of cell types, especially neuronal and cardiac, would be highly valuable.  
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5.5 Future work 
In addition to the straightforward application of the lysosome tracking assay to a far greater range 
of CLN3 cell models, or other LSD models, there are a number of more immediate opportunities for 
future work based upon this chapter. 
As the clustering of lysosomes observed in nocodazole treated cells was different from the expected 
clustering of lysosomes associated with the MTOC, a further study may be warranted to determine 
the effect of clustering under different conditions. For example, would the lysosomes in nocodazole 
treated cells reposition differently after starvation, compared to those in untreated cells. 
The results in this chapter describe a phenotype of reduced lysosome movement which was 
observed in the fibroblasts from CLN3 patients but not in the CLN3 KO HeLa cell model. To further 
interrogate the phenotype discovered in the fibroblast cell lines, the rescue or induction of the 
phenotype through manipulation of the CLN3 protein would strengthen these findings. This may be 
achieved with transfection of the CLN3 gene to express either the WT or a mutant copy of the CLN3 
protein, raising two key questions:  
• Can the reduced lysosome movement phenotype in CLN3 patient fibroblasts be rescued with 
the transfection of the WT CLN3 gene? 
• Can the reduced lysosome movement phenotype be replicated in WT fibroblasts with the 
transfection of a mutation carrying CLN3 gene? 
 
The difference between the results of the HeLa and fibroblast cell models suggests a fundamental 
consequence of either the CLN3 KO compared to patient mutations, or possible an effect of cell 
type.  
It is unlikely that the CLN3 KO was unable to replicate the effects of the disease, as this cell line 
represents a more complete disruption to CLN3 than the patient mutations. On the other hand, if 
some function of the CLN3 protein is conserved in the partial deletion or point mutation, it may be 
that the complete knock out allowed the cell to compensate for the mutation compared to the less 
severe impact of the Δex7/8 and D416G mutations. To compare this directly, a CLN3 KO fibroblast 
model would be ideal, or HeLa cells with the Δex7/8 deletion or D416G point mutation. 
An interesting point of future work would be to determine whether the reduced movement 
phenotype was induceable in HeLa CLN3 KO cells compared to HeLa WT. This may be achieved 
through manipulation of cell culture to induce stress, or otherwise influence the characteristics of 
the cells.  
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As one major difference between HeLa and fibroblast cell lines is the rapid proliferation of the HeLa 
cells, it may be possible to observe a phenotype if cells were inactivated. The mitotic inactivation 
of cells is described in Chapter 8 in relation to Mouse Embryonic Fibroblasts and this treatment 
could be applied to the HeLa cells. The rationale for these experiments is that the phenotype may 
be masked by the rapid proliferation of the cells in culture and mitotic inactivation would allow for 
the cells to be maintained in culture for longer and possibly in time to develop a phenotype.  
Finally, as previously discussed, there appeared to be a difference between the lysosomes which 
were moving by diffusion and those with directed motion. A method of analysis to differentiate 
particle movement based on these effects is Mean Square Displacement (MSD), which has been 
previously described in literature (Burlakov et al., 2010, Qian et al., 1991). This method would allow 
for lysosomes with movement that correlated to the longer trajectories, to be mathematically 
identified as directed movement rather than diffusion. As shown in this chapter, the differences 
between lysosome movement, arising from nocodazole treatment or CLN3 patient mutations, 
appeared to be found in the longest trajectories when these were plotted by percentile, rather than 
those which were likely to be diffusing. Therefore, implementation of MSD could be a great asset 
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6 Examining putative effects of CLN3 knockout on mitochondrial 




Mitochondria are important components of the calcium signalling toolkit. It has been widely 
demonstrated that mitochondria sequester calcium from the bulk cytosol at a relatively slow rate, 
and at a significantly faster rate when calcium channels on organelles proximal to mitochondria are 
activated (Collins et al., 2001). The sequestration of calcium by mitochondria buffers cytosolic 
calcium rises and can prevent the spreading of intracellular calcium waves (Mackenzie et al., 2004, 
Tinel et al., 1999). In addition, increases in calcium concentration within the mitochondrial matrix 
are linked to the stimulation of mitochondrial respiration via the activation of calcium-sensitive 
dehydrogenases within the citric acid cycle (Jouaville et al., 1999). Moreover, calcium uptake by 
mitochondria underlies the induction of apoptosis (Pinton et al., 2008, Harr and Distelhorst, 2010), 
and reduction of mitochondrial calcium uptake is one mechanism that cancer cells employ to 
escape cell death and gain a survival advantage (Distelhorst and Bootman, 2019). 
Dysfunctional mitochondria are common aspects of the pathology of neurodegenerative diseases 
including Parkinson’s and Alzheimer’s (Osellame and Duchen, 2013, Demers-Lamarche et al., 2016). 
The impairment of mitochondria in neurodegenerative diseases has also been linked to some 
lysosomal storage disorders, such as Gaucher disease (Osellame and Duchen, 2013). Complex 
dysfunctions in mitochondrial form and function have also been described in cell models of CLN3 
disease. These observations include alteration in mitochondrial membrane polarisation and Ca2+ 
storage in a CLN3 cell model carrying the Δex7/8 mutation (Chandrachud et al., 2015), and 
abnormal elongation of mitochondria and a decrease in cellular ATP (Fossale et al., 2004). 
Mitochondria and lysosomes are both dynamic and important organelles that are known to 
interact, especially through Ca2+ signalling (Peng et al., 2020).  A link between mitochondrial 
dysfunction and lysosomes has been described in neurodegenerative disease, with the generation 
of reactive oxygen species (ROS) as the proposed cause of lysosome impairment (Demers-Lamarche 
et al., 2016). Cells routinely produce ROS as a by-product of the oxidation of metabolites (Murphy, 
2009). In most cell types, mitochondria are the principal producers of ROS, with superoxide (O2-) 
being the most common product. Since this oxygen radical is highly reactive and can damage 
cellular proteins and lipids, it is typically rapidly reduced to hydrogen peroxide by superoxide 
dismutase. However, hydrogen peroxide, and other oxidative species, can still be harmful inside 
cells. Note: generally, ROS refers to both radical (e.g., superoxide and hydroxyl) and non-radical 
(e.g., hydrogen peroxide) oxidising species (Zorov et al., 2014). Whilst some ROS production is 
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physiological, a persistent accumulation of ROS likely to tip the balance toward pathological 
outcomes. Moreover, ROS production can lead to an autocatalytic effect, known as ROS-induced 
ROS release that can spiral out of control and cause cell death. A lack of mitophagy, preventing the 
removal of ROS-producing dysfunctional mitochondria has been linked to many of the phenotypic 
alterations that characterise Parkinson’s disease (Park et al., 2018). In addition to increased ROS 
production causing cellular damage, a decrease in the mechanisms by which cells buffer ROS 
production, such as production of the tripeptide glutathione, have been shown to lead to increased 
oxidative stress (Jahoor et al., 2019). With CLN3 disease, ROS production was found to be slightly 
increased (and to a greater extent, it is increased in CLN2 disease) (Vidal-Donet et al., 2013). In 
Drosophila, loss of CLN3 function sensitised the cells to ROS, suggesting a link between the role of 
the CLN3 protein and the response to ROS (Tuxworth et al., 2011).  
 
Aim 1: to characterise mitochondrial function 
Objectives: 
• Compare the mitochondrial membrane potential in wild type and CLN3 mutant cells 
 
Aim 2: to characterise ROS levels in the CLN3 HeLa cell model 
Objectives: 
• Characterise ROS levels in wild type and CLN3 mutant cells 
• Measure basal ROS levels and responses to challenge with ROS donors in wild type and CLN3 
mutant cells 
 
Aim 3: to characterise the calcium release from the endoplasmic reticulum (ER) 
Objectives: 
• Analyse Ca2+ release from the ER in response to agonist stimulation in wild type and CLN3 
mutant cells 
Compare mitochondrial Ca2+ uptake following agonist stimulation of cells in wild type and CLN3 
mutant cells  
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6.2 Methods 
The methods for cell culture, details of fluorescence imaging, and the preparation of chambers for 
fluorescence imaging of live cells are described in Chapter 2. These experiments were carried out 
using the Leica fluorescence microscope. WT and CLN3 KO HeLa cells grown on glass coverslips in 
12-well plates were transferred to imaging chambers just prior to use in an experiment. The loading 
and imaging buffer used in the TMRE and ROS Brite experiments was FluoroBrite DMEM (FB), 
supplemented with GlutaMAX and adjusted to pH 7.3 with HEPES to stabilise. The loading and 
imaging buffer used in the Cal-520/Rhod-2 experiments was HBSS, adjusted to pH 7.3. 
 
6.2.1 TMRE 
Tetramethylrhodamine ethyl ester (TMRE) was used to measure mitochondrial membrane 
potential (ΔΨm) in live cells. WT and CLN3 KO HeLa cells were loaded with 2 µm TMRE in FluoroBrite 
DMEM (FB) for 15 minutes. The loading solution was exchanged for fresh FB containing 0.1 µM 
TMRE immediately before imaging. The cells were imaged for 180 seconds, and at 60 seconds the 
solution was exchanged by superfusion of the cells with FB supplemented with either DMSO or 
FCCP.  
 
Table 18. The solutions used in the TMRE experiments. 
Compound Concentration Diluent Application 
TMRE 2 µM FluoroBrite DMEM Indicator 
DMSO 1 in 1000 dilution 
FluoroBrite DMEM 
with 0.1 µM TMRE 
Negative (vehicle) control 
FCCP 20 µM Positive control 
 
 
6.2.2 ROS Brite 
WT and CLN3 KO HeLa cells were incubated in a solution of FB containing either tBHP (150 µM), 
H2O2 (150 µM), or DMSO (1 in 500 dilution) for 1.5 hours. The cells were loaded with 5 µM ROS 
Brite 570 in FB for 15 minutes and the loading solution was exchanged for fresh FB immediately 
before imaging. The cells were imaged for 180 seconds to record a time series. 
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Table 19. The solutions used in the ROS Brite experiments. 
Compound Concentration Diluent Application 
ROSBrite 5 µM 
FluoroBrite DMEM 
Indicator 
DMSO 1 in 500 dilution Negative (vehicle) control 
tBHP 150 µM 
Positive control 
H2O2 1 mM 
 
 
6.2.3 Mito calcium – Cal-520/Rhod-2 
WT and CLN3 KO HeLa cells were loaded with of 1 µM Cal-520 and 1 µM Rhod-2 in HBSS for 30 
minutes, followed by 30 minutes of de-esterification in HBSS. Once placed on the microscope stage, 
the cells were superfused with HBSS as a wash before imaging and to confirm that there was no 
calcium response during the exchange of imaging medium. The cells were subsequently imaged for 
210 seconds, with the addition of 100 µM ATP in HBSS by superfusion at 30 seconds.   
 
Table 20. The solutions used in the Cal-520/Rhod-2 experiments. 
Compound Concentration Diluent Application 
Cal-520 1 µM HBSS with Rhod-2 
Indicator loading 
Rhod-2 1 µM HBSS with Cal-520 
N/A N/A HBSS Indicator de-esterification 
ATP 100 µM HBSS Agonist 
 
 
The recordings were quantified in ImageJ through the placement of an ROI on every cell and use of 
the Time Series Analyser V2 to record fluorescence signal over time. 
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6.3 Results 
6.3.1 Assessing mitochondrial polarity using TMRE 
The cationic cell-permeant fluorescent indicator TMRE was used to assess mitochondrial 
membrane in wild type and cells bearing a CLN3 mutation. Due to its cationic characteristic, TMRE 
partitions across cell membranes in proportion to the voltage across the membrane (i.e., in a 
Nernstian manner) (Perry et al., 2011). Since TMRE can traverse cell membranes rapidly, any change 
in membrane potential will lead to a re-equilibration of the TMRE concentration across the 
membrane that can be monitored using fluorescence imaging. The mitochondrial matrix is highly 
negative with respect to the outside of the cell (Δψm ~150 mV), TMRE accumulates significantly 
within active, polarised mitochondria and measures the potential across the inner mitochondrial 
membrane. TMRE has therefore been used in many studies to assess mitochondrial polarity and 
energetics. 
In this study, TMRE was loaded into cells grown on glass coverslips, as described in Chapter 2. 
Example images, illustrating the accumulation of TMRE within cells are shown in Figures 1Ai and 
Aiii. The TMRE fluorescence was relatively stable within the cells for a period of 3 minutes of 
recording. There was a gradual decline of the TMRE fluorescence that was likely due to TMRE 
leaving the cells or photobleaching. Superfusing the cells with extracellular solution (FB) caused an 
acute decrease in the cellular TMRE fluorescence (c.f. Figure 74Ai and Figure 74Aii; note that the 
timings for image capture and solution additions are indicated in Figure 74B). This drop in 
fluorescence was expected since TMRE partitions in a Nernstian manner across the plasma 
membrane and washing away the extracellular TMRE component would cause re-equilibration of 
the TMRE within the cell. Superfusion of cells with extracellular solution containing the 
mitochondrial uncoupler FCCP caused a significant drop in the TMRE fluorescence in both wild type 
and CLN3 KO cells (cf. Figure 74Aiii and Figure 74Aiv). The time course of changes in the TMRE signal 
is depicted in Figure 74C and D.  
Quantitation of the absolute change in TMRE fluorescence caused by superfusion with either 
extracellular solution or extracellular solution + FCCP is shown in Figure 2A. These data indicate that 
superfusion with extracellular solution alone evoked a ~10% decline in TMRE fluorescence, whilst 
the application of FCCP provoked a ~40% reduction in TMRE fluorescence. The extent of the decline 
in TMRE fluorescence caused by either extracellular solution or FCCP was not different between 
the wild type or CLN3 KO cells (Figure 75A).  
Page 154 of 264 
 
 
Figure 74. TMRE fluorescence in wild type and CLN3 KO cells. HeLa cells loaded with TMRE were 
imaged for 60 seconds prior to the addition of either a control solution or a solution containing 20 
µM FCCP. (A) Images of TMRE loaded HeLa cells before and after the treatments indicated. The 
scale bar indicates 10 µm. (B) Timeline of imaging experiment and solution addition at 60 seconds. 
Images used for analysis were taken from frames at 10 s and 70 s, pre- and post- addition. (C) TMRE 
signal in WT HeLa cells, plotted over time. (D) TMRE signal in CLN3 KO HeLa cells, plotted over time. 
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Figure 75. Quantitation of TMRE fluorescence in wild type and CLN3 KO cells. HeLa cells were 
untreated or treated with positive control (20 µM FCCP) to induce mitochondrial depolarisation. 
(A) shows absolute TMRE fluorescence levels in untreated and FCCP-treated cells. (B) depicts the 
normalised post-FCCP TMRE fluorescence. The bars indicate that the FCCP diminished TMRE 
fluorescence by a similar proportion in both WT and CLN3 KO cells. These data were analysed with 
an Ordinary one-way ANOVA with Tukey’s multiple comparisons test where **** indicates P ≤ 
0.0001. These data are mean ± S.E.M. per cell, with scatter points representing individual lysosome 
movement within each cell and n = 27 cells (from 3 coverslips on 3 days). 
 
6.3.2 Assessing ROS production using ROS Brite 
Cells produce a variety of chemically reactive molecules that are collectively termed reactive oxygen 
species (usually abbreviated to ROS) that can lead to cell damage, for example via lipid peroxidation. 
ROS molecules include superoxide, hydroxyl radicals and peroxides, which can originate from 
cellular metabolism, and in particular via mitochondrial electron transport (Connolly et al., 2018). 
The production of ROS occurs in physiological conditions but can accelerate in pathological 
situations such as with mitochondrial dysfunction.  
In this study, the ROS indicator ROS Brite was loaded into cells grown on glass coverslips, as 
described in Chapter 2. ROS Brite is weakly fluorescent until it is oxidised. The rate of increase in 
ROS bright fluorescent emission is directly proportional to ROS production within cells (until the 
ROS Brite concentration becomes limiting). Example images, illustrating the progressive increase of 
ROS Brite within control cells are shown in Figure 75A. In addition to measuring increased ROS Brite 
fluorescence due to basal ROS production with the wild type and CLN3 KO cells, the effects of 
treating the cells with the compounds tBHP and peroxide, known to cause oxidative stress, were 
also measured. The rationale for using the oxidative stress reagents was that any small differences 
in ROS production or buffering between wild type and CLN3 KO cells might be exaggerated. As 
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illustrated in Figure 75B, there was a progressive increase in ROS Brite fluorescence over time, and 




Figure 76. ROS Brite fluorescence in wild type and CLN3 KO cells. HeLa cells were untreated 
(negative control - DMSO) or treated to induce oxidative stress (positive controls - tBHP or H2O2). 
(A) Example images of TMRE-loaded WT HeLa cells at 0, 90 and 180 seconds of the imaging series. 
The scale bar indicates 10 µm. (B) Mean gray value of ROS Brite plotted to indicate oxidative stress 
at 0, 90 and 180 seconds. These data are mean ± S.E.M. per cell, with scatter points representing 
individual lysosome movement within each cell and n = 9 cells (from 3 coverslips on 3 days). 
 
The time course of ROS Brite fluorescence increases is depicted in Figure 77A – C for each of the 
conditions monitored. There was a roughly linear increase in ROS Brite fluorescence over the 
imaging period. Calculating the slope of the ROS Brite fluorescence data depicted in Figure 77A – C 
produced the same overall outcome as measuring the absolute change in ROS Brite fluorescence 
(cf. Figure 76B and Figure 77D): there was a progressive increase in ROS Brite fluorescence over 
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time, and both of the oxidative stress reagents enhanced the increase in ROS Brite fluorescence. 
Although the data from the wild type and CLN3 KO cells were not significantly different (when 
comparing data at the same time timepoint and with the same treatment), there was a tendency 




Figure 77. Time course of ROS Brite fluorescence in wild type and CLN3 KO cells. HeLa cells were 
untreated (control) or treated with positive controls (tBHP or H2O2) to induce oxidative stress. These 
data were analysed with an Ordinary one-way ANOVA with Tukey’s multiple comparisons test 
where * indicates P ≤ 0.05, ** indicates P ≤ 0.01, *** indicates P ≤ 0.001 and **** indicates P ≤ 
0.0001. These data are mean ± S.E.M. per cell, with scatter points representing individual lysosome 
movement within each cell and n = 9 cells (from 3 coverslips on 3 days). 
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6.3.3 Assessing relative mitochondrial calcium uptake using Cal-520 and Rhod-2 
To assess mitochondrial calcium uptake, cells were co-loaded with the cytosolic calcium indicator 
Cal-520 and the mitochondrial calcium indicator Rhod-2. As with TMRE, Rhod-2 possesses a net 
positive charge. Hence, Rhod-2 accumulates within the mitochondrial matrix, where it can report 
changes in calcium concentration. Unlike TMRE, however, Rhod-2 is loaded into cells in an esterified 
form, and once the indicator is de-esterified it is trapped in situ. By co-loading cells with cytosolic 
and mitochondrial calcium indicators it is possible to assess relative calcium signals in both 
compartments simultaneously.  
In this study, Cal-520 and Rhod-2 were loaded into cells grown on glass coverslips, as described in 
Chapter 2. Example images, illustrating ATP-induced calcium signals in Cal-520- and Rhod-2-loaded 
cells are shown in Figure 6. It is evident that there was a substantial and rapid increase in Cal-520 
fluorescence upon superfusion of the cells with ATP (applied at the 30-second time point). The 
Rhod-2 fluorescence increased more slowly than the Cal-520 signal but persisted for considerably 
longer. The temporal displacement of the Cal-520 and Rhod-2 responses indicates that there was 
not significant bleed through between the green and red imaging channels.  
 
 
Figure 78. Cal-520 and Rhod-2 signals in a HeLa cell stimulated with ATP. The ATP was applied at 
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Figure 79. Cal-520 and Rhod-2 responses in ATP-stimulated wild type and CLN3 KO HeLa cells. (A 
and C) cytosolic calcium measured with Cal-520. (B and D) mitochondrial calcium measured with 
Rhod-2. (C) and (D) show the mean of all replicates. Data are presented as mean ± S.E.M. n = 180 
(20 ± 7 cells per coverslip from 3 coverslips per condition, on 3 days). 
 
The traces shown in Figure 79A and B illustrate Cal-520 fluorescence (Figure 79A; cytosolic 
responses to ATP) and Rhod-2 fluorescence (Figure 79B; mitochondrial responses to ATP) over the 
time course of an experiment. Consistent with the images shown in Figure 78, the Cal-520 response 
rapidly rose to a peak that then declined back to baseline over a couple of minutes (Figure 79A). 
Moreover, similar to the relatively slower change in Rhod-2 fluorescence shown in Figure 79, the 
Rhod-2 signal developed with a latency and lesser rate of rise but was sustained for longer (Figure 
79). Averaging the traces from individual cells indicated that the time course of the Cal-520 and 
Rhod-2 responses were similar for the wild type and CLN3 KNO cells (Figure 79C and D). 
Quantification of the Cal-520 and Rhod-2 responses by calculating the peak ATP-induced 
fluorescence change and the area under the curve indicated that there was no significant difference 
for the wild type and CLN3 KNO cells (Figure 80). Moreover, neither the rate of rise nor the recovery 
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of the ATP-induced Rhod-2 responses were significantly different between the wild type and CLN3 




Figure 80. Quantification of Cal-520 and Rhod-2 responses in ATP-stimulated wild type and CLN3 
KO HeLa cells. The data are presented as mean ± S.E.M were analysed with a two-tailed unpaired 
t-test, with n = 180 (20 ± 7 cells per coverslip from 3 coverslips per condition, on 3 days). 
 
In addition to the quantification in Figure 80, it was interesting to look at the kinetics of the response 
to, and recovery from, stimulation with ATP, as measured with Rhod-2. The relevant timepoints for 
increase and recovery were plotted in Figure 81A and B, and the slopes quantified in Figure 81C and 
D for response and recovery respectively. There was no significant difference between the WT or 
CLN3 HeLa cells. 
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Figure 81. Mitochondrial calcium response to ATP (increase) and recovery (decrease). (A) shows 
the slope of the rise of the Rhod-2 signal from the point of ATP application to the fluorescence value 
30 seconds later (i.e., a straight line drawn between the value of the Rhod-2 fluorescence at time = 
30 seconds and t = 60 seconds). (A) shows the slope of the decline of the Rhod-2 signal (i.e., a 
straight line drawn between the value of the Rhod-2 fluorescence at time = 120 seconds and t = 
210 seconds). The data are presented as mean ± S.E.M were analysed with a two-tailed unpaired t-
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Summary of results 
• Under the same standard loading conditions, TMRE accumulated within the wild type and 
CLN3 KNO cells to the same level (Figure 74). 
• Superfusion of the wild type and CLN3 KNO cells with extracellular solution containing FCCP 
caused a drop in TMRE fluorescence consistent with rapidly depolarisation of the cells’ 
mitochondria (Figure 74).  
• The magnitude of the FCCP-evoked decline in TMRE fluorescence was not significantly 
different between the wild type and CLN3 KNO cells (Figure 74, Figure 75).  
• ROS Brite indicated the progressive production of oxidising species with the wild type and 
CLN3 KNO cells (Figure 76). 
• The rate of increase in ROS Brite fluorescence could be accelerated by application of tBHP 
and peroxide, consistent with the known actions of the oxidising agents (Figures 3 and 4). 
• The extent and rate of ROS Brite fluorescence increase was not different between the wild 
type and CLN3 KNO cells (Figure 76, Figure 77). 
• The tendency of CLN3 cells to show higher ROS Brite levels could indicate a reduced ability 
to ameliorate the effects of increased ROS production in cells, making an increase in ROS 
levels more harmful.  
• Co-loading of Cal-520 and Rhod-2 allowed ATP-evoked calcium signals to be simultaneously 
monitored in the cytosolic and mitochondrial compartments (Figure 79). 
• There was no difference in the peak or cumulative Cal-520 and Rhod-2 signals in cells 
stimulated with ATP when comparing the wild type and CLN3 KNO cells (Figure 80, Figure 
81). 
• There was no difference in the rates of increase or recovery of the Rhod-2 signals in cells 
stimulated with ATP when comparing the wild type and CLN3 KNO cells (Figure 81). 
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6.4 Discussion 
The link between mitochondria dysfunction and neurodegenerative disease has been well 
established (Deus et al., 2020). Cell models of CLN3 disease have revealed some changes to 
mitochondrial function (Fossale et al., 2004, Chandrachud et al., 2015). The experiments in this 
chapter aimed to further investigate the role of mitochondria in CLN3 disease using the CLN3 KO 
HeLa cell model. These assays covered critical mitochondria functions such as the membrane 
potential (TMRE assay), the ROS production within the cells (ROS Brite assay), and as mitochondria 
and lysosomes are linked by their function as calcium stores, the cellular calcium response to ATP 
(Cal-520/Rhod-2 assay). Within this comprehensive assessment of a number of parameters, there 
was no statistical difference that could be established between the WT and CLN3 KO HeLa cells. 
Therefore, either the assays were not sensitive enough to measure modest differences between 
WT and CLN3 KO cells, or the use of the HeLa cell model did not represent the changes found in 
more sensitive cells that are typically affected by CLN3 disease. This could be further investigated 
with a combination of additional assays and cell types. 
 
6.5 Future work 
Since the principle cellular defect(s) caused by CLN3 mutation are not known, using a plethora of 
assays remains a viable approach to understanding what may have changed within cells. 
The measurements were collected from multiple cells across three coverslips and the n number 
reflected the number of cells. The robustness of the statistical analysis could be improved in future 
experiments by introducing a greater number of coverslips and using each coverslip as an n of 1, to 
improve the independence of the sampling.  
To follow on from the ROS Brite experiments, a more specific ROS indicator may be useful. For 
example, MitoSOX could reveal whether there were any changes specifically to mitochondrial 
superoxide production as a result of the CLN3 mutation. 
The assays described in this chapter could be applied to additional CLN3 cell models to investigate 
cell types which may be more sensitive. Additionally, the manipulation of the HeLa cells lines such 
as starvation or prolonged culture may reveal a phenotype if the CLN3 KO cells are less capable of 
handling stress. It would also be interesting to compare the assays used in this study with responses 
from cell models of neurodegenerative diseases in which clear phenotypic and function lysosomal 
and mitochondrial changes have been found. In addition to the calcium assays using Cal-520 and 
Rhod-2, it would be extremely interesting to measure lysosomal calcium in these cells. A similar 
experimental setup with the co-loading of Cal-520 or Rhod-2 with an indicator for lysosomal calcium 
would facilitate the direct comparison of calcium traces, as shown for Cal-520 and Rhod-2 in Figure 
79.  
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7 Ultrastructural changes in cardiac myocytes from CLN3 and WT 
control mice  
7.1 Introduction 
As discussed in Chapter 1, there have been a handful of papers documenting CLN3 disease patients 
developing a cardiac pathology towards the end of life (Reske-Nielsen E, 1981, Michielsen et al., 
1984, Tomiyasu et al., 2000, Dilaveris P, 2014, Ostergaard JR, 2011). In addition, changes to the 
heart were identified in some animal models of CLN3 disease. For example, in the CLN3Δex7/8 mouse 
model, the heart had an increased average weight compared to that in WT control mice at 20 
weeks, but this was not reflected in any measurable functional change (Staropoli et al., 2012). The 
heart of the zebrafish model of CLN3 disease was enlarged and abnormally shaped, but no further 
investigation into functional changes of this phenotype was carried out (Wager et al., 2016). 
Accumulation of storage material has been described in heart tissue of humans and dogs in both, 
cardiac myocytes and the conduction system (Armstrong et al., 1986, Fidziańska et al., 2013). In 
fact, before genetic diagnosis was possible, storage material in skeletal muscle was used as a marker 
for the diagnosis of NCLs (Goebel, 1975). On the whole, there has been little focused study of the 
pathology of CLN3 disease in the heart. Recent reviews have summarised the available literature of 
both humans and animal models, and highlighted the anecdotal clinical observations of those 
working with CLN3 disease patients; highlighting the need for more in-depth studies of structural 
and functional changes that underpin the cardiac pathology in CLN3 disease (Ostergaard, 2016, 
Rietdorf et al., 2019).  
As described in Chapter 1, the correct and efficient function of the heart is reliant upon the highly 
organised tissue arrangement. Changes in heart tissue, such as from disorganisation of structure 
and/or organelle dysfunction, could affect heart function and therefore provoke a progressive 
cardiac pathology in patients. Mitochondria are important in heart tissue, where they provide 
energy for contraction of cardiac myocytes. The link between mitochondrial dysfunction and 
conditions leading to heart failure has been well documented (Li et al., 2020, Rosca et al., 2013). 
The findings included changes to mitochondria in various stages of disease and ageing. For example, 
an increase of mitochondrial DNA damage, an increase in ROS production, increase in fission and a 
decrease in density of mitochondria in heart failure (Li et al., 2020). It was reported that increased 
demands of hypertrophy could be matched by an increase in the number and size of mitochondria, 
but rapidly declined when this condition progressed to heart failure (Rosca et al., 2013). In CLN3 
patients, hypertrophy (particularly of the left ventricle) was the most commonly reported condition 
in the heart (Rietdorf et al., 2019).  
Ageing has been widely accepted as a risk factor for heart failure, and exercise has been linked to 
amelioration of the pathological changes related to cardiac ageing, such as an increase in cardiac 
myocyte size (Li et al., 2020). Both number and volume of mitochondria measured in the left 
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ventricle of hearts from mice allowed to voluntarily exercise were greater than in matched control 
mice; this was despite no significant change in the number or volume of cardiac myocytes in the 
heart, or overall heart weight (Eisele et al., 2008). It is interesting that the study set out to study 
the influence of exercise on heart mass, but it revealed that significant changes were in fact seen 
in the mitochondria within the tissue, rather than the cardiac myocytes or overall tissue mass.  
Throughout their lifespan, mitochondria undergo fission to divide and fusion to merge; processes 
that have been implicated in ageing as a risk factor for heart failure (Liu et al., 2020). Fission and 
fusion events impact the mitochondria availability and activity, potentially altering the energy 
output in the form of ATP (Kowald and Kirkwood, 2011, Liu et al., 2020). The number of 
mitochondria per cell affects the expression of mitochondrial DNA (mtDNA) and processes such as 
ATP or ROS production (Cole, 2016). The number of mitochondria present in a cell is also influenced 
by mitophagy, a process for removal of dysfunctional mitochondria. Mitophagy also declines with 
age and therefore may allow accumulation of dysfunctional mitochondria over time (Liu et al., 
2020). 
In addition to mitochondrial number, the size of mitochondria may be affected by disease and 
ageing (Hoppel et al., 2009). For example, extremely large mitochondria, termed 
‘megamitochondria’, were found in a patient with cardiomyopathy (Tandler et al., 2002). 
Mitochondria inside cells can have different shapes and vary in their functional aspects (e.g., their 
membrane potential or ability to take up Ca2+). Often, a higher density of mitochondria is found 
near the nucleus than in a cell’s periphery. The shape of mitochondria may be rounded, or more 
elongated in appearance, which might be relevant to their individual or syncytial function (Collins 
et al., 2002). The localisation of mitochondria and their movement inside a cell is affected by the 
cytoskeleton (Anesti and Scorrano, 2006). Mitochondria that are found in the tightly packed 
continuous groups in cells were described as ‘power-transmitting cables’ to describe how these 
may be functionally more efficient for example in the equilibration of electrochemical signals 
(Skulachev, 2001). Studies have found that when energy demand increases, mitochondria formed 
clusters, rather than having the appearance of individual entities during periods of low energy 
demand (Skulachev, 2001).  
Cardiac myocytes are characterised by a high energy demand, and a highly organised arrangement 
of myofibres. There are three types of mitochondria within cardiac myocytes: perinuclear, sub-
sarcolemmal, and interfibrillar mitochondria. Mitochondria from these three groups differ in their 
typical shape, morphology of their cristae and their function. Sub-sarcolemmal mitochondria are 
found under the sarcolemma. They vary in shape and provide the energy for transport processes 
involving the sarcolemma. Perinuclear mitochondria are found near the nucleus. They are thought 
to provide energy for processes taking place inside the nuclei and are spherical in shape and 
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typically smaller than the interfibrillar mitochondria that are found between the myofibres. The 
interfibrillar mitochondria are typically elongated in shape, larger than perinuclear mitochondria, 
and provide energy for the myocyte contraction (Hollander et al., 2014, Ong et al., 2017). In this 
chapter, the subpopulation of interest is the interfibrillar mitochondria.   
As mentioned before, no systematic study has yet investigated changes in the heart of patients or 
animal models of CLN3 disease. However, studies in other cell types indicate how mitochondrial 
structure and function can be affected in CLN3 disease. The accumulation of subunit C of the ATP 
synthase in the lipofuscin storage materials in cells affected by CLN3 disease has long been 
established (Kominami et al., 1992). Studies in cells from individuals with CLN3 disease have shown 
various abnormalities in the mitochondrial function, including lower ATP levels, reduced overall 
function, altered Ca2+ homeostasis and changes in shape (Luiro et al., 2006, Fossale et al., 2004, 
Chandrachud et al., 2015). 
In this chapter, a detailed characterisation of the ultrastructure of cardiac myocytes from the hearts 
from the CLN3Δex7/8 mouse model will be presented. Because changes in mitochondrial structure 
and function have been described in other cell types, a detailed analysis of mitochondrial changes 
was performed. TEM imaging of the fixed hearts from the CLN3Δex7/8 mouse model and matched WT 
control mice was performed and images were analysed as described in Chapter 2. 
 
Aims and objectives 
The work presented in this chapter compared the number, size, shape, and distribution of 
interfibrillar mitochondria within ventricular cardiac myocytes, observed by transmission electron 
microscopy (TEM) of WT and CLN3Δex7/8 mice at the ages of 6, 12 and 18 months of age.  
The specific aims were: 





2) To quantify the distribution (clustering) of mitochondria in tissue  
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7.2 Methods 
Hearts from the mouse model of CLN3 disease carrying the CLN3Δex7/8 mutation (henceforth 
referred to as ‘CLN3 mouse’ or ‘CLN3 mice’), with matched control mice carrying the wild type (WT) 
CLN3+/+ gene (henceforth referred to as ‘WT mouse’ or ‘WT mice’), were available from Professor 
Jonathan Cooper at Washington University School of Medicine in St. Louis. When these animals 
were sacrificed at 6, 12 and 18 months, the hearts were preserved by PFA fixation and transferred 
to The Open University where they were stored frozen. Prior to imaging, 1mm3 sections were cut 
from the ventricles and subsequent sample preparation and contrast staining was carried out by 
staff at the Electron Microscopy (EM) Suite at The Open University. The samples were randomised 
and coded by the EM Suite staff to ensure that imaging and analysis were carried out blinded. 
Images were taken using the JEM1400 transmission electron microscope (TEM) as described in 
Chapter 2.  
To ensure that only comparable areas were included in the analysis, regions for imaging and 
analysis were selected based on the presence of uncontracted myofibers. These were identified as 
having evenly spaced Z-lines with I-bands visible in light grey in-between the Z-lines and the 
myofibres (or A-bands) (Figure 82). This selection was made to avoid comparing regions in different 
states of contraction (as can happen in cardiomyocyte sample preparation) and therefore ensure 
that measurements could be compared from region to region and across multiple samples. 
 
 
Figure 82. TEM image of mouse cardiac myocytes, illustrating mitochondria (red), Z-lines (purple) 
and myofibres (blue). Regions of uncontracted tissue were identifiable by the light and dark areas 
of the myofibres between z-lines. In uncontracted muscle, the light grey I-bands are visible between 
the A-bands.  
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7.2.1 Number of mitochondria 
All images were taken at a magnification of 2000x. To ensure consistency during the analysis, this 
magnification was performed on images maximised to the screen size, resulting in a view scaled at 
31.8% of the original image. In ImageJ, a grid of 0.5 inches2 as shown in Figure 83 was applied with 
the Grid plugin to aid counting. Mitochondria were counted using the Cell Counter plugin. Where 
mitochondria were touching the top and left boarders of the image they were included in the count, 
while those on the bottom and right were excluded. If boundaries between mitochondria were not 
completely clear (as in the case of tightly packed mitochondria), the number of mitochondria were 
estimated by careful inspection of the shape of the outer membrane, which typically dipped 
inwards between mitochondria. Where these dips were visible within a cluster, a separate 
mitochondrion was counted.  All images were saved with the count overlay to check for any error 
in counting. 
 
Figure 83. Example of the 0.5 inches2 grid applied to images in ImageJ. This was used to aid 
counting of mitochondria or clusters of mitochondria across the entire image and for the selection 
of mitochondria for measurement, starting from the first mitochondria in the first complete grid 
square in the upper left corner. Alternate squares were used for counting to reduce the area that 
had to be counted whilst ensuring that an area spanning the whole image was counted in an 
unbiased manner. 
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7.2.2 Shape and size 
To measure the shape and size of mitochondria, 10 mitochondria were measured from each of 10 
images, resulting in 100 measured mitochondria per heart. To remove bias in attempting to 
randomly select mitochondria to measure, they were selected based on the grid, shown in Figure 
83, measuring the top left mitochondria from alternating grid squares across the image until 10 
were reached. 
To estimate the size and shape of mitochondria, their diameter was measured across the centre, as 
illustrated in Figure 84. The first measurement, called d1 (Figure 84a-c), was taken across the 
mitochondria at the widest point, noted as ‘length’, and a second measurement, called d2, was 
taken perpendicular to the first (Figure 84a-c), noted as ‘width’.  
 
  
Figure 84. Example measurements of three representative mitochondria (a-c), to calculate size 
and shape. Measurement of the diameter at the furthest points (line d1) to indicate length and 
measurement of the perpendicular line as diameter (line d2) to indicate width. 
 
From these length (d1) and width (d2) measurements of diameter as described in Figure 84, the 
size and shape of mitochondria were calculated. Size was calculated as the approximate area of 
mitochondria, illustrated in Figure 85, using the assumption that mitochondria were generally close 
to being either circular or elliptical in shape. The measured diameters of length (d1) and width (d2) 
were divided by 2 to calculate each radius. The radius of length (r1) and radius of width (r2) were 
then used in the equation π*r1*r2 to determine the area. This method did not provide an absolute 
size, as some error will be introduced by the assumption of elliptical shape but allowed a rapid 
quantification for comparison of mitochondria size in different samples. 
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Figure 85. Example measurements of representative area for three example mitochondria (a-c). 
The calculated area is illustrated by the red circle or ellipse, where area = π*(d1/2) *(d2/2). 
 
To test if mitochondria were indeed spherical or elliptical shape, their shape was determined by the 
length divided by width. A ratio of 1 would indicate a circular mitochondrion, while the higher the 
ratio the greater the deviation from circular and more elongated the shape. 
 
7.2.3 Distribution of mitochondria within the tissue and clustering 
Typically, the interfibrillar mitochondria in cardiac myocytes form long clusters that are in close 
contact Figure 86a). However, in some images the mitochondria appeared to be scattered between 
and within the myofibres, either individually or in very small clusters (illustrated in Figure 86b). 
Clusters were defined as a group of mitochondria (i.e., two or more mitochondria) formed by 
contiguous, directly-contacting organelles that ended when a gap was visible. A mitochondrion that 
was not touching another was counted as one. The number of clusters was quantified to determine 
whether the distribution of mitochondria was altered with the CLN3 mutation, compared to WT 
and with age of both WT and CLN3 mice. The results were normalised to an area of 100 µm2. 
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Figure 86. EM images showing distribution of mitochondria in cardiac myocytes. Panel a illustrates 
a region in which mitochondria are forming long clusters (groups of mitochondria in continuous 
contact with each other). Panel b illustrates a region in which most mitochondria are isolated, and 
only a few small clusters are visible, such as the group in the bottom right corner of the image.  
Mitochondria are closer packed in panel a and therefore counted as fewer clusters, whereas 
distribution of mitochondria in panel b demonstrates many mitochondria in small clusters or 
individually. The scale bar is 1 µm. 
 
The quantification of the mitochondria was carried out blinded and each sample was analysed prior 
to decoding. The results were plotted with the average of 10 images per sample represented as a 
column on a bar graph and each image represented as one scatter point on the bar. Once decoded, 
the bars were grouped by type (genotype and age). To compare the effects of age and genotype, 
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7.3 Results 
The heart tissue that was analysed came from WT control and CLN3 mice that were sacrificed at 6 
months (6m), 12 months (12m) and 18 months (18m) of age.  
 
 
Figure 87. Representative TEM images of cardiac myocytes. Images of heart tissue from; (a) WT 
mouse at 6 months, (b) CLN3 mouse at 6 months, (c) WT mouse at 12 months, (d) CLN3 mouse at 
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7.3.1 Number of mitochondria per 100 µm2 
 
To understand the variability in the number of mitochondria between animals of the same age and 
genotype, the average number of mitochondria for each image is shown as scatter point in Figure 
88. Each bar represents the measurements taken from one animal of the specified age and 
genotype. Especially for the 18 months-old animals, a considerable variation in the number of 
mitochondria can be seen. Whilst the majority of these cardiac myocytes showed the largest 
number of mitochondria seen, one of the hearts from a CLN3 mouse showed a very low number of 
mitochondria. Summarised, there was a considerable variation in the number of mitochondria in 
the cardiac myocytes of the different animals. 
 
 
Figure 88. Number of mitochondria per heart. The data are presented as the number of 
mitochondria per 100 µm2 (mean ±S.E.M.). Each point on the columns represents the average 
measurement from 10 cardiac myocytes images for each heart. 
 
The numbers of mitochondria per heart, as shown in  Figure 88, were grouped by age and genotype, 
and are presented in Figure 89. The average number of mitochondria was greater in the images of 
cardiac myocytes from the WT mice at 18 months, compared to all other animals. In contrast, 
mitochondria did not appear in greater numbers with age in CLN3 hearts. In 18-month animals, 
cells from WT mice contained significantly more mitochondria than those of CLN3 mice. However, 
the data points in Figure 88 indicate that the variation between the two 18-month CLN3 mice was 
greater than in any other group. 
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Figure 89. Number of mitochondria. This bar graph was obtained by combining the data shown in 
Figure 7 for each of the CLN3 and WT cardiac myocytes at the specified ages. The data were 
analysed using a Kruskal-Wallis test with Dunn’s post-hoc comparison. * indicates p<0.05, *** 
indicates p<0.001 and **** indicates p<0.0001. n = 20 - 30 images per condition (2 or 3 hearts each 
with 10 cardiac myocytes images per heart, as depicted in Figure 7). The data are presented as 
mean ± S.E.M. 
 
 
7.3.2 Average size of mitochondria  
To investigate if the average size of mitochondria also showed a variability between the cardiac 
myocytes of hearts of animals from the same age and genotype, the data obtained from the 
different animals were plotted separately and are shown in Figure 90. Whilst the number of 
mitochondria was a total for each image, normalised to 100 µm2, the size of mitochondria was the 
average measurement taken from only 10 mitochondria per image. The average size of 
mitochondria for each heart as plotted in Figure 90 varied from between 0.322 µm2 and 0.700 µm2 
with the largest being approximately twice the size of the smallest. However, there was no 
identifiable pattern or grouping of these values for the different conditions. The largest inter-group 
variation was between cardiac myocytes in the pair of 18-month WT hearts (average 0.322 - 0.636 
µm2). 
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Figure 90. Size of mitochondria (µm2). Data are presented as mean size of mitochondria per heart 
± S.E.M. The average size of mitochondria was calculated from 10 mitochondria per image each 
plotted as scatter point on the bar. Per heart, a total of 100 mitochondria was analysed; 10 
mitochondria measured per image from 10 images each). 
 
To analyse if age or genotype affected the size of mitochondria, the data from different animals of 
the same age and genotype were grouped and plotted (Figure 91). As shown in Figure 91, there was 
no significant difference in the average size of mitochondria across any of the ages or genotypes. 
Therefore, size did not change with age of the mice and did not significantly vary between the WT 
or CLN3 disease model mice.  
 
 
Figure 91. Average size of mitochondria (µm2). This bar graph was obtained by combining the data 
shown in Figure 9 for each of the CLN3 and WT hearts at the specified ages. The data were analysed 
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using a Kruskal-Wallis test with Dunn’s post-hoc comparison. n = 20 - 30 images per condition (2 or 
3 hearts each with 10 images per heart, as depicted in Figure 90). The data are presented as mean 
± S.E.M. 
 
7.3.3 Roundness of mitochondria 
The roundness of mitochondria was assessed with a ratio of length to width measurements, where 
a value of 1 is a circle and the greater the value, the more elongated the mitochondria. To 
investigate variability of the roundness within the different ages and genotypes, the data obtained 
from the different animals were plotted in separate bars, shown in Figure 92. No mitochondria were 
found to be perfectly round, as a mathematically determined circle, although some were close. 
There was no clear pattern in roundness between the ages and genotypes, although on the whole 
the mitochondria in the cardiac myocytes of CLN3 mice appeared to be rounder than in the WT 
tissue. There was considerable variation in the shape within each image and in each group.  
 
 
Figure 92. Roundness of mitochondria (ratio of length to width). A value of 1 indicates a perfect 
circle and the greater the increase the more elongated the shape of the mitochondria. Data are 
presented as mean roundness for each heart ± S.E.M. with average calculated ratio from 100 
mitochondria, across 10 images (10 mitochondria per image, average size from each image plotted 
on each bar). 
To analyse if age or genotype affected the roundness of mitochondria, the data from different 
animals of the same age and genotype were grouped and plotted in Figure 93. Mitochondria were 
significantly more elongated in cardiac myocytes of WT mice at 6 months, compared to CLN3 mice 
of all ages, but not to WT mice at 12 or 18 months. The roundest mitochondria were in the cardiac 
myocytes of the CLN3 mice at 12 months; these were significantly rounder than in the cardiac 
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myocytes of WT mice at 6 and 18 months. Although there were no significant differences between 
the roundness of mitochondria in WT mouse cardiac myocytes at any age, it is notable that only the 
mitochondria in the WT mouse cardiac myocytes at 12 months were not significantly more 
elongated than the mitochondria in the CLN3 mouse hearts at 12 months. As shown in the Figure 
93, the mitochondria in the cardiac myocytes of CLN3 mice on the whole had a tendency to be 
rounder than in the WT mice of similar age, although this difference was not significant.  
 
 
Figure 93. Roundness of mitochondria (ratio of length: width). This bar graph was obtained by 
combining the data shown in Figure 92 for each of the CLN3 and WT hearts at the specified ages. 
The data were analysed using a Kruskal-Wallis test with Dunn’s post-hoc comparison. * indicates 
p<0.05, ** indicates p<0.01 and **** indicates p<0.0001. Data are presented as mean ± S.E.M., of 
2-3 hearts, with n = 20-30 (average roundness of mitochondria calculated from 10 mitochondria, in 
10 images (scatter points on each bar) for each heart).   
 
7.3.4 Distribution of mitochondria within tissue 
Typically, the mitochondria in cardiac myocytes form long clusters of interfibrillar mitochondria that 
are in close contact. To quantify any changes or fragmentation of the mitochondria, these clusters 
were counted as described in the methods above. A small number of clusters indicates that these 
are likely to contain several mitochondria, forming a string in-between the myofilaments. However, 
this analysis did not actually count how many mitochondria are present in each cluster.  
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The average number of clusters per cardiac myocytes, as plotted in Figure 94, varied dramatically, 
with numbers ranging between 9 and 65 clusters per 100 µm2. No pattern in the variation was 
evident, and it was noticeable within groups, and especially obvious for example in the cardiac 
myocytes of the CLN3 mice at 6 and 18 months. 
  
 
Figure 94. Number of clusters of mitochondria per 100 µm2. Data are presented as mean number 
of clusters per 100µm2 per heart ± S.E.M., each scatter point indicated the average number of 
clusters from 10 images (plotted on each bar) per heart. 
 
To analyse if age or genotype affected the number of clusters per image, the data from different 
animals of the same age and genotype were grouped and plotted in Figure 95. The cardiac myocytes 
with the smallest number of clusters were from the WT animals at 6 months. The number of clusters 
was significantly lower compared to cardiac myocytes from CLN3 mice of the same age, and to 
cardiac myocytes of 18 months-old animals from both genotypes.  
In contrast, the greatest number of clusters was found in the cardiac myocytes of WT mice at 18 
months. This was significantly greater than in cardiac myocytes of both younger ages of WT mice 
and of hearts from 12 months-old CLN3 mice. Overall, there was a trend for an increase in the 
number of clusters in WT mouse cardiac myocytes with age. However, this change with age was 
not obvious in cardiac myocytes from CLN3 mice. 
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Figure 95. Number of clusters of mitochondria per 100 µm2. This bar graph was obtained by 
combining the data shown in Figure 94 for each of the CLN3 and WT hearts at the specified ages. 
The data were analysed using a Kruskal-Wallis test with Dunn’s post-hoc comparison. * indicates p 
< 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates p < 0.0001. n = 20 - 30 
images per condition (2 or 3 hearts each with 10 images per heart, average of these 10 images is 
presented as a scatter point on the bars). The data are presented as mean ± S.E.M. 
 
An alternative way of looking at the data was to relate the number of clusters to the total number 
of mitochondria in an image, thereby providing a more accurate understanding of average number 
of mitochondria per cluster (I.e., number of mitochondria / number of clusters). As before, the data 
are first presented on a per animal basis to understand the variability between mice of the same 
age and genotype (Figure 96). For most animals, the clusters only contained a relatively small 
number of mitochondria, between 3-9 mitochondria per cluster. Only one heart of a WT mouse of 
6 months of age showed a far higher average of 16 mitochondria.  
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Figure 96. Estimated number of mitochondria per cluster. Both, the number of mitochondria and 
the number of clusters were normalised to the value per 100 µm2. The cluster size was calculated 
by dividing the number of mitochondria by the number of clusters and is presented as mean ± 
S.E.M. n = average number from 10 images (plotted as scatter points on each bar) per heart. 
 
To analyse whether age or genotype affected the number of mitochondria per cluster, the data 
from different animals of the same age and genotype were grouped and plotted in Figure 97.  It 
showed a significantly higher number of mitochondria per cluster in cardiac myocytes from 6 
months-old WT mice compared to CLN3 mice of the same age, and to mice of both genotypes at 18 
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Figure 97. Estimated number of mitochondria per cluster. This bar graph was obtained by 
combining the data shown in Figure 96 for each of the CLN3 and WT hearts at the specified ages. 
The data were analysed using a Kruskal-Wallis test with Dunn’s post-hoc comparison. ** indicates 
p < 0.01. n = 20 - 30 images per condition (2 or 3 hearts each with 10 images per heart). The data 
are presented as mean ± S.E.M. 
 
7.3.5 Storage Material in cardiac myocytes 
This aspect of the study aimed to investigate the accumulation of storage material in cardiac 
myocytes of WT and CLN3 mice of the different ages. No storage material was found in tissue 
from WT mice. It was possible to find areas containing storage materials in tissue from CLN3 mice. 
However, these were very rare, not allowing for a quantification in randomly chosen regions. 
When present, storage material could be seen between myofibres Figure 98 (top panels), but was 
often present at the periphery of the cell Figure 98 (bottom panels).  
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Figure 98. Examples of storage material found in heart tissue from 18 months-old CLN3 mice. The 
panels show examples of storage material between myofibres (top panels), storage material in the 
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Summary of the results 
So far, the results have been presented one-by-one. However, to make it easier to see a bigger 
picture of potential mitochondrial changes with age or genotype, the same data are presented as a 
summary (Figure 99). As shown in the previous figures, there were a limited number of hearts 
available and considerable variation within the groups which should be taken into account when 
looking at the averages. 
• The largest number of mitochondria (Figure 99a) was found in cardiac myocytes from 18 
month-old WT mice, but this was primarily due to one replicate. It was higher than that in 
cardiac myocytes from both groups of younger WT mice and that in cardiac myocytes from 
18 month-old CLN3 mice. There was a trend for a larger number of mitochondria in the old 
CLN3 mice, but the difference was not statistically significant. 
• There was no difference in the size of mitochondria between cardiac myocytes of different 
ages and genotypes within the samples available (Figure 99b).  
• Cardiac myocytes from the 6 month-old WT mice had less rounded mitochondria than CLN3 
mice of all ages. Mitochondrial roundness did not change with age in the WT or in CLN3 
mice sampled (Figure 99c). 
• Cardiac myocytes from 6 month-old WT mice contained fewer clusters of mitochondria 
than those of age-matched CLN3 mice and than those of 18 month-old animals of both 
genotypes. There is a trend for an increased number of clusters with age in cardiac 
myocytes of WT mice, which is not obvious in CLN3 mice (Figure 99d).  
• In contrast, cardiac myocytes from 6 month-old WT mice contained more mitochondria per 
cluster than those of age-matched CLN3 mice or than 18 month-old animals of both 
genotypes (Figure 99e), despite the cardiac myocytes of the old animals containing more 
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Figure 99. Summary plots to illustrate interaction of genotype (WT and CLN3) with age (6, 12, 18-
months). Plotting mitochondria quantified by; (a) number, (b) size, (c) roundness and clustering by 
(d) number of clusters and (e) number of mitochondria per cluster. Data are presented as mean 
±S.E.M., of 20-30 images (10 images per heart, from 2-3 hearts) per condition. No additional 
statistical analysis was performed, and results of the previous analysis is not shown here, but can 








A progressive deterioration of cardiac function is observed in individuals with CLN3 disease. Whilst 
first differences in ECG traces can be observed early in the disease (unpublished, personal 
communication), it is only in later stages that more profound changes, as described in Chapter 1, 
manifest themselves. This part of the study aimed to examine whether structural changes were 
present in hearts from CLN3Δex7/8 mice, and if these changed with age. The relative ageing of mice 
comapred to humans is not entirely linear (Dutta and Sengupta, 2016, Hagan, 2017); therefore the 
x-axis for the data in this chapter was plotted relative to time, but not necessarily accurate to the 
age represented in equivalent human years. However, the hearts from the mice at 6 and 12 months 
would have been equivalent to adults in a reproductive stage, while the heart at 18 months 
equivalent to adults in a post-reproductive age, just prior to old age (Dutta and Sengupta, 2016). 
The analysis focussed on changes in the mitochondria, as these organelles are critical to provide 
energy for the regular contractions of the heart, and because changes in mitochondria have been 
described in other cell types with mutations in the CLN3 gene.  
This study found an increased number of mitochondria in cells from 18 months-old mice of both 
genotypes which was higher in the WT mice than in CLN3 mice. However, it is important to note 
that there was a considerable variability in the number of mitochondria found in the cardiac 
myocytes of different 18 months-old animals of the same genotype. Variable results have also been 
reported in the literature: one study found a reduction in the number (and increase in size) of 
mitochondria in 14 months-old mice (Corsetti et al., 2008), whilst another study found  no changes 
in the number of mitochondria in ventricular myocytes from 24 months-old mice (Masoud, 2018).  
The apparently increased number of mitochondria found here could be explained as an adaptation 
for the decline of the efficiency in energy production that has been described to happen with age 
(Boengler et al., 2017). Another explanation would be a reduction in the level of mitophagy, the 
process by which defect mitochondria are degraded. This decreased clearance of mitochondria has 
been described in ageing cardiac myocytes (Leon and Gustafsson Å, 2016). 
Reduced mitophagy can lead to an increase in the average size of mitochondria (Corsetti et al., 
2008). However, this study found no effect of age or genotype on the size of mitochondria in the 
samples that were available (Figure 91).  
Earlier studies described mitochondria in cardiac myocytes become more rounded with age (Cheng 
et al., 2013), without reporting the number of mitochondria. However, this study found no 
progressive change in the shape of mitochondria in the WT control animals from the different ages 
(Figure 93). Whilst mitochondria of the youngest WT animals seemed most elongated (or least 
rounded), this difference was not statistically significant when compared to that of the 12- or 18 
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months-old WT mice. It is possible that the change in roundness would be influenced by other 
factors such as the count, which here increased dramatically at 18 months. Therefore, the changing 
shape may not be a single process, but a combination of factors, for example mitochondria may 
become rounder with age but if an  increased number has to be packed into the tissue, they might 
become elongated, potentially explaining the lack of a change in shape.  
When studying the effect of the genotype on mitochondrial shape, mitochondria from 6 months-
old WT animals were significantly less rounded than those of CLN3 mice from all ages (Figure 93). 
This contradicted results from a previous study, in which mitochondria cells with the same mutation 
in the CLN3 gene were found to be more elognated than those in WT cells (Fossale et al., 2004). 
However, it is important to note that this earlier study was performed in iPSC-derived neuronal 
precursor cells. These cells typically have shorter mitochondria, and the elongation was seen as 
abnormality related to CLN3 disease. In contrast, an elongated shape is normal in interfibrillar 
mitochondria of cardiac myocytes. Considering the different starting points, a shape change caused 
by the mutation in the CLN3 gene could have a different outcome in cardiac myocytes than in iPSC-
derived neuronal precursor cells.  
The count of number of clusters (Figure 95) and the number of mitochondria per cluster (Figure 97) 
showed a lower number of clusters in cardiac myocytes from WT mice overall, which each 
contained more mitochondria. Large clusters of interfibrillar mitochondria is the pattern expected 
to be present in cardiac myocytes from young WT animals. In contrast, CLN3 mice contained 
significantly more clusters, each with significantly fewer mitochondria. Note that the absolute 
number of mitochondria in these two groups was the same. This indicates that the mitochondrial 
clusters were more fragmented in CLN3 mice, potentially affecting their function of efficient energy 
supply to the contracting myofibres. For WT animals, a progressive increase in the number of 
clusters, and decrease in the number of mitochondria they contain was seen with age  (significant 
at 6 vs. 18 months of age). Interestingly, the increased number of mitochondria found in 18 months-
old animals (Figure 89) did not prevent the clusters becoming smaller. This change to a higher 
number of smaller clusters again potentially indicates a less efficient energy delivery to the 
myofibres.  The numbers for 12- and 18 months-old CLN3 mice are similar to those in WT control 
mice. However, different to the WT control mice, there is no progressive change with age.   
Structural changes occuring with age were expected to occurr progressively, rather than returning 
the to values seen at an earlier age. However, the change in roundness of mitochondria and number 
of clusters for CLN3 mice both have their lowest values in 12 months-old animals (Figure 98),which 
could be seen as a shift in the direction of change. But it is important to remember that there were 
no significant differences for these values between the ages of the CLN3 mice, and these data 
cannot be over-interpreted. Here, it was mostly found in tissue from 18 months-old CLN3 mice 
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(Figure 98), either between myofibres or at the cell periphery. Storage material can be classified 
based on the shape (Anderson et al., 2013) and differs between the NCLs. Curvilinear storage 
material and fingerprint bodies are most prominent in the hearts from humans (Gilbert-Barness, 
2004, Fidziańska et al., 2013) and in skeletal muscle biopsies (Goebel, 1975). The material found 
here does not have the characteristic shapes described in human hearts.  
Based on the progression of CLN3 disease, it may have been reasonable to expect that the disease 
would mirror any phenotype observed with age in a more severe manner, and/or occurring at a 
younger age.  As previously mentioned, the mice were sacrificed at 6, 12 and 18 months of age and 
the hearts were fixed and stored to allow simultaneous comparison of the hearts. If the relative 
ages of mice to humans is taken to be linear across the life span, the mice at 6 months represent 
20 human years, 12 months represent 40 human years and 18 months represent 65 human years 
approximately. This was based on the calculation of 40.6 human days to 1 mouse days, as reported 
by (Dutta and Sengupta, 2016). However, whilst this comparison might be useful, the authors 
warned that the relative ageing of mice varies by stage of life. Mice at 6 and 12 months would have 
been equivalent to adults in a reproductive stage, while the heart at 18 months equivalent to adults 
in a post-reproductive age, just prior to old age (Dutta and Sengupta, 2016, Hagan, 2017). Relative 
to CLN3 patients, the mouse CLN3Δex7/8 model outlived the typical lifespan of human patients by 
extending beyond early adulthood. The CLN3Δex7/8 animal model was discussed in more detail in 
Chapter 1. So far, no systematic study has investigated changes in the heart function in the CLN3 
mice used in this study. It is therefore unclear whether the CLN3Δex7/8 mice accurately reflect the 
cardiac symptoms experienced by many CLN3 patients. The cardiac phenotype in patients emerges 
later than other symptoms, so changes in the heart may accumulate over a longer time than in 
organs such as the brain and eyes, which present with symptoms earlier in disease progression. 
Surprisingly, the overall effect of the genotype (based on a significant difference within the same 
age) was more frequently found for the young, 6 months-old animals (in roundness, number of 
clusters and number of mitochondria per cluster), than for the older animals (no difference for 12 
months-old animals and only the number of mitochondia was different for 18 months-old animals). 
Therefore, the assumption that the tissue from CLN3 mice may deteriorate with age to a larger 
extent than that from the WT mice, in the manner expected from such a progressive disease, was 
not found to be true within the scope of this study.  
Several reasons might explain the lack of differences found here between cardiac myocytes from 
WT control and CLN3 mice, for example the variability found between animals or the region of the 
heart that was analysed. All images only represented an extremely small section of heart as is the 
nature of TEM imaging. Assessing a larger number of samples could help to understand the reasons 
for the variability found in images of hearts from animals of the same age and genotype (most 
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extreme in the 18 months-old CLN3 animals). It is unknown which cell type, or which region of the 
heart contributes to the cardiac phenotype seen in individuals with CLN3. Here, only ventricular 
myocytes were analysed. There may have been considerably more changes in other regions of the 
heart, e.g. the atria, the SA- or the AV-node, that were not captured in the analysis.  
Ideally, an analysis of the mitochondrial size, or area, should be performed on a 3D reconstruction. 
Within an TEM image, not all mitochondria will be cut in the same plane, or at the same angle, 
adding variability to a size-analysis based on 2D images. Instead of the estimation of the 
mitochondrial size used here, calculating the mitochondrial volume based on a 3D reconstruction 
would provide more accurate results. Such a 3D reconstruction is planned for WT and CLN3 KO 
HeLa cells in the future. Performing it for cardiac myocytes would be of great interest to strengthen 
the results. However, we are confident that the methodological and blinded manner of the analysis 
allowed the collection of reliable data.  
 
 
7.5 Future work 
This chapter detailed an exciting and much needed area of research for CLN3 disease. There were 
some limitations on sample availability and there is scope to follow on from this project. 
Improvements can be grouped into three areas: sample preparation, relevance of species, and 
collection of additional data.  
The samples analysed here were obtained from animals using a protocol that was not optimised 
for cardiac samples. For example, no glutaraldehyde was included in the fixative, and no contraction 
inhibitor was given to the animal, to ensure that the cardiac myocytes were not contracted. The 
long-term storage of the hearts at -20°C may have caused some degradation of sample quality. 
Hearts from patients with CLN3 disease have shown changes in the cristae and inclusions in 
mitochondria (Fidziańska et al., 2013). These could lead to a reduced ability of the mitochondria to 
produce ATP. However, the quality of the fixation performed here did not preserve the cristae 
structure well enough to analyse it. Finding out if there are structural changes that could cause 
mitochondrial dysfunction would be a valuable result for an extension of this study.  
The samples analysed here were obtained from mice. Mice hearts differ from human hearts in 
several points, for example their higher beating frequency (Janssen et al., 2002). The usefulness of 
mice as model for heart changes in humans is debated, and large animal models are seen as 
superior (Camacho et al., 2016). The use of hearts from large animal models of CLN3 which may be 
more comparable to humans, for example the pig (Johnson et al., 2019), may provide a more 
faithful imitation of cardiac changes in patients than mice did. A full study in which animals could 
Page 190 of 264 
 
have ECG data collected while alive, prior to collection and imaging of the hearts, would give a fuller 
picture of the way the heart is affected from symptoms through to ultrastructure. Additionally, 
collecting data such as heart weight prior to fixation, could be valuable in understanding differences 
between mice of the same age and genotype. 
Obtaining access to human samples would also be hugely beneficial, but also brings the pitfall of a 
non-optimal fixation (considerable amount of time passing between death and taking the sample) 
and the possible lack of well-matched control samples. Therefore, similar imaging and 
quantification as documented in this chapter, with a wider range of tissue from different CLN3 
disease models, in combination with a study of heart function in the animals would be an interesting 
aspect of future work. This would also allow to understand the contribution of the cardiac 
conduction system; to understand whether initiation of contraction is affected, and to support the 
assessment of structural changes as a potential cause of contraction abnormalities in patients. 
Finally, in addition to the analysis detailed in this chapter, it would be interesting to expand the 
measurement to quantification of additional structures such as t-tubules. As t-tubules are 
important structural features of cardiac tissue with a role in function (such as calcium signalling), 
locating and measuring these could be highly beneficial. Additionally, the proximity of the 
measured mitochondria to the t-tubules could provide an interesting context for the measurements 
if any variation was found.  
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8 Methodology and troubleshooting iPSC culture and 
differentiation to cardiac myocytes 
8.1 Introduction 
In recent years, there has been a call for research to study the cardiac phenotype of CLN3 disease, 
as reported by clinicians and a small number of papers (Rietdorf et al., 2019, Ostergaard, 2016). The 
existing research and the importance of further investigation were discussed in Chapter 1. Chapter 
7of this thesis described findings from the analysis of hearts from the CLN3 Δex7/8 disease mouse 
model compared to hearts from matched wild type mice, using electron microscopy. The imaging 
and analysis of heart tissue with electron microscopy was a valuable approach to investigate 
ultrastructural changes. However, to extend the research into studying functional changes in 
cardiac myocytes, it was beneficial to consider additional models for experimental investigation of 
the CLN3 mutation within cardiac cells. A comparison on the different models of CLN3 disease, 
including animal and cell models, was discussed in Chapter 1.  
The momentous publication of a method to induce pluripotency in fibroblasts presented a 
significant opportunity for research (Takahashi and Yamanaka, 2006). The use of induced 
pluripotent stem cells (iPSCs) allowed propagation of the iPSC cell lines in culture, and, when 
needed, the transformation of fibroblasts from patients into cell types which are otherwise difficult 
to obtain and culture, such as neurons and cardiac myocytes. These differentiated cells can then be 
used for experiments. In the CLN3 disease research community, iPSC cell lines have been generated 
and utilised in study of the disease. iPSCs carrying a CLN3 mutation were generated from patients 
with CLN3 disease (Lojewski et al., 2014) and an isogenic pairing of wild type (WT) control and CLN3 
disease model cell lines was generated by insertion of a CLN3 mutant gene into the WT iPSC line 
(Gomez-Giro et al., 2019). Cell types studied as a result of the differentiation of CLN3 mutation 
carrying iPSCs include retinal neurons (Wiley et al., 2016) and cerebral brain organoids (Gomez-Giro 
et al., 2019). However, at the time of writing, there were no research groups known to be using 
cardiac myocytes generated from iPSCs in the study of CLN3 disease.  
There are a number of limitations to the use of iPSC derived cell models of lysosomal storage 
disorders, such as CLN3 disease (Borger et al., 2017). Broadly, these include considerations such as 
the unknown impact of the disease-causing mutation on the reprogramming of the cells, as well as 
selection of control cells with a suitable genetic background (Borger et al., 2017). Established iPSC 
lines that are known to reliably differentiate into cardiac myocytes might not be a good age or 
gender match for the iPSCs generated from CLN3 patients. To identify changes caused by mutations 
in CLN3 it was not only important to compare their function to those of cardiac myocytes derived 
from iPSCs (from here onwards referred to as iPSC-CMs) from healthy donors, but also to compare 
their function to that of primary cardiac myocytes, as outlined below. 
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iPSC-CMs have been described as structurally and functionally immature compared to adult cardiac 
myocytes, resembling foetal cardiac myocytes more closely (Ronaldson-Bouchard et al., 2018). 
When planning to use iPSC-CMs to study CLN3 disease, the lack of maturity was considered as risk 
of masking any phenotype of CLN3 disease that may present only in adult cardiac myocytes. In CLN3 
disease patients, any cardiac symptoms are reported in adulthood, whereas the visual and 
neurological symptoms arise in childhood. However, patients have been reported to show 
abnormalities on ECG prior to the complaint of symptoms and the cellular phenotype leading to 
this may have developed earlier still. For the planned study, we wanted to use cardiac myocytes 
with as mature a phenotype as possible, using previously established maturity markers.     
In order to judge the maturity of iPSC-CMs, a number of studies have tracked characteristics in iPSC-
CMs using  a wide range of markers (Karbassi et al., 2020). Expression of these markers differs 
significantly between foetal and adult cardiac myocytes, as described below.  
Troponin is a protein in skeletal and cardiac muscle cells which regulates contraction. Different 
isoforms of cardiac troponin are being expressed during development: expression of ssTnI has been 
predominantly found in neonatal or foetal cardiac myocytes, whilst cTnI is expressed in adult 
cardiac myocytes (Bedada et al., 2016, Zuppinger et al., 2017).  
Transverse tubules (T-tubules) are cell membrane invaginations found in adult striated muscle. 
They bring the cell membrane receptors in close contact with the sarcoplasmic reticulum (SR). 
Foetal cardiac myocytes have little to no T-tubules. The absence of t-tubules and the troponin 
isoform expressed in newly differentiated iPSC-CMs were comparable to foetal cardiac myocytes, 
indicating a lack of maturity (Cadet and Kamp, 2017).  
Structure and function of cardiac myocytes are very closely linked, as was explained in Chapter 1. 
Calcium signalling is providing one such link between structure and function (Koivumäki et al., 
2018). In mature cardiac myocytes, following the depolarisation of the cell membrane a strong 
calcium releases happens from the SR. However, in newly differentiated iPSCs this does not happen, 
and around 15-21 days of iPSC-CM culture to establish (Hwang et al., 2015). After this time, the SR 
functions like that of a mature cardiac myocyte.  
Cardiac myocytes have a high energy demand. Mature cardiac myocytes contain a large number of 
mitochondria, as was shown in Chapter 7. Newly differentiated iPSC-CMs contain fewer 
mitochondria. Under closer inspection, these also differed in their function: they expressed 
different enzymes, showed a lower respiratory activity and had a lower membrane potential in 
comparison to iPSC-CMs which had matured during extended time in culture. These are 
characteristics of immature cardiac myocytes. However, after culturing the cells for 100 days, a 2.8 
x greater number of mitochondria was found, and these functionally resembled mature cardiac 
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myocytes more closely  (Dai et al., 2017).  As explored in Chapter 6, mitochondria are an organelle 
of interest in CLN3 disease and they are of significance as a readout to examine any influence of the 
CLN3 mutation in cardiac myocytes. A final consideration for the use of iPSC-CMs to study CLN3 
disease was that unlike cardiac myocytes from the hearts of animal models of CLN3 disease, or 
CLN3 patients, these cells had no history in the heart as an organ, receiving input from the 
conduction system, or been contact with other cell types. Therefore, any aberrant systemic 
changes, such abnormalities arising from initiation or conduction of electrical signals, would not be 
identified with the iPSC-CM model. While this presented a limitation of the model, it also allows for 
the study of phenotype that may arise within cardiac myocytes independent of any potential 
changes resulting from aberrant signalling from the conduction system or further afield throughout 
other cell types. Consequently, there would be great value in comparison between cardiac 
myocytes derived from iPSCs and the hearts of animal models. 
 
This chapter describes the establishment of methods to differentiate cardiac myocytes from iPSCs. 
These should be used in the next chapter to assess the structure and function of iPSC-CMs at various 
time points, spanning 100 days post-differentiation to allow cells to reach a mature state. Patient-
derived iPSCs carrying the Δex7/8 mutation and an iPSC-line with a CRISPR generated point 
mutation at Q352X were available for the study.  
 
Aims and objectives 
The aims of the work in this chapter were:  
1. Learning two techniques of iPSC culture  
a. a feeder-free culture 
b. a feeder-dependent culture 
2. Learning the differentiation of iPSCs into cardiac myocytes 
3. Setup a quality control method to check the success of the differentiation  
4. Establishing these techniques at The Open University 
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8.2 Methods 
Two main techniques for culturing iPSCs exist: they can grow feeder-free on coated surfaces or 
grow on a layer of feeder-cells. iPSCs carrying a CRISPR-generated mutation in the CLN3 gene and 
iPSCs from Nottingham were grown feeder-free, whilst those derived from CLN3 patients, carrying 
the Δex7/8 deletion were grown on feeder cells (Table 21). To avoid the interfering with the 
conditions for growth, each iPSC line was cultured according to the protocol used in the laboratory 
of origin, meaning that both techniques had to be established at The Open University.  
The cell culture was carried out in sterile cell culture conditions, as explained in Chapter 2. All cell 
lines were carefully monitored for signs of infection. Flasks were visually inspected for changes such 
as discoloured or cloudy medium, or any appearance of foreign bodies visible under the 
microscope. No infection was observed in any cultures and all mycoplasma testing (upon receipt of 
the cells and every 3 months afterwards) was negative for all iPSC lines. 
 
8.2.1 Culture of iPSCs 
The iPSCs that were received from collaborators are detailed in Table 21. Due to the sensitivity of 
iPSCs and high risk of irreversible spontaneous differentiation, special care was taken to retain 
consistency in culture conditions for iPSCs. The major difference between the feeder-free and 
feeder-dependent methods from the different laboratories was the matrix: iPSCs were either 
cultured feeder-free on Matrigel plate coating, or in a feeder-dependent manner with inactivated 
mouse embryonic fibroblasts (MEFs) on a gelatin coating. 
 
Table 21. iPSC cell lines: genotype and cell culture method used in the originating laboratory. iPSC 
cell lines kindly supplied by: 1Prof Chris Denning at The University of Nottingham, 2Prof Jens 
Schwamborn at The University of Luxembourg, 3Prof Tristan McKay at Manchester Metropolitan 
University. 
Cell line Genotype Culture method 
Rebl-PAT1 WT, healthy donor 
Feeder-free (Matrigel) CLN3 Q352X2 CLN3 Crispr-Cas9 generated Q352X mutant 
A13777 WT2 WT, healthy donor 
PA 3383 CLN3 patient cell line (p.Val142LeufsX39 and Δex7/8) 
Feeder-dependent (iMEF) 417 PB3 CLN3 patient cell line (D416G) 
CTRL NHDF3 WT, neonatal human dermal fibroblasts 
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8.2.1.1 Feeder-free method 
The feeder-free method for the culture of iPSCs on Matrigel, was taught by Professor Chris 
Denning’s laboratory at The University of Nottingham. It was used for the iPSCs used in training at 
The University of Nottingham (ReBL-PAT) and the isogenic CLN3 mutation-carrying cell line with 
matched control iPSCs from Prof Jens Schwamborn (CLN3 Q352X and A13777 WT respectively). 
Matrigel is a matrix containing extracellular membrane proteins and growth factors widely used for 
culturing iPSCs.  Matrigel was handled carefully due to the risk of polymerisation in solution even 
at low temperature, which would prevent Matrigel from forming an even coating. 
To prepare Matrigel aliquots, the stock bottle was defrosted slowly overnight on ice, in a 2-8°C 
refrigerator. The stock bottle was removed from the fridge before the ice had fully melted and 
pipetted into pre-labelled 1ml Eppendorf tubes in 0.5 ml aliquots. All pipettes and tubes were 
chilled in the -20°C freezer prior to use and pipetting was carried out rapidly to minimise any risk of 
polymerisation occurring. The aliquots were transferred immediately stored in a -80°C freezer. 
To prepare Matrigel coated flasks, 50 ml of DMEM (without supplements) was filtered into a 50 ml 
falcon tube using a 0.2 µm syringe filter. The falcon tube was then chilled in the freezer alongside 
all pipettes and tips but removed before the DMEM began to freeze. Flasks were labelled and 
stacked in the cell culture hood and a tray of ice was placed next to the hood for intermediate 
storage of the tube of DMEM and tips, which were all wiped and sprayed with 70% IMS prior to 
transfer into the hood. Finally, the Matrigel aliquot was mixed into the ice cold DMEM by pipetting 
DMEM onto the frozen Matrigel and mixing up and down before transferring the DMEM back to 
the falcon tube. This process was repeated until the Matrigel was completely thawed and 
transferred in to the DMEM. A chilled 25 ml pipette was used to mix the solution by slowly pipetting 
up and down, and to transfer the solution to flasks and plates as required (5 ml/T25, 10 ml/T75 and 
2 ml per well/6-well plate). The coated plasticware was gently rocked to ensure an even coverage 
of the surface and either left in the in the hood for 45 minutes at room temperature, or transferred 
to the fridge overnight, for the Matrigel to polymerise and form a matrix. If flasks were prepared in 
advance and refrigerated, these were stored for a maximum of 1 week and allowed to warm to 
room temperature before use. DMEM was kept in the coated flasks to prevent Matrigel from drying 
out and this was exchanged for the appropriate fresh medium prior to use. Before use, all Matrigel 
coated plasticware was inspected under the cell culture microscope for any disruption to the 
matrix, indicated by clumps of coating which would suggest a premature polymerisation of the 
Matrigel in the coating solution.  
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8.2.1.2 Feeder-free method: Culture of iPSCs 
8.2.1.2.1 Recovery from storage 
To thaw iPSCs, the vial was transferred from the freezer to 37°C water bath where it was rapidly 
defrosted until only a small block of ice was left in the middle. This was transferred to a 15 ml falcon 
tube containing 9 ml of medium to make 10 ml, defrosting the last of the frozen cell suspension by 
rinsing the tube with medium. The falcon tube was then spun at 160 g for 4 minutes, before the 
supernatant was aspirated and the pellet gently resuspended in E8 medium supplemented with 10 
µm Y-27632. The Rho Kinase (ROCK) inhibitor, Y-27632, was added to medium whenever iPSCs were 
in suspension to protect against apoptosis (Watanabe et al., 2007). The medium was exchanged for 
fresh, warmed E8 medium to remove the Y-27632 after 24 hours. The iPSCs were cultured for 3-5 
days, until they reached approximately 80% confluency, during which time the medium exchanged 
for fresh E8 medium every 24 hours. At 80% confluency, the iPSCs were either passaged for 
maintenance of the culture, to set up iPSCs for differentiation or to freeze. 
 
Figure 100. Expansion of ReBl-PAT iPSCs over 3 days in culture. The iPSCs were cultured in Matrigel 
coated T25 flasks. As passage, the cell suspension was diluted 1 in 6 for seeding which was 
estimated at around 0.6-0.8 million iPSCs transferred to the new flask. The images taken were at 
(A) 24 hours, (B) 48 hours and (C) 72 hours, post-passage. At 72 hours, the flask required passaging 
to avoid becoming over confluent. The scale bar is 0.25 mm. 
 
8.2.1.2.2 Passaging and cell dissociation 
Prior to passaging the iPSCs, the storage medium was aspirated from a Matrigel coated flask, gently 
washed once with PBS and replaced with fresh E8 medium supplemented with 10 µm Y-27632. The 
flask was placed in the hood to equilibrate to room temperature. To passage the iPSCs, the medium 
was aspirated, and the flask was washed with PBS warmed to room temperature. After aspirating 
the PBS, 1 ml of 0.5 µM EDTA solution was added. The flask was then returned to the incubator for 
4 minutes. After this time, the flask was carefully removed to avoid disrupting the iPSCs and 
observed under the microscope to confirm that iPSCs had become rounded. If the iPSCs were not 
rounded, they were returned to the incubator for a further 30 seconds and observed again. When 
the cells were rounded, the EDTA was very carefully aspirated to avoid losing any iPSCs. The flask 
was then tapped to release the iPSCs from the coated surface and 1 ml of fresh medium was 
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pipetted into the flask from the neck and across the cell surface, to rinse any iPSCs which remained 
attached. The 1 ml of cell suspension was then removed from the flask and divided amongst the 
new flasks. To passage to a flask of the same size, a 1:6 ratio was typically used. To passage a T25, 
166 µl of the cell suspension was pipetted into the fresh flask containing 5 ml supplemented E8 
medium and placed in the incubator for 24 hours, before repeating the iPSC culture steps as 
described above. The protocol was scaled accordingly, for example, up to 500 µl was transferred to 
a T75, for the purpose of expanding and freezing the culture. The EDTA passage method was used 
to dissociate iPSCs in clumps for regular passaging to limit the damage to iPSCs when exposed to a 
harsher dissociation method. 
The EDTA dissociation method was unsuitable for obtaining a cell count, as the large number of 
clumps hindered an accurate count. Therefore, when dissociating with EDTA for expansion or 
maintenance of the iPSC culture, a ratio was used to dilute the iPSCs for seeding in a new flask. 
Where an accurate cell count was required, such as freezing or preparing a flask for differentiation, 
the alternative Accutase enzyme dissociation method was used. To passage iPSCs in a T75 with 
Accutase: the medium was aspirated, the flask washed with 10 ml of warmed PBS and 1.5 ml of 
Accutase solution was added to the flask. The flask was returned to the cell culture incubator for 3 
minutes. On removal, the flask was tapped several times until the majority of iPSCs were detached 
and suspended in the Accutase solution. If some iPSCs remained after 4-5 taps, these were left 
attached as retrieving all iPSCs was of less importance than avoiding damage to the iPSCs through 
additional tapping and expose to Accutase. By pipetting from the neck across the cell surface, 13.5 
ml of E8 medium was added to the flask, to dilute the Accutase and rinse any iPSCs which may have 
remained loosely attached. A sample of the iPSC suspension was taken and counted while the 
remainder was transferred to a 50 ml falcon tube and centrifuged at 160 g for 4 minutes. 
 
8.2.1.2.3 Passage for differentiation 
To passage iPSCs for differentiation, they were dissociated with the Accutase method, counted and 
centrifuged. The iPSC pellet was resuspended in E8 medium with 10 µm Y-27632, at the appropriate 
volume to dilute and seed the required number of iPSCs for differentiation. The iPSCs were then 
cultured for 2 days following the feeder-free iPSC culture before beginning differentiation at Day 0, 
as described in section 8.2.2, below. 
 
8.2.1.2.4 Generation of frozen stocks 
To generate frozen stocks, iPSCs were cultured in T75 flasks to a maximum of 80% confluency. 
Cryovials were labelled and aliquots of FBS and FBS with 20% DMSO were both thawed and placed 
in the hood. The cryovials were then filled with 0.5 ml of FBS with 20% DMSO and the caps loosely 
Page 198 of 264 
 
replaced. The iPSCs were then dissociated with Accutase, counted and centrifuged, as described 
above. The resulting pellet was re-suspended in FBS at a volume calculated to achieve 2 million 
iPSCs per ml. The suspension was divided amongst the pre-prepared cryovials, adding 0.5 ml to 
each so that the result was 1 million iPSCs per vial in FBS with 10% DMSO. The caps were secured, 
and the vials rapidly transferred to a freezing chamber which was placed in a -80°C freezer before 
transfer of the vials to liquid nitrogen storage the following day. 
 
8.2.1.3 Feeder-dependent method:  
The feeder-dependent method for the culture of iPSCs using mouse embryonic fibroblasts (MEFs), 
was taught by Professor Tristan McKay’s laboratory at Manchester Metropolitan University (MMU). 
It was used for culturing two CLN3 patient cell lines and a control cell line which he provided (PA 
338, 417 PB and CTRL NHDF). The feeder cells were MEFs, which had been mitotically inactivated 
(referred to as iMEFs, post-inactivation) on a gelatin coated plate. This method required culturing 
two different cell types: iPSCs and MEFs. Procedures for the culturing of both are described below.  
 
8.2.1.3.1 Culture and inactivation of Mouse Embryonic Fibroblasts (MEFs) 
Instead of a matrix mimicking the extracellular matrix, like Matrigel, iPSCs can be grown on a layer 
of feeder cells. Inactivated MEFs, which do not divide any longer, are commonly used for this 
purpose. To prepare the coating substrate for feeder cells, a 0.1% gelatin solution was prepared by 
dissolving gelatin in distilled water and autoclaving the solution, which was then stored in the 2-8°C 
refrigerator for up to 2 weeks. To coat plasticware, the gelatin solution was warmed to room 
temperature and pipetted onto the base of the flask or plate. This was then gently rocked to allow 
the solution to cover the surface and incubated in the cell culture hood for 20 minutes at room 
temperature. The solution was aspirated, and the flasks or plates were immediately used.  
 
8.2.1.3.2 MEF culture, freezing and recovery 
Mitotically active MEFs were purchased from Cambridge Bioscience and cultured in DMEM 
supplemented with 10% FBS, 4mM L-Glutamine and 1x Pen-Strep. Frozen stocks of the active MEFs 
were prepared between passage 1 and 3 as described for the thawing of iPSCs in 8.2.1.2.  
To create a large number of iMEFs stocks for later use, the active MEFs were expanded until passage 
4, where they were cultured to approximately 90% confluency prior to mitotic inactivation by 
addition of 2 µg/ml Mitomycin C to the cell culture medium. After 3 hours of keeping the cells in 
the cell culture incubator, the medium was replaced with fresh culture medium without Mitomycin 
C.  
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These iMEFs were dissociated and frozen for later use, according to the protocol described in 
8.2.1.2., but with the modification of TrypLE Express used in place of Accutase. For use in iPSC 
culture, iMEFs were rapidly thawed and plated as per thawing protocol described in 8.2.1.2, 
modified by resuspending in DMEM and placing iMEFs in a gelatin coated plate. The plate was 
placed in the incubator at 37°C for a minimum of 7 hours to allow iMEFS to settle before the 
addition of iPSCs. For use with iPSCs, the iMEFs were plated in the wells of a 6-well plate so that 
iPSC colonies could be accessed for picking 
 
8.2.2 Feeder-dependent method: Culture of iPSCs 
Feeder-dependent iPSCs were grown in FD medium, consisting of DMEM/F12 supplemented with 
manufacturer recommended concentrations of non-essential amino acids, Knockout Serum 
Replacement, Pen-Strep and 10 ng/ml basic fibroblast growth factor (bFGF). 
The iPSCs were thawed according to the protocol described in 8.2.1.2 and resuspended in warm FD 
medium , to be consistent with the conditions in which the iPSCs were previously cultured in 
Professor Tristan McKay’s laboratory. The iPSC suspension was gently pipetted into wells of a 6-
well plate, pre-prepared with iMEFs and equilibrated to room temperature. For the first 24 hours 
post-thaw or passage, the FD medium was additionally supplemented with 10 µM Y-27632. The FD 
medium was changed every 24 hours and colonies were closely observed for morphological 
changes indicating spontaneous differentiation, as illustrated in Figure 101. If iPSC colonies began 
to look flatter, darker and less uniform they were removed, as they were considered to be 
spontaneously differentiating and at risk of triggering differentiation in surrounding colonies. The 
removal of colonies was carried out using a small, sterile pipette tip to gently scratch the colony in 
order to detach it from the surrounding iMEFs. Once the colony or colonies for removal were 
detached and in suspension, the medium was changed for fresh FD medium. After removing 
colonies that were spontaneously differentiating, the remaining colonies were detached to passage 
the cultures. Passage was required when colonies became too large, or the iMEFs appeared to have 
deteriorated in condition, most commonly observed as a contraction of iMEFS indicating that they 
were no longer suitable to support iPSC growth. When colonies were detached for passage, they 
were transferred to a new 6-well plate prepared with iMEFs, in a 10 ml serological pipette and 
gently pipetted up and down to break up the colonies to smaller clusters. The FD medium was 
supplemented with 10 µM Y-27632 for 24 hours, before exchange to fresh FD medium.  
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Figure 101. iPSC colonies growing with iMEF feeder cells. The cells in colonies A and B appeared 
darker and less dense, with irregular morphology of the iPSCs of the colony. The cells in colonies C 
and D had the brighter, more regular appearance of undifferentiated iPSCs. Panel E highlights the 
iMEFs surrounding the iPSC colonies. The scale bars are 250 µm. 
 
8.2.2.1 Conditioning of feeder-dependent iPSCs prior to differentiation 
The differentiation protocol starts with iPSCs grown in a feeder-free culture. Consequently, feeder-
dependent iPSC cultures required reconditioning to the feeder-free protocol prior to 
differentiation. To achieve this, 80% confluent iPSCs were gently washed with PBS and briefly 
incubated in TrypLE Express to dissociate the colonies. The iPSCs, along with any iMEFs, were then 
transferred to a Matrigel coated flask with mTeSR medium supplemented with 10 µm Y-27632 for 
24 hours. The subsequent medium change to fresh mTeSR removed any suspended iMEFs which 
had not attached after the transfer.  
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8.2.2.2 Differentiation of iPSCs to cardiac myocytes 
The differentiation of iPSCs to cardiac myocytes (iPSC-CMs) was carried out using the method 
taught by Professor Chris Denning’s laboratory at The University of Nottingham. The differentiation 
process is initiated by adding a large number of signalling molecules and other compounds in a 
specific order to the iPSCs. Prior to establishing it at The Open University, aliquots all of these 
compounds had to be prepared. On the day of use, the aliquots were diluted according to the 
working concentration (Working conc.) set out in Table 22, in the pre-warmed medium specified in 
‘Diluent,’ Table 22. All aliquots were prepared in sterile conditions and stored frozen. The signalling 
molecules for differentiation were: Activin A (growth factor), BMP4 (bone morphogenetic protein 
4) and the small molecules KY02111 and XAV939 (WNT inhibitors). To generate stocks, Matrigel 
was thawed as described in section 8.2.1.1 and divided into single use aliquots. Activin A was 
reconstituted with 4 mM hydrochloric acid (HCl) with 0.1% human serum albumin (HSA) and BMP4 
was reconstituted with 4 mM HCl and 0.1% bovine serum albumin (BSA). The dissociation solution 
was formulated from: Collagenase II enzyme, N-benzyl-p-toluene sulphonamide (BTS) to inhibit 
beating while in suspension and therefore protect the cytoskeleton and HEPES pH buffer. DNase II 
was used in a blocking solution during dissociation. KY02111, XAV939 and BTS were reconstituted 
in dimethyl sulfoxide (DMSO). Collagenase II was reconstituted in calcium (Ca2+)-free Hank’s 
Balanced Salt Solution (HBSS), HEPES was dissolved in deionised water and DNase II was 
reconstituted in phosphate buffered saline (PBS). 
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Table 22. Preparation of aliquots for the culture, differentiation and dissociation of iPSC-CMs. 
Aliquots were prepared in advance at a high concentration and diluted to the working 
concentration as required. Small aliquots, especially those in DMSO, were vortexed and centrifuged 
prior to use. 











Matrigel 8-10 mg/ml None 80-100 µg/ml RPMI medium 
Activin A 5 µg/ml 4mM HCL 0.1% HSA 8 ng/ml RPMI medium 
BMP4 10 µg/ml 4mM HCl 0.1% BSA 1 or 10 ng/ml  RPMI medium 
KY02111 10 mM DMSO 10 µM RPMI medium 








 Collagenase II 200 U/ml HBSS (- Ca
2+) 200 U/ml N/A 
HEPES 1 M dH2O 1 mM Collagenase II 
BTS 30 mM DMSO 30 µM Collagenase II 
DNase II 12 mg/ml PBS 12 µg/ml Blocking solution 
 
 
8.2.2.3 Differentiation process 
The differentiation of iPSCs to cardiac myocytes, as summarised in Table 22, was carried out using 
the ReBl-PAT iPSC line under the instruction of Professor Chris Denning’s group. These iPSCs were 
cultured with the feeder-free (Matrigel) method. For iPSCs originally grown with feeder-dependent 
culture methods, these would have been transferred to Matrigel prior to differentiation and 
passaged in E8 medium 2-3 times to condition the cells to this medium. Each stage of the 
differentiation was carried out according to precise timing, so that no incubation time was reduced 
or extended. 
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Table 23. Summary of the timeline for feeder-free culture of iPSCs and differentiation to cardiac 
myocytes (CMs). The time frame was based on ReBl-PAT iPSCs, but growth varied between cell 
lines. Steps marked with → indicate repeat until appropriate confluency/maturity is reached for 
next stage. *Estimated day of dissociation based on ReBl-PAT. All incubations were in a humidified 
cell culture incubator at 37°C and 5% C02 unless otherwise stated. 




1 hour (RT) Matrigel coating of flasks/plates 
24 hours iPSC plated in E8 + Y-27632 on Matrigel 
Day 2 → 24 hours Change to E8 medium 






12 hours StemPro-34 + BMP4 + Matrigel (pre-condition) 
36 hours StemPro-34 + BMP4 + Activin A 
Day 2 48 hours RPMI/B27 without insulin. + KY02111 + XAV939 
Day 4 48 hours RPMI/B27 + KY02111 + XAV939 
Day 6 → 48 hours Change to RPMI/B27 medium 
Beating cells observed in tight colonies: proceed to dissociation 
Cardiac myocyte 
maintenance 
Day 12* 24 hours Dissociation: plating in RPMI/B27 + Y-27632 
Day 13* → 72 hours Change to RPMI/B27 (maintenance) 
 
 
During training, the differentiation was carried out at a range of densities (25k/cm2, 40k/cm2, 
50k/cm2 and 65k/cm2) in a 6-well plate, to determine appropriate seeding density for the ReBl-PAT 
iPSCs. The optimal seeding density for high percentage of iPSC-CMs post-differentiation was 
analysed for each new cell line, or for re-optimisation in the case of poor differentiation outcome. 
In T25 flasks, 0.6-1 million ReBl-PAT iPSCs were seeded 48 hours before commencing differentiation 
at Day 0. 
The protocol for differentiation of iPSCs to cardiac myocytes began on the morning of ‘Day 0’ with 
a pre-conditioning step. Pre-conditioning was achieved with the exchange of complete E8 medium 
for StemPro-34, containing 1 ng/ml BMP4 and 1/100 Matrigel. Matrigel was added to the medium 
with the intention to forming a second Matrigel layer on top of the cells, practically sandwiching 
the differentiating iPSCs between the two layers. The iPSCs were incubated at 37°C for 6-10 hours, 
before the media was changed for StemPro-34 containing 10 ng/ml BMP4 and 8 ng/ml Activin A to 
stimulate WNT signalling pathway. The cells were then incubated for 36 hours, until the morning of 
Day 2, when the media was replaced with fresh RPMI medium supplemented with B27 (without 
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insulin), and with 10 µM KY02111 and 10 µM XAV939. From pre-conditioning Day 0 to Day 2, the 
appearance of the culture changed from branching colonies to a dense monolayer as shown in 
Figure 102 and retained the monolayer appearance throughout the next stages of differentiation.  
 
 
Figure 102. ReBl-PAT iPSCs in the early stages of differentiation: (A) On Day 0, after pre-
conditioning, the iPSCs were grouped into branching, interconnected colonies with visible empty 
spaces in between. (B) On Day 2, the iPSCs spread to fill in the gaps and form a dense monolayer. 
This batch originated with 0.7 million ReBl-PAT iPSCs, seeded in a T25 at 48 hours before 
commencement of differentiation at Day 0. The scale bar is 250 µm. 
 
The flasks were returned to the incubator for 48 hours, when the medium was exchanged for fresh 
RPMI medium supplemented with B27, 10 µM KY02111 and 10 µM XAV939. The flasks were 
returned to the incubator for 48 hours and the medium was exchanged for fresh RPMI medium 
supplemented with B27. From this point, the medium was exchanged every 48 hours for fresh RPMI 
medium supplemented with B27 to maintain the culture. During this period, the morphology of the 
culture gradually transformed from the monolayer to a more complex, fibrous appearance as in 
Figure 103. 
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Figure 103. ReBl-PAT iPSCs towards the end of differentiation, prior to dissociation. (A) On Day 6, 
the medium was exchanged to maintain the differentiating cells; at this stage they still had the 
appearance of a dense monolayer. (B) On Day 9, the cells were pulling together in tight layers to 
reveal some space between the interconnected clusters of cells. This batch originated with 0.7 
million ReBl-PAT iPSCs, seeded in a T25 flask at 48 hours before commencement of differentiation 
at Day 0. The scale bar is 250 µm. 
 
When cells were observed to be in tight, uniform colonies with spontaneous movement to suggest 
that the cells were displaying synchronised (but not necessarily regular) beating, they were ready 
for dissociation. This was expected around Day 12 for ReBl-PAT iPSCs, but could be seen beginning 
as early as Day 9, as depicted in Figure 104. 
 
Figure 104. ReBl-PAT iPSCs post-differentiation, prior to dissociation. The differentiated cells at 
Day 9 at: (A) 4x magnification and (B) 10x magnification. The culture formed overlapping bands of 
cells with a 3D appearance and began to exhibit ‘twitching,’ suggesting the beginning of 
spontaneous beating. This batch originated with 0.7 million ReBl-PAT iPSCs, seeded in a T25 flask 
at 48 hours before commencement of differentiation at Day 0. The scale bar is 250 µm. 
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The methods for iPSC culture through to differentiation and dissociation were summarised in Table 
23. Each stage was carried out according to precise timing, so that no incubation time was reduced 
or extended. However, after completing the differentiation procedure, the cells were maintained 
until the appropriate morphology was observed for dissociation, as described above. 
 
8.2.2.3.1 Dissociation of differentiated cells  
To analyse the success rate of differentiation into cardiac myocytes, from now on termed ‘quality 
control,’ and for other experiments, the cells had to be transferred from the flasks in which they 
were differentiated to plates. The differentiated cells were maintained in RPMI medium with B27 
supplement changed every 3rd day until they had the tight, uniform morphology as shown in Figure 
104. 
A dissociation solution was made using collagenase II at 200 U/ml in Ca2+ free HBSS, supplemented 
with 10 µm Y-27632, 30 µM N-Benzyl-p-toluene sulphonamide (BTS) and 1 mM HEPES and 
equilibrated to room temperature. Matrigel coated plates were prepared in advance and warmed 
in the incubator immediately before use. To begin dissociation of the differentiated cells, the 
medium was aspirated and Ca2+ free HBSS was carefully pipetted in and aspirated twice to ensure 
no residue of medium remained. Sufficient dissociation solution to cover the base of the flask or 
plate well (2.5 ml for a T25) was added and incubated for 3.5 hours in the cell culture incubator. 
The flask was then removed from the incubator and cells gently suspended by slowly pipetting up 
and down in a 10ml serological pipette. A sample was checked under the microscope to ensure that 
cells were well separated and no longer clumped together before being transferred to a 50 ml 
falcon tube.  
To inactivate the dissociation solution a pre-warmed (37°C) blocking solution composed of RMPI 
medium (no B12 supplement) containing 10% FBS, 12 µM Deoxyribonuclease II (DNase II) and 10 
µm Y-27632 was used. The DNase II ensured that no free DNA, which is sticky and can cause cells 
to clump together, was present in the solution. The blocking solution was first used to wash the 
flask, removing any loosely attached cells, was added to the 50ml falcon tube containing the cell 
suspension and centrifuged for 15 minutes at 800 rpm. The tube was handled gently upon removal 
from the centrifuge and medium was aspirated carefully to avoid dislodging the loose pellet created 
by the relatively slow centrifugation. The blocking buffer was replaced with 5-10 ml (depending on 
the size of the pellet) of pre-warmed RPMI medium (with B12 supplement and 10 µm Y-27632) and 
passed through a 100 µm cell strainer for the removal of any clumped cells, or debris. The number 
of the cells in the filtered solution was counted and subsequently divided amongst Matrigel coated 
plates for experiments at an appropriate seeding density. The differentiated iPSC-CMs were 
expected to continue proliferation far more slowly than iPSCs. For some experiments, iPSC-CMs 
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were supposed to be kept for a prolonged period, so their proliferation had to be taken into account 
when seeding the cells.   
 
8.2.2.4 Effect of cell density on successful differentiation 
To test at which density the differentiation to iPSC-CMs is most successful, iPSCs were seeded four 
densities, ranging from 25,000 to 65,000 cells per well of a 12 well plate, and differentiated. 
 
8.2.2.5 Determining the success of differentiation into cardiac myocytes: Quality control 
To determine the success of the differentiation, the proportion of cardiac myocytes in the 
population of differentiated cells was calculated. α-actinin, an actin-binding protein expressed in 
skeletal and cardiac muscle, was used as a marker for cardiac myocytes. It is absent in 
undifferentiated iPSCs.  
For fixation, the medium was removed from the wells and exchanged for PBS to dilute and wash 
away any residual medium. The PBS was then exchanged for ice-cold PFA solution (4% PFA in PBS) 
and incubated for 15 minutes at room temperature. All following steps were carried out at room 
temperature. All washes were performed with 200 µl of the respective solution. The PFA solution 
was carefully removed, and the PBS wash repeated. To permeabilise the cells, PBS containing 0.1% 
Triton X-100 was added to the wells and incubated for 15 minutes. Following this, the cells were 
washed again, this time with a wash buffer comprised of 0.1% Tween 20 in PBS, which was used for 
all subsequent wash steps. A blocking buffer of 5% Human Serum Albumin (HSA) in PBS, was then 
added to the wells and incubated for 30 minutes. The primary antibody was diluted to 1/1000 in 
blocking buffer. The blocking solution was exchanged for 50 µl of antibody-solution in each wells 
and incubated for a further 45 minutes. The primary antibody was monoclonal anti-α-actinin 
(sarcomeric), produced in mouse (Sigma A7811) diluted 1/1000 in blocking solution. The cells were 
then washed three times with wash buffer, and the solution replaced with a FITC-labelled secondary 
antibody, diluted 1/500 in blocking solution.  
The cells were washed twice more with wash buffer, which was then exchanged for PBS. Finally, 
the cells were stained with DAPI, sealed and incubated for 45 minutes before the plate was read 
and analysed using the Operetta confocal plate reader and software. The quantification of iPSC-
CMs in the cell population was based on the percentage of all cells (quantified as number of DAPI 
stained nuclei) that were positive for α-actinin (antibody stained cardiac specific marker). 
As controls, cells were fixed in the same way and underwent the same staining protocol with the 
following modifications: (1) only the secondary antibody was added (2) neither a primary nor a 
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secondary antibody were added. Images were captured under identical conditions to provide 




8.3.1 Culture of iPSCs 
The main aim for the culture of iPSCs was to expand and freeze each cell line, while avoiding 
contamination or spontaneous differentiation. The ReBl-PAT iPSCs were successfully cultured 
during training at The University of Nottingham, using the feeder-free culture method. The feeder-
free protocol was therefore set up at The Open University, as described in sections 8.2.1.1 and 
8.2.1.2., and the following iPSC lines were cultured at The Open University: ReBl-PAT, and the 
CRISPR engineered iPSC pair of CLN3 Q352X and A13777 WT.  
Necessary troubleshooting to achieve a successful culture was needed to prevent poor attachment 
of iPSCs. Two potential reasons for this were identified: cell confluency and the Matrigel coating. 
The culture protocol recommends to passage iPSCs when they reach 80% confluence to prevent 
the detachment of cells. Here, it was observed that flasks with 60% confluency at the end of a day 
would reach 80% confluency overnight and start to detach before passaging. Therefore, passaging 
was performed when cells reached a confluency of >60%. This prevented the loss of cultures due 
to detachment.  
Matrigel can polymerise during handling, causing an uneven coating which is an inferior cell 
attachment surface. When it was observed that iPSCs showed poor attachment after passaging, 
they were transferred into a new batch of Matrigel-coated flasks. On each occasion the iPSCs 
attached to the surface as expected. This indicated that the Matrigel coating deteriorated and 
caused the low level of attachment. If this was observed, all plasticware from this batch of Matrigel-
coating was disposed of. After these steps, the three feeder-free iPSC lines were grown successfully 
at The Open University, expanded and stocks were frozen for future use. These cell lines were 
expanded and frozen to generate early passage stocks, which were found to recover well from 
storage in liquid nitrogen. Troubleshooting steps were further discussed in section 8.4, below.  
Three iPSC lines, the control line CTRL NHDF and the CLN3-patient derived lines PA 338 and 417 PB 
had to be cultured on feeder cells. These lines were of special interest because they include the 
most frequent mutation in the CLN3 gene.  However, culturing them proofed difficult because the 
colonies were lost through a combination of spontaneous differentiation or failure to attach to the 
iMEFs in culture.  
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The iPSCs initially formed colonies with the appearance of healthy undifferentiated iPSCs, but as 
the colonies expanded the iPSCs rapidly underwent spontaneous differentiation, as shown in 8.2.2, 
Figure 101.  To prevent differentiation of all the cells in the culture, small colonies that still had the 
appearance of undifferentiated iPSCs were picked and transferred to a fresh plate of iMEFs. 
However, many of the iPSCs did not adhere to the flask and remained in suspension at the time of 
medium change the following day. The iPSCs that attached to the iMEFs were generally the larger 
fragments of the original colonies, which rapidly deteriorated in condition and spontaneously 
differentiated again.  
Several steps were performed to prevent this spontaneous differentiation and address any 
problems with attachment:  
• Testing different densities of iMEFs for the layer of feeder-cells 
• Testing different length of time for separating the colonies by pipetting to have a better 
dispersal of cells, enabling a better attachment 
None of these steps prevented the spontaneous differentiation observed. Therefore, the culture of 
feeder-dependent iPSCs were abandoned in favour of the feeder-free iPSC lines which had 
demonstrated reliable growth.  
All cell lines were free from any visible contamination and negative for mycoplasma each time they 
were tested. The feeder-free iPSC lines were most vulnerable to contamination as they were 
cultured in the absence of antibiotics, but this also meant that contamination was unlikely to be 
masked.  
  
8.3.2 Differentiation of iPSCs to iPSC-CMs 
The differentiation of iPSCs to iPSC-CMs was carried out when iPSCs reached an appropriate 
density. The density of iPSCs had an effect on the differentiation capabilities of the culture, with 
the optimal density known to differ between iPSC lines. When setting up for differentiation, the 
dissociated iPSCs were counted and seeded in the wells of a 12-well plate at a range of densities. 
After differentiation and dissociation, the cells were transferred to a 96-well plate for analysis. The 
results were used to advise on the appropriate density of seeding when seeding a T25 flask, set out 
in Table 24.  
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Table 24. The range of iPSC seeding densities tested on a 12-well plate, per cm2. Each number of 
iPSCs per cm2 was scaled to calculate the number of iPSCs for a T25 (25 cm2 cell surface) flask. 







Post-differentiation and transfer to a 96-well plate, the cells in each well were fixed and 
immunostained for α-actinin, followed by staining with DAPI before imaging on the Operetta 
confocal plate reader (Figure 105). To judge the success of the differentiation, the % of cell 
population positive for the cardiac myocyte marker α-actinin was quantified (Figure 106). The 
images in Figure 105 clearly showed the presence of α-actinin surrounding the majority of DAPI 
stained nuclei at the two lower densities (Figure 105 A and B), indicating that the culture was 
comprised of a predominantly iPSC-CMs. At 50 k/cm2 (Figure 105 C) there were noticeably fewer 
cells with α-actinin staining present, indicating a drop in differentiation efficiency. However, at the 
highest density used for differentiation (Figure 105 D) the smaller number of cells is lower and the 
proportion of α-actinin positive cells is smaller. This suggests two things: the majority of these cells 
had failed to correctly differentiate to iPSC-cardiomyocytes, and that the differentiated cells had 
difficulty in adhering to the new plate after dissociation. This was possibly a result of stress from 
over-confluency during culture and differentiation, or the unknown morphology of the incorrectly 
differentiated cells.  
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Figure 105. Quality control for seeding density: to determine the percentage of cells that were 
successfully differentiated to iPSC-CMs. The seeding densities were: (A) 25 k/cm2, (B) 40 k/cm2, (C) 
50 k/cm2 and (D) 65 k/cm2 48 hours prior to differentiation. All nuclei were labelled with DAPI (blue) 
regardless of cell type, while the presence of α-actinin (green) selectively indicated iPSC-CMs. The 
images were taken with the Operetta confocal plate reader. The scale bars are 100 µm. 
 
The cells imaged and presented in Figure 105 were also quantified by the plate reader software. 
The DAPI-staining identified all cells. The software then quantified the % of cells positive for α-
actinin, which represented the % of iPSC-CMs in the culture. As plotted in Figure 106, the results 
confirmed a successful differentiation of almost all cells in the populations seeded at the two lowest 
densities. A slightly lower but still good differentiation (88.98 %) was achieved at a density of 50 
k/cm2. The highest density resulted in a low success rate for the differentiation. Therefore, a density 
of 25-40 k/cm2 iPSCs was considered optimal based on the range tested, translating to 0.625-1 
million iPSCs in a T25 flask when setting up a differentiation.  
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Figure 106. The percentage of iPSC-CMs in the cell population., indicated by α-actinin staining. 
The cells were plated from wells initially seeded with iPSCs at 25, 40, 50 or 65 k /cm2 prior to 
differentiation. Staining was performed with DAPI and the cardiac marker -actinin. Each bar 
represents the mean percentage ± S.E.M. and n = 4 wells on 1 plate.  
 
Control experiments tested if the staining shown in Figure 105 was specific for -actinin. For these 
experiments, cells were incubated with DAPI to label the nuclei. The immunostaining was 
performed either without the primary antibody, or without any antibody addition. Using identical 
setting to those for imaging the iPSC-CMs shown in Figure 105, virtually no cells were found to be 




Figure 107. Control for specificity of the staining protocol. iPSC-CMs were stained with DAPI. No 
primary antibody was added. Cells were either incubated with the secondary antibody only 
(secondary only), or without any antibody (-ve), and imaged under identical conditions to those 
used for the -actinin immunostaining. This control was only performed once.   
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The differentiation described above was performed in wells of a 12-well plate. To test if it can be 
scaled up and be performed in a T25 flask, two batches of ReBl-PAT iPSCs were seeded at 0.7 million 
and 1 million iPSCs per T25 flask (the densities that gave the best differentiation in the 12-well 
plate). These were cultured for 2 days and differentiated. After dissociation, a sample of each batch 
was placed in a 96-well plate for quality control. The images (Figure 107, quantified in Figure 109) 
showed the majority of cells to be positive for α-actinin, indicating that they had been successfully 




Figure 108. Quality control for iPSC-CM differentiation: to determine the percentage of cells that 
were successfully differentiated to iPSC-CMs. Batch 1 (A) and Batch 2 (B), were differentiated 
during training at The University of Nottingham. All nuclei labelled with DAPI (blue) regardless of 
cell type, while the presence of α-actinin (green) selectively indicated iPSC-CMs. The images were 
taken with the Operetta confocal plate reader. The scale bars are 100 µm. 
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Figure 109. Quality control: Percentage of cells positive for α-actinin, indicating successful 
differentiation to iPSC-CMs. (a) ReBl-PAT iPSCs post-differentiation, training batch 1 and 2, 
presented as a mean ±S.E.M. and n = 4 wells on 1 plate.  
 
After successfully differentiating the ReBl-PAT iPSCs, the next step was to differentiate iPSCs 
carrying mutations in the CLN3 gene. First, differentiation of the CLN3 Q352X and A13777 WT iPSCs 
was attempted, as these cells were conditioned for feeder-free culture. The cells were plated at the 
density that was found to be optimal for the ReBl-PAT iPSCs.  
In contrast to the ReBl-PAT iPSCs, these cells changed their phenotype after the initial pre-
conditioning on Day 0. Instead of growing and spreading to form a monolayer, as shown in 8.2.2.2. 
Figure 102, the iPSCs contracted to a ‘string-like’ appearance of long, connected colonies and began 
to detach from the Matrigel. By Day 2, the differentiation was abandoned due to the detached iPSCs 
and the failure to form a monolayer. 
It was shown for ReBl-PAT iPSCs that the plating density affects the differentiation success (Figure 
106). To test if plating at a different density prevents the change in phenotype observed above, a 
fresh batch of each iPSC line was plated at a range of seeding densities on a Matrigel coated 12-
well plate. The string-like morphology was more pronounced at very low seeding densities, 
probably due to the less dense and therefore thinner groups of iPSCs linking the colonies. 
Conversely, at higher densities, the iPSCs had an improved appearance of monolayer formation, 
but a large number of iPSCs detached and the stress of over-confluent iPSCs put them at high risk 
for spontaneous differentiation. In these experiments, no seeding density could be identified that 
provided a good compromise between a successful monolayer formation without the problems of 
a high confluency, indicating that the difficulties with the differentiation might not only be caused 
by the cell density.  
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In addition, when recovering and culturing the CLN3 Q352X and A13777 WT iPSCs at the same time, 
it was observed that despite being an isogenic pair, they had different growth rates. Therefore, the 
iPSCs reached considerably different densities when seeded at the same original number. This was 
potentially problematic, as any difference between the two lines may have had a knock-on effect 
on differentiation efficiency. Furthermore, the introduction of variation between the two cell lines 
that could modify any readout in subsequent experiments may have rendered them less suitable 
as a matched pair to study CLN3 disease.  
To determine whether the difficulty related to the cell lines or the method in general; further 
troubleshooting was carried out using the ReBl-PAT iPSCs, which had proven capability for 
differentiation to iPSC-CMs. However, the ReBl-PAT iPSCs also failed to form a monolayer and had 
a high proportion of iPSCs detach after pre-conditioning. Therefore, the most likely issue was in 
either the preparation of the iPSCs for differentiation, the execution of the method or the reagents 
used for pre-conditioning.  
Changing the Stem-Pro24 medium to a new batch did not improve the attachment. One critical 
component that has been shown to affect the attachment was Matrigel. A new batch of Matrigel 
was tested, with careful examination of the flasks to check for polymerisation of the Matrigel. A 
uniform coating with no appearance of polymerisation was not sufficient to improve attachment 
alone, suggesting that this was not the underlying cause of the poor attachment. 
During differentiation, plasticware is not only coated with Matrigel, but Matrigel is also used to 
form another layer, forming a ‘sandwich’ between which the iPSCs grow and differentiate. Matrigel, 
as described in section 8.2.1.1, required careful handling to avoid warming the solution above 
freezing before it was ready to polymerise. This was achievable when coating flasks, as they could 
be refrigerated or cooled in the freezer prior to use. However, the addition of a Matrigel-containing 
solution to a flask of iPSCs which had previously been in the 37°C incubator appeared to cause 
premature polymerisation and a failure to form a matrix. The suspected polymerisation was 
observed as lumps of foreign substance in the medium after pipetting into the flask. The Matrigel 
addition was practised and tested on many flasks and plates, but usually with the presence of 
polymerisation. A second batch of Matrigel was trialled to ensure that polymerisation had not 
already occurred in the original stock, but this did not resolve the issue. With practise, the 
polymerisation appeared less prominent and this may have been a combination of allowing the 
flask time to cool from 37°C to room temperature and taking care to ensure that the medium and 
all pipettes were chilled to control temperature. Additionally, gently but firmly pipetting the 
medium into the flask, avoiding disrupting the iPSC layer but rapidly covering the cell surface and 
allowing the flask to sit flat to encourage formation of the matrix in a layer.  
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When growing iPSCs in the Matrigel ‘sandwich’, fewer iPSCs detached. However, by Day 4 or 6 of 
the differentiation, the majority of cells were in suspension at the time of medium change and the 
differentiation had to be re-started. To test the protocol in full at The Open Universities 
laboratories, with no intention to use the cells for experiments, some flasks with high detachment 
were carried through to dissociation. However, the few remaining cells did not appear to survive 
the dissociation procedure and failed to adhere to the new plate for quality control. Due to the 
appearance of stressors and the incorrect morphology of the culture, it was unlikely that these cells 
had differentiated to iPSC-CMs. 
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8.4 Discussion 
The training for feeder-free iPSC culture and differentiation to iPSC-CMs at The University of 
Nottingham culminated in the successful differentiation of the ReBl-PAT iPSCs. The differentiation 
of iPSCs at a range of densities (Figure 105 and Figure 106) provided valuable information for the 
optimal differentiation of ReBl-PAT iPSCs. Additionally, the results in Figure 106 showed that iPSC 
density had a great impact on the success of differentiation. The differentiation of ReBl-PAT iPSCs 
was >97% iPSC-CMs for each batch (Figure 108) indicated that the protocol was successfully carried 
out. The result indicated a good foundation for experimental work, as there was <3% risk of 
analysing a cell type that was not a iPSC-CM. By analysing a field of cells per experiment, with 
repeats, the presence of incorrectly differentiated cells was unlikely to affect the results in a 
significant way. Furthermore, results of undifferentiated cells may have been removed from 
analysis if they could be excluded from the analysis due to exhibiting a different morphology to the 
surrounding iPSC-CMs, or from the data set during outlier analysis if applicable. 
As the culture and differentiation had been successfully carried out during training, the next aim 
was to transfer the protocols to The Open University, and to apply them to the feeder-free and 
feeder-dependant iPSC cell lines with mutations in CLN3. The transfer of the iPSC culture and 
differentiation protocols involved three stages: 
i. Setting up a dedicated laboratory space, ordering all plasticware, medium and reagents and 
making aliquots of all supplements and reagents such as small molecules. 
ii. Receipt and growth of iPSCs: expansion of cultures to generate a large number of early-
passage stock vials to be stored frozen. 
iii. Differentiation of iPSCs to cardiac myocytes, troubleshooting and quality control. 
A dedicated laboratory space was set up for iPSC culture at The Open University and all reagents 
were purchased, prepared and stored as aliquots suitable for use with the culture and 
differentiation protocols. Once this was complete, after considerable investment of time but no 
other hinderance, the iPSC lines were received at The Open University. 
The CRISPR-engineered iPSC line carried a rare point mutation in the CLN3 gene (Q352X). Using this 
cell line offered the advantages associated with the use of an isogenic control, with the limitation 
that this rare mutation may not be comparable to the more common CLN3 mutations. As our 
differentiation protocol uses a feeder free culture methods, it was an advantage that this cell line 
was conditioned to feeder-free methods in the originating laboratory. However, we also decided to 
use cells carrying the most common CLN3 mutation, the Δex7/8 deletion. At the time of this study, 
these were only available as patient-derived cells. The collaborators we received the cells from, 
grew them in a feeder-dependent culture. So, in addition to the differentiation, we also had to 
condition these cells to feeder-free culture, which is not always successful.  
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As described in section 8.3.1, several feeder-free iPSC lines were successfully cultured and 
expanded to achieve viable stocks. Some troubleshooting steps were required when subsequent 
passages had a high level of iPSC detachment, but after finding a suitable cell density and solving 
issues with Matrigel this part was accomplished. 
Although the feeder-free iPSC lines expanded rapidly and appeared to retain a healthy morphology, 
this was not the case with the feeder-dependent iPSCs. These showed high rates of spontaneous 
differentiation and high levels of detachment. Troubleshooting steps included using different 
densities of feeder cells and trying to more efficiently breaking up the colonies before replating, to 
improve cell attachment. However, these attempts did not resolve the problems encountered. 
Scientists in the labs that provided the cells were contacted for remote troubleshooting, but 
without achieving significant improvements. Therefore, the feeder-dependent iPSCs were 
abandoned in favour of the feeder-free iPSC lines which had demonstrated reliable growth. 
After creating a large number of stocks, the feeder-free CLN3 Q352X and A13777 WT iPSCs were 
trialled for differentiation, as these cell lines would have provided a model of CLN3 disease for 
subsequent experiments. However, these cells changed their morphology and growth pattern 
during the pre-conditioning, growing in strings instead of forming a monolayer. For ReBl-PAT iPSCs 
it was shown that the differentiation success was highly dependent on the plating density (Figure 
105). Troubleshooting for the CLN3 Q352X and A13777 WT iPSCs therefore included using various 
plating densities. High plating densities achieved the cells forming a monolayer, but the cells quickly 
detached from the surface. No density could be found that offered a viable compromise that 
allowed to carry the cells through the differentiation process. An additional challenge was the fact 
that WT and CLN3 mutated cells grew at different rates, making it difficult to proceed with the 
differentiation process in parallel. It also raised questions if the different rates of proliferation 
would affect the cell responses independent of the differences in CLN3. As the CLN3 Q352X and 
A13777 WT had not been differentiated to iPSC-CMs by any laboratory, it was possible that these 
lines may be particularly difficult to differentiate to iPSC-CMs. 
To determine whether the difficulty related to the cell lines or the method in general it was 
attempted to differentiate the ReBl-PAT iPSCs at The Open University. These cells had proven 
capability for differentiation to iPSC-CMs during the training at Chris Denning’s laboratory. 
However, the ReBl-PAT iPSCs also failed to form a monolayer and had a high proportion of iPSCs 
detach after pre-conditioning. Therefore, the most likely issue was in either the preparation of the 
iPSCs for differentiation, the execution of the method or the reagents used for pre-conditioning. 
During differentiation, Matrigel is used to ‘sandwich’ the iPSCs, which helps with their 
differentiation to cardiac myocytes. Because problems with Matrigel has been shown earlier to 
contribute to poor cell attachment, extensive troubleshooting was performed to test if the Matrigel 
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coating of the plasticware affected the attachment, which it did not, and to improve the formation 
of an even layer of Matrigel on top of the cells. Whilst it was possible perfect this technique, the 
cells in the sandwich did not differentiate successfully, but still detached during the process.  
Although the Matrigel step was suspected to be the cause of failure in the differentiation process, 
the troubleshooting was challenging, as there were a large number of variables which the iPSCs 
could have been sensitive to. It was possible that some stages took longer or were carried out 
slightly differently, for example the amount of force used to detach iPSCs passaged with EDTA or 
Accutase. The iPSCs may have failed to respond correctly to differentiation if they had been 
detrimentally affected by the culture methods previously used. As the ReBl-PAT iPSCs had 
differentiated correctly under supervision in a different laboratory, inexperience may have been 
part of the difficulty with the protocol. The handling of tricky reagents such as Matrigel, and the 
identification of visual cues in an iPSC culture (e.g. stress or spontaneous differentiation) may have 
been improved with more time learning from iPSC experts. Additionally, although the protocol was 
strictly followed, any of the aliquots of medium or supplements used in culture may have 
inadvertently differed from the stocks from the originating laboratory. Finally, it was possible that 
the iPSCs were infected despite being negative for mycoplasma and having no obvious 
contaminants in the medium. However, as the lack of antibiotics allowed uninhibited growth, it was 
unlikely that an infection would have been remained invisible under the microscope. 
With the failure of differentiation, the planned experiments to characterise structural and 
functional differences in iPSC-derived cardiac myocytes with mutations in CLN3 could not be 
performed in this study.  These included: contraction, number/volume of organelles including 
nuclei and mitochondria, calcium release from the sarcoplasmic reticulum and staining for the 
Troponin isoform expressed. Once these experiments were completed in an iPSC-CM model of 
CLN3 disease with appropriate paired controls, they would also have served to inform where 
further study could investigate any potential CLN3 disease phenotype.    
To further utilise these experiments, additional readouts would have been incorporated, such as a 
more in-depth assessment of calcium signalling, measurement of lysosome number and dynamics 
and autophagosome accumulation. Therefore, the maturity study had the secondary objective of 
identifying the development of any CLN3 disease phenotype, in addition to assessing the structure 
and function of cells for a matured phenotype as reported in literature. The experiments aimed to 
establish the extent to which iPSC-CMs were affected by the CLN3 mutation in comparison to a 
matched control.  
These experiments are explained in Future Work as they are still critical to understand the effects 
of mutations in the CLN3 gene on the heart. Despite the setback encountered, the system of iPSC-
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derived cardiac myocytes offers a lot of promise to perform this work but needs more local 
expertise in iPSC culture and differentiation to succeed.  
 
8.5 Future Work 
Despite the challenges, the generation of an iPSC-CM model of CLN3 disease would have been an 
excellent addition to the study of the heart, to address the gap in CLN3 disease research. The 
experiments planned for the iPSC-CMs (Table 25) were carefully selected. The first experiment, α-
actinin staining as detailed in section 8.2.2.5 was important for quality control.  
Next, a number of readouts for the comprehensive characterisation of iPSC-CM maturity over time 
in culture, as discussed in section 8.1., aimed to inform an appropriate window for experiments in 
which the iPSC-CMs no longer mostly resembled foetal cardiac myocytes. It was planned to assess 
the following parameters a 20-day intervals whilst culturing the iPSCs. 100 days was set as the end 
date, because at this time iPSCs have been described as reaching a mature state regarding their 
(Dai et al., 2017).   
These experiments included the identification of the Troponin isoform expressed, number of nuclei 
per cell as markers for structural changes during maturation. The number of mitochondria has been 
demonstrated to increase with iPSC-CM maturity (Dai et al., 2017), and we intended to quantify the 
number of mitochondria and use this as a marker for maturity.  
To measure the function of the iPSC-CMs, overall size and contraction capability, alongside readouts 
for calcium (Ca2+) signalling, responses to electrical field stimulation (EFS) were planned. Immature, 
foetal-equivalent iPSCs lacked a sarcoplasmic reticulum Ca2+ store which developed over time in 
culture (Hwang et al., 2015). The extent of the SR Ca2+ store was supposed to be used as a marker 
for maturity.  
Although lysosomes were not specifically identified as a marker of iPSC-CM maturity in literature, 
they are an organelle of interest in CLN3 disease and experimental work. Therefore, the 
confirmation of lysosome presence and measurement of number, size or localisation with time 
would be provide useful results. Likewise, a pathological change in autophagy has been linked to 
CLN3 disease and therefore, although autophagosomes are not specifically a marker of age, as with 
lysosomes they are of interest to measure over time (Chandrachud et al., 2015). 
This combination of experiments would provide a systematic and comprehensive understanding of 
the timeline of maturation for iPSC-derived cardiac myocytes, and thus help the cardiac field. But, 
more importantly for this work, it would provide knowledge on changes observed in cells with 
mutations in CLN3, that could help to explain the cardiac defects seen in individuals with CLN3 
disease.  
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Table 25. Planned experiments for CLN3 model and matched control iPSC-CMs. A combination of 
analysis from different imaging methods including fluorescence plate reader (CX5), fluorescence 
microscope (Fluo), electron microscope (EM) and brightfield microscope (BF). 
Experiment Reagent(s) Method 
Structure: proteins 
α-actinin α-actinin antibody 
CX5: imaging & quantification Troponin I cTNI (cardiac adult) cTNI antibody 
Troponin I ssTNI (slow/ fetal) ssTNI antibody 
Structure: organelles 
Number of nuclei /cell DAPI + WGA Fluo: Count DAPI per cell  
Mitochondria number 
MitoTracker 
Fluo: Measure % coverage of cell 
Mitochondria size Fluo: Measure average lengths 
Lysosome number LysoTracker or LAMP2 
antibody for electron 
microscopy (EM) 
Fluo: Count per cell 
Lysosome size EM: measure size (area) 
Lysosome localisation EM: distance from nucleus 
Function: live cell experiments 
Contraction 
Brightfield, no stain 
BF: Musclemotion plugin (ImageJ) 
Cell size BF: Measure average lengths 
Ca2+ EFS response Cal-520 Fluo: EFS pacing changes 
Ca2+ ER release Cal-520 Fluo: Caffeine induced release 
Autophagy (basal) 
CytoID 
Fluo: (1) complete medium + count 
Autophagy (starvation) Fluo: (2) starvation medium + count 
ROS/superoxide Cell ROX/ MitoSOX Fluo: count 
 
Following the maturity study (Table 25) it may have been possible to identify any emerging CLN3 
disease phenotypes. Therefore, these would inform the most pertinent areas of study for a more 
thorough set of experiments to fully investigate the phenotype. If no phenotype was found during 
the experiments detailed above, this would indicate that either: culture conditions should be 
extended or improved to establish a greater maturity to capture a phenotype emerging with time, 
that the cells might need challenging to reveal any changes, or the cardiac symptoms of CLN3 
disease may be a result of extracellular changes, such as within the conduction system. If the latter 
is true, this would be an important result in itself which may be verified with a combination of 
studies involving primary cardiac myocytes isolated from an animal model of CLN3 disease. 
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To improve maturity, there are a number of published strategies if the cells do not mature quickly 
enough in time. These include co-culture, 3D culture and electrical stimulation amongst other 
strategies to improve markers of cardiac myocyte maturity (Besser et al., 2018). Thus, there is 
considerable scope for improving upon any immaturity apparent in the iPSC-CM cultures, which 
may allow the identification of any CLN3 disease phenotype that was otherwise masked by the 
immaturity of the iPSC-CMs. By making a detailed characterisation to inform both the extent of 
comparability to adult cardiac myocytes and the identification of any CLN3 disease phenotype, the 
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9 General Discussion 
 
This thesis aimed to explore the effects of the CLN3 mutation on organelle activity and structure 
using cell models of CLN3 disease. The methodology for the assessment of these live cell models 
forms an important part of this thesis, and these robust and carefully designed assays can be 
applied to future studies. In particular, the novel lysosome tracking assay (Chapter 4) presented the 
opportunity for a detailed investigation of lysosome movement, with a high number of tracked 
lysosomes per sample. The assays described in this study were principally carried out using HeLa 
and fibroblast cells and primarily explored the activities of lysosomes and mitochondria in CLN3 
disease. The final chapters of the thesis detail the assessment of CLN3 mouse heart tissue and the 
attempt at establishing an iPSC derived cardiac myocyte model of CLN3 disease to further 
investigate the cardiac phenotype in CLN3 disease. The assays developed and described throughout 
the thesis would have been applied to the iPSC-CM model had this been feasible, but this is now 
future work. 
Chapter 3 detailed the use of lysosome probes and their appropriateness for experimental 
purposes. The fluorescent labelling of lysosomes using LysoTracker, CellLight and 
immunofluorescence of a LAMP2 antibody showed a high degree of co-localisation, which pointed 
to their comparative specificity for lysosomes. The comparison of these lysosome probes also 
revealed a large number of characteristics, which were of relevance for the selection of the most 
appropriate probe for imaging experiments. These characteristics included a tendency towards 
photobleaching, signal bleed-through and background noise. The use of background subtraction in 
ImageJ, with the rolling ball radius set to 5 pixels, was also introduced and this method was used 
with all subsequent experiments in which lysosomes were imaged.  
LysoTracker was used to label lysosomes in the experiments presented in Chapter 4, which 
introduced methods for automated image analysis that were explored and compared to manual 
methods. In particular, a novel method for the analysis of lysosome movement was presented. 
Lysosome movement was observed first in a qualitative manner before application of the 
quantification to establish the most informative readouts. Important considerations, such as the 
extent of cell ‘background’ movement and the effect of temperature on lysosome movement, were 
discussed as critical controls for the lysosome movement assay.  The type of lysosome movement 
(short or long trajectories) was examined and it was surprisingly found that even long trajectories 
did not have a smooth and continuous profile, with the distance varying on a frame-by-frame basis. 
The measurement of lysosome movement pathways was calculated based on the sum of the total 
path (the addition of all frame-to-frame distances), which allowed for velocity of movement to be 
determined. This ‘sum of distance’ (and velocity) readout did not provide information on whether 
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the lysosome had travelled within the cell or continuously moved at the same fixed point. 
Therefore, the ‘maximum distance’ was calculated to determine the distance which the lysosome 
had travelled in the cell body during imaging. The maximum distance differentiated clearly between 
lysosomes with long trajectories that had travelled in a relatively linear, directional manner and 
those with short trajectories that had moved around an apparently fixed point within the cell (or 
had undergone major directions changes). It was therefore the maximum distance that showed the 
clearest change in response to microtubule depolymerisation, suggesting that the inhibition of 
microtubule-dependent travel of lysosomes could be induced as a phenotype in live cell models. 
The correlation between maximum distance and sum of distance was not as close as might be 
expected, and the microtubule depolymerisation had relatively little influence on the sum of 
distance compared to the maximum. The lack of correction suggests that lysosome movement is 
not always dependent upon a directionality. Based on the work to characterise the lysosome probes 
in Chapter 3 and the attention to robust techniques of imaging and analysis in Chapter 4, the 
lysosome tracking assay was developed as a sensitive and reliable tool for the investigation of 
lysosome movement.  
The assays established in Chapter 4 were followed up in Chapter 5 and applied to the study of CLN3 
disease using the cell models available. In addition to the comparison of the WT and CLN3 cells, the 
sensitivity of the lysosome tracking assay was tested in cells with microtubules depolymerised 
through treatment with nocodazole, which induced a phenotype of reduced lysosome movement 
distance. The key finding of this chapter was that there was no significant change to lysosome 
movement between the WT and CLN3 KO HeLa cells, but when the WT fibroblasts were compared 
to the two patient cell lines (Δex7/8 and D416G) there was a significant reduction in lysosome 
movement in CLN3 patient cells. This highly significant effect on lysosome movement distance in 
fibroblasts was not replicated with a comparable change to velocity, although there was a trend 
towards slower lysosome movement in the D416G cells. The fact that the assay revealed a 
phenotype in the fibroblast cell models of CLN3 disease and not in the HeLa was of interest. The 
comparison of lysosome movement in untreated WT HeLa and fibroblast cells revealed that 
lysosomes travelled far greater distances overall in HeLa cells compared to fibroblast cells. This 
observation suggests an effect of cell type on lysosome movement. In the context of CLN3 disease, 
it is the more highly differentiated and sensitive cell types, such as neurons and cardiac myocytes 
that are more severely affected in the disease, and it would be of considerable interest for the assay 
to be applied to primary cells from patients or robust models. 
Following the investigation lysosome movement, the next organelles of interest were the 
mitochondria, and assays relating to the function of these were set out in Chapter 6. Overall, these 
experiments suggested no significant functional change to the mitochondria in the CLN3 KO HeLa 
cells compared to the WT. The mitochondrial membrane potential was comparable, with no 
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difference in response to the control treatment. ROS production also appeared to be comparable, 
with no difference between WT and CLN3 KO in ROS production during imaging, or in response to 
the response to oxidising agents that were used as control treatments. Finally, there was no 
significant difference in the calcium sequestration measurements in the WT and CLN3 KO HeLa 
cells, or the response of these cells to the agonist treatment. 
Chapters 7 and 8 presented the cardiac aspect of this project. Heart tissue from the mouse model 
of CLN3 disease was available from mice sacrificed at 6, 12 and 18 months, with tissue from the 
matched WT mice at each age. This presented an opportunity to investigate the ultrastructural 
changes within these tissues. Quantitating information within images is not always straightforward. 
To avoid an impressionistic interpretation of the EM images, a series of analysis protocols were 
developed that enabled the images to be systematically quantitated. Moreover, the samples were 
randomised at the imaging stage and the analysis was performed blinded. There appeared to be a 
tendency for variation in the appearance of the mitochondria with ageing, but few statistically 
significant findings. It is plausible that more data sets are required. 
Each of these experimental chapters could be expanded in future work, as described in the 
individual chapter discussions. In general, the expansion of this project would incorporate a greater 
number of cell models of CLN3 disease and apply the assays (e.g., lysosome tracking) to specialised 
cell types such as neurons and cardiac myocytes that are known to be highly affected. There is great 
scope for the expansion of the cardiac aspect to this project. A detailed exploration of the cardiac 
CLN3 phenotype would be possible via the use of animal models, and through the differentiation 
of iPSCs carrying the CLN3 mutation to cardiac myocytes.  However, these future studies should 
proceed with caution as animal models, such as the CLN3 mice, may not faithfully capture the 
cardiac phenotype seen in human patients, and the use of iPSC derived cardiac myocytes come with 
many challenges such as establishing an adequate maturity of these cultures to examine the 
phenotype. 
CLN3 disease involves a terrible, progressive degradation that is devastating for affected individuals 
and their families. It is of huge importance to understand the cellular consequences of the disease-
causing CLN3 mutations. It is frustrating that the clearly vital function of this lysosomal protein is 
still so elusive. The development and characterisation of CLN3 models, such as those used in this 
study, will hopefully shed increasing light on the processes affected by CLN3 mutations, as well as 
those that are not affected. It is hoped that this growing body of knowledge will one day lead to a 
better prognosis, or even curative options, for the children that receive a diagnosis of CLN3. It is in 
that spirit that the work described in this study was undertaken and is offered to all who might 
benefit from it. 
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